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Changes to feed availability resulting from global climate change have the potential to 
exacerbate fertility issues already facing the NZ livestock industry. Appropriate feeding levels 
during gestation is gaining more attention as a number of studies have illustrated that 
underfeeding during gestation can have negative impacts on the fertility of female offspring. 
However, the mechanisms underlying this relationship remain obscure. Therefore, the aims of 
this study were to firstly establish a model in sheep whereby restricted gestational nutrition 
influenced fertility of the female offspring. A second aim was to identify potential mechanisms 
underlying the relationship between restricted gestational nutrition and postnatal fertility. 
Ewes were provided with either a maintenance diet, or a 0.6 of maintenance diet for the first 55 
days of gestation. Thereafter, all ewes were fed ad-lib for the remainder of gestation. Fetuses 
were collected at days 55 and 75 of gestation to examine fetal ovarian development using 
stereology, and RNAseq was used to examine gene expression. Steroid profiles were generated 
from both maternal and fetal (day 75 only) plasma samples. Female offspring were monitored 
from birth until 19 months of age. From these offspring, the time of onset of puberty was 
recorded, indicators of fertility (ovulation rate and antral follicle counts) were assessed at 8 and 
19 months of age, and key hormone profiles were generated at 19 months of age. 
Surprisingly, female offspring at 19 months of age, but not 8 months of age, showed increases 
in key indicators of fertility: ovulation rate (p < 0.05) and antral follicle count (AFC, p < 0.01). 
Additionally, these animals showed an increase in plasma progesterone concentrations (p < 
0.05) indicative of increased embryo survival. Changes to the pattern of FSH secretion (p < 
0.05) were also observed. 
Fetal ovaries exposed to restricted nutrition contained more germ cells at day 75 but not at day 
55 of gestation (p < 0.01). RNAseq identified 69 sequences differentially expressed in fetal 
ovaries at day 55, and 145 sequences at day 75. Fold changes observed at day 75 were less than 
those observed at day 55. Amongst differentially expressed genes, germ cell specific genes 
were prominent at both ages. Prominent Gene Ontology categories at both ages were ion 
transport and protease inhibitors. Pathways identified as affected using IPA analysis included 
some related to the metabolism of arginine to nitric oxide and citrulline, LXR/RXR and 




Taken together, the data supports increased indicators of fertility in female offspring whose 
dams were exposed to restricted nutrition during gestation. The observed differences appear to 
originate within the ovary. The results are consistent with the concept that it is not the restricted 
nutrition alone, but the change in nutrition from restricted to ad-lib which may be generating 
the observed changes in the offspring. Further, the data offers insights into potential 
mechanisms underlying the phenotype observed with both nitric oxide and protease inhibitors 
being possible candidates for involvement. 
The results open new avenues of research to either address current fertility issues in livestock, 
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Chapter 1 . Introduction 
The Barker hypothesis was first proposed in 1990 (1), and describes a relationship between 
intra-uterine growth retardation and the prevalence of disease in the offspring. Since this time, 
interest in the developmental origins of health and disease has grown. Links between maternal 
environment and postnatal hypertension (2), heart disease (3, 4), obesity (5), diabetes (6), lung 
disease (7), and fertility (8), have been described. The relationship between maternal 
environment and postnatal fertility first gained attention through studies of women born during 
the Dutch famine in the later stages of World War II (9). In addition to possible implications 
for human health, the effects of environment (such as maternal nutrition) on lifetime fertility 
has implications for the livestock industry. The NZ livestock industry faces significant fertility 
challenges, particularly for beef and dairy farming. Changes to feed availability resulting from 
global climate change has the potential to contribute further to fertility issues already facing the 
livestock industry. The issue of feed availability during pregnancy has become increasingly 
important as a number of studies have shown that restricted maternal nutrition can affect fetal 
ovarian development, and subsequently, negatively affect the fertility of female offspring (10, 
11). While the relationship between maternal under-nutrition and decreased fertility in female 
offspring is gaining increasing attention, the underlying mechanisms behind this effect are yet 
to be clearly established. The development of practicable strategies to overcome this effect 
would benefit from a greater understanding as to how maternal under-nutrition can impact 
fertility in the offspring. 
The overall aim of this study was to use sheep as a model to examine the underlying 
mechanisms by which maternal under-nutrition may affect fetal ovarian development and 
subsequently fertility in female offspring. As this study involves aspects of fetal development, 
as well as adult fertility, this introduction will firstly outline fetal, and fetal ovarian 
development, with a particular emphasis on the sheep. Secondly, adult fertility in the sheep will 
be outlined, with particular emphasis on ovarian follicle development and function. Finally, 





1.1 Fetal ovarian development 
Gestation in the sheep spans 147 days and can be divided into three equal trimesters (12). 
During the first trimester, both embryonic/fetal growth and metabolic activity are high, 
however, as the embryo is small, maternal energy requirements are relatively low (13). During 
the second trimester, fetal development is relatively low, while growth and differentiation of 
the placenta remains high. Finally, during the last trimester, fetal growth is rapid and maternal 
nutritional demand is high. The implication is that as maternal energy requirements increase 
throughout gestation, nutrition restriction later in gestation is more likely to produce effects on 
the offspring, at least with regard to overall fetal growth. 
Critical to the development and growth of the fetus is the placenta. This organ is responsible 
for the exchange of nutrients and waste products between the maternal and fetal circulatory 
systems (14). In the sheep, placental development begins during the final stages of implantation, 
between days 16 and 22 of gestation (15). Following implantation, the placenta undergoes 
exponential growth until around day 75 of gestation, but slows there-after (16). Most studies 
suggest that during the first trimester the placenta is able to adapt to restricted nutrition so that, 
providing normal nutrition is restored, fetal nutrition and growth is maintained during late 
gestation (17, 18). Conversely, nutrition restriction in mid to late gestation alters placental 
development and leads to intra-uterine growth restriction (16, 19). Interestingly, in adolescent 
sheep, over-feeding also reduces placental development around mid-gestation, leading to intra 
uterine growth restriction in late gestation (20). Overfeeding resulted in changes to nutrient 
partitioning, promoting rapid growth of the  adolescent animal (particularly the deposition of 
fat) at the expense the placenta (21). The consensus view of the literature is consistent with the 
view that under-nutrition during the mid to late stages of gestation is more likely to affect 
overall fetal growth (and subsequently birth weight) than under-nutrition during the early stages 
of gestation (12, 22).  
Fetal organ development occurs simultaneously with the period of exponential placental growth 
(days 22 to 75). As the developmental pattern of each organ differs, susceptibility to maternal 
under-nutrition may vary between organs (23). Pillai and colleagues demonstrated in sheep that 
altered maternal nutrition, even for a short period early in gestation, can affect organ 
development (24). In the Pillai study,  underfeeding between days 30 to 45 of gestation resulted 
in increased liver size at day 45, while overfeeding between days 30 to 45 resulted in increased 
kidney size at day 45 (24). Thus, while altered maternal nutrition during early gestation seems 
less likely to affect overall fetal growth, effects on individual organs have been demonstrated. 
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The developing ovary (or gonadal ridge) is first observed around day 22 in the sheep as a 
thickening of the coelomic epithelium on the medial aspect of the mesonephros (25). Primordial 
germ cells migrate to, and populate the gonadal ridges. This migration is partially regulated by 
the cytokine, stem cell factor (26), as well as extracellular matrix proteins, particularly 
fibronectin (27). At these early stages, the developing ovary consists of primordial germ cells, 
invading mesonephric stromal cells, and gonadal ridge epithelial like cells (GREL) derived 
from the surface epithelium of the mesonephros (28). Invasion or migration of mesonephric 
cells into the developing ovary continues until around day 90 in the sheep. These mesonephric  
cells are initially a loose arrangement of mesenchymal cells (29) and/or cells of the giant 
nephron (30), but subsequently these become a discrete continuum of cells which are thought 
to develop in to the ovarian rete (31).   
Morphological sexual differentiation occurs around day 32 in the sheep.  A number of factors 
are essential for the differentiation of the ovary including β catenin, follistatin, FOXL2, R-
respondin, and Wnt4 (32). In contrast to the testis, the ovary develops into two zones. The 
medulla in the central area, and an outer cortical region. From the time of sexual differentiation 
until at least day 45, the ovary is capable of producing increasing amounts of oestradiol (33). 
Within the ovary, germ cells located in the cortex form close associations (desmosomes) with 
GREL cells. GREL cells have a distinctive gene expression profile (28) and ultrastructure (34), 
and are thought to be the precursors of granulosa cells. Following sexual differentiation, in 
addition to germ cells and GREL cells, the ovary also consists of mesenchymal cells, 
endothelial cells of the developing vasculature, and cells at the ovarian surface (referred to as 
superficial GREL cells) (28). From its first appearance until approximately day 90 of gestation, 
the ovary lacks a true surface epithelium as a continuous underlying basement membrane is 
absent (28, 34). Throughout this period (day 22 to day 90), germ cells continue to proliferate. 
The process of ovigerous cord development defines the ovarian cortex (which contains the germ 
cells and ovigerous cords) from the medulla, and occurs between days 38 and 90 in the sheep. 
Ovigerous cord development and subsequent dissolution is outlined in Figure 1.1. This process 
is first characterised by the development of cytoplasmic extensions from the GREL cells that 
isolate individual germ cells, and the increasing appearance of basal lamina material adjacent 
to the germ cells.  By day 55, germ cells and pre-granulosa cells are confined within a distinct 
membrane enclosed tube or cord. The cords extend from the innermost cortical regions radially 
out towards the ovarian surface where they are open ended. Penetration of stromal cells into the 
ovarian cortex further defines the appearance of the ovigerous cords. 
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Historically the formation of cords in developing rodent ovaries has not been well described, 
prompting debate in relation to potential developmental differences between rodent and sheep. 
In the mouse, cord formation is sometimes overlooked or confused with the formation of 
clusters (nests) of germ cells. The development of these nests has been well illustrated in a 
number of publications (32, 35). The developmental pattern in mouse is clearly outlined by 
Sarraj and Drummond (36) and is strikingly similar to sheep, with clusters of mitotic germ cells 
forming between days 10.5 to 13.5 post conception, followed by formation of ovigerous cords 
containing meiotic germ cells from day 14.5 post conception. Cords and nests both appear to 
isolate oocytes and pre-granulosa cells from the surrounding stroma. The absence of germ cell 
nest formation (as described in the mouse) from sheep development may represent a subtly 
different pattern of development between rodents and ruminants. It is thought this difference 
reflects differences in the time period between sexual differentiation and the onset of meiosis 
(37).  
During the development of ovigerous cords, germ cell numbers in the fetal sheep ovary increase 
substantially from 50,000 at day 40, to reach peak numbers of approximately 1 million at day 
75 (38). Further, it is estimated that over the same period, pre-granulosa cell numbers increase 
from 200,000 to 4.2 million (39).  Each germ cell is in direct contact with pre-granulosa cells, 
yet BrdU labelling suggests that while germ cell proliferation is high, proliferation of pre-
granulosa cells within the cords is very low (34). Given that the germ cells are isolated from 
the surrounding stroma by a basement membrane, it has been postulated that further recruitment 
of pre-granulosa cells occurs from GREL derived cells near the ovarian surface where the cords 
are open. Arguably this then represents two waves of pre-granulosa cell recruitment in the fetal 
sheep ovary, one before cord formation, and one after. Such a scenario is strikingly similar to 
the two waves of recruitment proposed in the mouse by Mork  and colleagues (40).  
From approximately day 55, the key germ cell developmental processes of meiosis and 
apoptosis are evident (41), with formation of follicles appearing from day 75 (38). Within the 
cords, a gradient of germ cell development is observed, with the more developed cells located 
in the innermost regions of the cortex, and the lesser developed germ cells located towards the 
periphery. This pattern is observed both morphologically for meiosis and follicle formation, 










Figure 1.1 Schematic illustration of ovigerous cord development.  At day 38, proliferating 
germ cells are in direct contact with pre-granulosa cells. By day 45, extensive deposits of basal 
lamina are observed around oogonia. By day 55, ovigerous cords are well established but 
remain open to the ovarian surface. Within the cords, mitosis, meiosis and apoptosis of germ 
cells is evident and these continue to be observed at day 75. At day 75, the first follicles are 
forming at the base of the cords. By day 90, most germ cells are arrested in prophase I of meiosis 
and cords become separated from the ovarian surface epithelium, which now rests on a discrete 
basement membrane. By day 100, most germ cells are present in isolated follicles and the first 






Meiosis largely occurs between days 55 and 90 of gestation. The initiation of meiosis is widely 
thought to be regulated by retinoic acid (42). Retinoic acid acts by diffusing through tissues and 
binding to nuclear receptors (RARs) that heterodimerise with nuclear retinoid X receptors 
(RXRs). The dimers bind to retinoic acid response elements (RARES) in the promoter region 
of target genes and thereby control the regulation of retinoic responsive genes (43). In the fetal 
mouse ovary, retinoic acid is thought to be sourced from the mesonephros (44). In humans, 
retinoic acid produced by the fetal ovary is thought to initiate meiosis (45). The source of 
retinoic acid in the fetal sheep ovary has not been studied. However, the migration of a discrete 
continuum of cells from the mesonephros to the ovary, coinciding with the initiation of meiosis 
(34), would suggest that this continuum of cells may be a source of ovarian retinoic acid.  
Meiosis is a tightly regulated process, with retinoic acid produced by the ALDH1A genes, and 
metabolised by CYP26B1 (46). Expression levels of these genes play a pivotal role in the 
regulation of meiosis. A number of other genes are critical for successful meiosis, these include 
DMC1, POU5F1, STRA8, and SYCP3 (47).  
Increased evidence of germ cell death is observed coinciding with the onset of meiosis. Death 
of germ cells in fetal sheep ovaries becomes especially prevalent between days 75 and 90 of 
gestation. During this interval, germ cell numbers fall from approximately 1 million to 120,000 
(38). This precipitous decline in germ cell numbers is a common feature during development 
in most mammals. As germ cells undergo cell death, it is evident that their associated pre-
granulosa cells are not destined to the same fate, but are “reassigned” to adjacent germ cells 
(34, 48). In mice, germ cell loss occurs in two waves, one wave during meiosis, and one wave 
during follicle formation (36). 
 Despite recent evidence implicating a role for autophagy in the death of germ cells (49), the 
consensus is that most germ cells die via an apoptotic pathway (50). Apoptosis is largely 
regulated by members of the BCL-2 family, consisting of the anti-apoptotic factors BCL-X, 
BCL-2 and MCL-1, as well as the pro-apoptotic factors BID, BAX, BOK and BAD. The 
relative expression of these factors contribute to the level of apoptosis (51). Also critical in 
apoptosis are caspases and their target poly(ADPribose) polymerase (PARP), with both of these 
factors used as markers of early apoptosis (49). Caspases are cysteine proteases that execute 
cell death, either as initiators of apoptosis, effectors of apoptosis, or acting through cytokine 
activation. Initiator caspases are activators of the effector caspases which, upon activation, 
execute the apoptotic process. Using immunoblotting, Fulton and colleagues demonstrated the 
presence of the initiator caspases 8 and 9, effector caspases 2, 3 and 7, and PARP in human 
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fetal ovaries at the time of peak germ cell apoptosis (48). The same study also showed activated 
caspase 3 localised to germ cells undergoing apoptosis (48), thus highlighting the importance 
of these factors in gem cell apoptosis.  
From approximately day 75 of gestation in the sheep, ovarian follicles can be observed at the 
base of the ovigerous cords (52). There are two proposed mechanisms by which isolated 
follicles arise. Hummitzsch and colleagues (28) proposes an active role of the ovarian stroma 
in penetrating ovigerous cords, dividing the cords into smaller nests and subsequently isolating 
individual follicles. Juengel and Smith(25), and Sawyer and colleagues (34) propose increasing 
secretion of basal lamina material by the germ cell - pre-granulosa cell complexes, causing 
dissolution of the cords leading to isolated follicles. It is plausible that both mechanisms play a 
role in the formation of isolated follicles. 
By approximately day 90 of gestation, the first growing follicles are observed, and by day 120 
antral follicles are present. The mechanisms by which resting follicles are recruited into the 
growing pool of follicles are not clearly understood. Thecal cells can be morphologically 
identified surrounding follicles early in their growth. The origin of theca cells has been debated 
for some time. As early as 1991, Hirshfield proposed that thecal cells were associated with 
follicles at the time of initiation of growth (53). Young and McNeilly proposed follicle driven 
differentiation of stromal cells into thecal cells (54). Honda and colleagues proposed a 
population of thecal stem cells (55), while Hatzirodos and colleagues reported factors 
associated with stem cell niches in the theca externa (56). Juengel and colleagues proposed that 
mesonephric derived cell streams are likely sources of theca cells (29). In a recent study, Liu 
and colleagues proposed a dual source of thecal cells (57), WT-1 positive cells intrinsic to the 
ovary, and GLI-1 positive cells derived from the mesonephros. While still the subject of debate, 
the Liu hypothesis appears to include elements from most of the hypotheses listed above. Liu 
and colleagues propose populations of pre-determined cells, some of mesonephric origin, being 




Figure 1.2 summarises the timing and duration of the key developmental steps during fetal 
ovarian development in the sheep, and compares this to human development. In both sheep and 
human, all the key developmental processes occur before term (147 days for sheep and 280 
days for humans). The similarities in the pattern of development between species suggests that 
the sheep may be a good model for human ovarian development. The sheep is already a widely 
accepted model for studying Poly Cystic Ovarian Syndrome (PCOS) (58), a condition affecting 
10% of women worldwide (59). The model uses prenatal exposure to androgens to produce 
changes in fetal ovarian development, leading to female offspring displaying symptoms 
resembling PCOS in humans (60). 
While there is the potential for the hypothesised germ line stem cells to make an ongoing 
contribution to the ovarian reserve (61, 62), it is widely accepted that following follicle 
formation, germ cell and follicle numbers (the ovarian reserve) are already established for an 
individual (rodents being an exception, where ovarian development continues into the postnatal 
period). Therefore, in sheep, as with most mammals, the ovarian reserve is set before birth (39). 
The size of the ovarian reserve then has a significant impact on the individual’s fertility in 


















Figure 1.2 Chronology of events during ovarian development.  Comparison of the timing of 
the key developmental effects during fetal ovarian development in sheep (red bars and 
arrowheads) and humans (blue bars and arrowheads), with both species showing a similar 




1.2 Postnatal fertility in the female sheep 
Sheep are seasonal breeders. In the New Zealand environment females display oestrous activity 
usually between March and July, although wide variations are apparent depending on the breed 
of the animal and geographical location (latitude). Lambs are usually born between August and 
November, with most animals attaining puberty by April or May of the following year, at 8 to 
9 months of age (66). 
The initiation of puberty in sheep is a complex process and not fully understood. In sheep, 
typical of mammals, body weight and the level of fat deposition is critical in determining 
puberty onset. The consensus proposes that blood borne factor(s) reflecting the metabolic status 
of an animal affect the neuroendocrine system ultimately resulting in increased gonadotrophin 
secretion and triggering puberty. Various factors have been implicated in this process including 
glucose (67), amino acids (68), free fatty acids (69), insulin (70), insulin like growth factor 1 
(IGF-1) (71) and leptin (72).  
Leptin is primarily produced in adipose tissue but its production has been observed in other 
tissues including the pituitary (73) and the placenta (74). In the context of this thesis, the 
relationship between nutrition, leptin (commonly described as the satiety hormone), puberty, 
and fertility makes this hormone worth discussing. 
The effects of leptin on puberty in rodents have been well studied but results vary. Leptin 
administered to immature mice accelerated the onset of puberty (75, 76).  In rats administration 
of leptin did not advance puberty initiation but did negate the effects of food restriction on the 
timing of puberty (77), with the authors concluding that leptin was not the primary signal but 
one of a number of permissive factors for initiation of puberty (i.e. a threshold level is essential 
to allow the onset of puberty). 
In cattle, Zieba and colleagues (78) found that body weight was the largest contributing factor 
accounting for variations in age at puberty onset and this was highly correlated with serum 
leptin levels. However unlike the mouse, administration of leptin did not advance the onset of 






Mutations in the leptin receptor gene have been identified in sheep which are associated with 
differences in  the timing of puberty onset (81) as well as  decreases in fertility in these animals 
(82), suggesting a role for leptin not only in the onset of puberty but also in fertility. However 
by contrast, Recabarren and colleagues (83) showed that maintenance feeding of prepubertal 
female sheep for 10 weeks when compared to ad libitum feeding initially reduced leptin 
concentrations. At the completion of the 10 week experiment, leptin concentrations in the 
maintenance group were comparable to those in the ad libitum group. While the onset of puberty 
was not reported in this study, the authors concluded from their data that leptin concentrations 
may not be associated with the onset of puberty. 
While the studies reported above appear somewhat contradictory, it appears that, in sheep, 
leptin has a role to play, but is likely to be one of a number of signals regulating puberty. The 
control of diets (restricted, maintenance and ad libitum) in these studies, as well as the metabolic 
state of the animals during the trials, may also account for some of the variation in the effects 
seen. Further, species differences may also account for some of the variation in the importance 
of leptin demonstrated in these studies, particularly given that some animals are seasonal 
breeders while others are capable of breeding all year round, some are polyovular while others 















The reproductive performance of sheep mated at 8 to 9 months of age (having just attained 
puberty) is lower than that observed in adults. The poor reproductive performance in these 
animals is due to lower ovulation rates, failure to mate, failure of fertilisation, and increased 
embryo loss (84). Why peri-pubertal animals have lower fertility is currently the subject of 
several studies. One potential clue comes from the study of Mork and colleagues, which 
describes two waves of pre-granulosa cell recruitment in mice (40). Follicle dynamics (growth 
rates) in prepubertal mice are different from adults (85), with this difference being linked to the 
recruitment of granulosa cells during fetal development. During the prepuberty period, growing 
follicles contain granulosa cells derived from the first wave of follicle recruitment, while 
postpubertal follicles contain granulosa cells derived from the second wave of recruitment. 
Prepubertal follicles grow substantially faster (86), display a different morphology (85), and 
show a different expression pattern of steroidogenic genes (87) when compared to postpubertal 
follicles. Should these findings in mice translate to sheep, the differences in granulosa cell 
origin and follicle dynamics between prepubertal and postpubertal animals may account for the 
differences in fertility observed between pubertal and mature sheep. The concept of multiple 
waves of granulosa cell recruitment also highlights the importance of cells, other than germ 
cells, during ovarian development to postnatal fertility. 
Reproduction in sheep, as with most mammals, is regulated by the hypothalamic-pituitary-
gonadal (HPG) axis (Figure 1.3). Gonadotrophin releasing hormone (GnRH) produced by the 
hypothalamus stimulates pituitary production of both luteinising hormone (LH) and follicle 
stimulating hormone (FSH) (88). All three hormones are secreted in a pulsatile manner.  FSH 
and LH act on the ovary to support follicle growth (FSH) and induce final follicle maturation 







Figure 1.3 Regulation of sheep reproduction.  Pulsatile GnRH produced by the hypothalamus 
stimulates pulsatile secretion of FSH and LH from the pituitary. FSH stimulates follicle growth, 
while LH stimulates final follicle maturation and ovulation. Ovarian steroids provide negative 
feedback on the pituitary, but high concentrations of oestradiol during the follicular phase 
provides positive feedback on the hypothalamus to stimulate the pre-ovulatory gonadotrophin 
surge. Throughout the cycle, ovarian produced inhibin provides negative feedback on the 
pituitary, while activin, produced in the pituitary and ovary, acts in a paracrine manner 
stimulating both pituitary and ovarian function. Increasing levels of oestradiol from the pre-
ovulatory follicle drive simultaneous peaks of FSH and LH which result in ovulation. Figure 
compiled from (90-93). 
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The emergence of each follicle wave is accompanied by a transient increase in FSH 
concentration (94). Administration of exogenous FSH results in the emergence of an additional 
follicle wave (95). These studies conclude that the emergence of each follicle wave is driven 
by FSH. While oestradiol and inhibin produced by the follicle are known to affect FSH 
secretion, their importance in regulating the rhythmical pattern of FSH secretion throughout the 
ooestrous cycle is unclear. Baby and Bartlewski highlighted the potential for progesterone to 
influence the pattern of FSH secretion and the number of follicle waves within a cycle (94), 
concluding however, that more work is required to clarify the factors involved in the 
establishment of follicle waves. However, Duggavathi et al (96) demonstrated a continued 
rhythmical pattern of FSH secretion in ovarectomised ewes, concluding, at least in part, an 
ovarian independent rhythmical pattern of FSH secretion. 
 
As described in Section 1.1, in sheep, as with most mammals, the ovarian reserve is set during 
fetal life. Several studies have established concepts that highlight the importance of the ovarian 
reserve and its relationship to fertility. Firstly, the establishment of the ovarian reserve is highly 
variable between individual animals, and appears to establish the relative fertility of the 
individual (63, 97). This variability is consistent with the concept that establishment of the 
ovarian reserve may be influenced by maternal environment. The impact of maternal 
environment on ovarian reserve has been demonstrated with maternal nutrition (65)  and 
maternal disease (98), both being shown to influence the size of the ovarian reserve. Secondly, 
ovaries with a high ovarian reserve have a high antral follicle count (64, 97) (the number of 
growing follicles present within the ovary, referred to as AFC). Thirdly, individuals with a low 
AFC show low fertility compared to individuals with a high AFC (63, 97)  . This evidence is 
consistent with a strong link between the ovarian reserve, AFC, and fertility. However, 
Monniaux and colleagues contend that fertility is compatible with a range of AFC values, and 
that the number of ovulations characteristic of each species does not depend on the reserve of 
growing follicles (64). Their conclusion however, does not preclude within-species variations 










Figure 1.4 Characteristics of the sheep oestrous cycle. Patterns of hormone secretion 
throughout the estrous cycle in relation to the pattern of emergence of three waves of follicles, 
indicated by the arrows. Follicles are indicated by black circles. Throughout each wave, the 
majority of follicles are lost to atresia. Data compiled from Baby and Bartlewski (94). 
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Follicles are continually recruited from the non-growing pool until the reserve becomes 
depleted to such an extent that reproduction declines substantially (as in sheep)  (99), or ceases 
(as in humans). Follicles develop through a number of well-defined developmental stages 
(Figure 1.5) as they progress to ovulation. However, most follicles do not reach the ovulatory 
stage but die through a process of atresia at various stages of development. Non-growing 
follicles (primordial follicles) are characterised by an oocyte surrounded by a single layer of 
flattened granulosa cells (type 1, Figure 1.5). The first sign of follicle growth is the 
transformation of some cells from flattened to cuboidal in shape (transitional or type 1a, Figure 
1.5). While this classification system is widely accepted and applied to most mammalian 
species, it is known that at least in sheep, some follicles are formed with a mixture of flattened 
and cuboidal granulosa cells (25). Whether these follicles are actually growing is not known. 
Thereafter, growth involves proliferation of granulosa cells, the establishment of multiple 
concentric rings of granulosa cells, and the development of a fluid filled antral space (type 5, 
Figure 1.5). During follicle development, the oocyte increases in size from 35 µm to around 
120 µm (100).  
Growth factors and hormones are produced by the follicles and act in both an endocrine and 
paracrine manner. Follicles between 0.1 and 3 mm in diameter are often classified as 
gonadotrophin responsive (type 3, 4 and 5. Figure 1.5), where exposure to gonadotrophins, 
particularly FSH, will elicit a cellular response (101). In the absence of gonadotrophins, follicle 
growth still continues up to approximately 3 mm (85, 102). At approximately 3 mm in diameter 
(late type 5), follicles are classified as gonadotrophin dependent. In the absence of 
gonadotrophins, follicle growth does not proceed beyond this stage (102). Factors produced by 
the ovary which include progesterone, oestradiol, and inhibin, in turn feed-back to act on the 
pituitary and hypothalamus to regulate secretion of both LH and FSH (91, 103). Additionally, 
pituitary produced activin acts in a paracrine manner to increase gonadotrophin secretion (92). 
The process of follicle development, along with the factors and their receptors, either produced 
by or present in the developing follicles, are outlined in Figure 1.5. This is not an exhaustive 










Figure 1.5 Morphological and functional development of ovarian follicles.  Beginning with 
type 1 non-growing follicles up to 60 µm, follicles progress through developmental stages. 
Initial growth is characterised by a change in shape of follicular granulosa cells, then 
proliferation of the granulosa cells which form concentric rings. From type 5, a fluid filled 
antrum develops. Most growing follicles die through atresia at various developmental stages. 
Throughout the process, genes (in italics) controlling growth factors (right hand side) and 
receptors (left hand side) are activated, and the presence of growth factor and receptor proteins 
(regular font) can be detected. (p) following italicised items indicates both gene and protein 
have been detected. The figure has been compiled across a number of mammalian species from 
the following references (104-117). 
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Discussion of all the hormones and factors regulating reproduction and ovarian development is 
beyond the scope of this literature review. However, some of the factors potentially relevant to 
this study known to be involved in ovarian/follicle development (inhibins, activins, AMH, 
steroids) along with leptin which is involved in both nutrition and reproduction, will be 
discussed. 
Inhibins and Activins. Inhibins and activins are members of the TGFβ superfamily. Both 
inhibins and activins are dimers comprised of two similar subunits (118). The structure of 
activins and inhibins is shown in Figure 1.6. Genes encoding inhibin and activin subunits are 
expressed during follicle development (108, 109). During fetal development, expression of both 
inhibin α and inhibin βA subunit are detected in the sheep fetal ovary only late in gestation once 
growing follicles are present (119, 120). Expression of type 1 and type 2 receptors has also been 
observed in developing follicles (121). Activins interact with two classes of receptors (type 
1/ALK receptors, and type 2 receptors) (103). Inhibin signalling is somewhat more complex, 
but involves binding to ACTR2. While the structure of activins and inhibins is similar, their 
functions differ markedly. Inhibins suppress synthesis and secretion of FSH, whereas activins 
enhance FSH synthesis and secretion.  
 
 
Figure 1.6 Structure of activins and inhibins.  Activins and inhibins are proteins. Each is a 
dimer comprising of two related inhibin subunits represented by the black lines (either inhibin 
α, inhibin βA, inhibin βB or inhibin βC) linked by disulphide bonds. Each subunit is derived 
from a specific gene. The subunit composition determines the identity and function of the 
protein.  Figure compiled from (92). 
Both inhibins and activins are produced by follicular granulosa cells and have been associated 
with a number of functions within the ovary including cell proliferation, gonadotrophin receptor 
regulation, and steroid synthesis (122). While fetal ovarian production of inhibins and activins 
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is not apparent in the sheep fetal ovary until late in gestation, inhibins and activins have been 
found in gonadal extracts and amniotic fluid from sheep fetuses of both sexes (123). Whether 
these levels are due to ovarian production is unclear, as the placenta also produces increasing 
amounts of activins and inhibins from as early as the first trimester (124). However, in the 
primate, Billiar and colleagues proposed an important role for activins and inhibins in 
development (125). They showed an association between decreased numbers of follicles and 
increased expression of the α inhibin subunit and suggested the ratio of inhibins:activins was 
critical for development. In the human fetal ovary, activin A has been implicated in regulating 
germ cell proliferation (121).  
Anti Mullerian hormone (AMH). AMH is also a member of the TGFβ superfamily and was 
originally described as the molecule responsible for the regression of the mullerian ducts in the 
male fetus (126). AMH acts through two receptors, AMHR2 and a type 1 receptor which has 
yet to be identified with any certainty. While there is some doubt about the type 1 receptor, 
Belville and colleagues have implicated ALK3 as a likely candidate (127). In the adult female, 
AMH is expressed in the granulosa cells of follicles from the type 2 to 3 follicle stage of 
development (128). Expression is greatest in follicles at antrum formation and declines 
thereafter, with this decline being correlated with increased CYP19A1 expression (129). The 
expression pattern of AMHR2 is similar to that for AMH (115). In the rodent, AMH is thought 
to be an important regulator of the initiation of primordial follicle growth and later follicle 
development (130). However, this does not appear to be the case in sheep. In sheep, AMH 
appears to regulate the number of follicles transitioning from the gonadotrophin responsive 
phase to the gonadotrophin dependent phase (129). Of greatest relevance to this study is the use 
of AMH as an indicator of fertility. High plasma concentrations of AMH have been associated 
with high AFC, high ovarian reserve and high fertility in a number of species including human, 
rodents, cow, and sheep (63, 131, 132). This relationship is now widely accepted, and AMH 
concentrations are the basis of a number of diagnostics tests to assess fertility in humans (133, 
134). 
Steroids. Ovarian steroid hormones can be assigned to three types: oestrogens (e.g. oestradiol, 
estrone), androgens (e.g. androstenedione, testosterone) and progestogens (e.g. progesterone). 
Each of these classes of steroids play a critical role in ovarian function, follicle development, 
and development of the fetal ovary. In the mature ovary, androstenedione produced by follicular 
thecal cells, serves as a substrate for oestrogen synthesis by granulosa cells from the same 
follicle (135, 136). Oestrogen is critical for development of the follicle to the ovulatory stage, 
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and regulation of the gonadotrophin hormones FSH and LH (137, 138). Additionally, both 
androgens and oestrogens play a role in apoptosis of follicular granulosa cells, with androgens 
enhancing apoptosis, and oestrogens inhibiting apoptosis (136, 139). Oestrogen has also been 
demonstrated to play a role in establishing the size of the ovarian reserve in mice (140). 
Progesterone is produced by the corpus luteum following ovulation, and its key roles are the 
establishment and maintenance of pregnancy (15). A number of studies have demonstrated a 
relationship between increased progesterone concentrations and increased embryo survival 
(141-143).  
In the fetus, while the placenta is a major site of steroid production, the fetal ovary can produce 
steroids during early gestation (33, 144). Oestrogens, androgens and progesterone have all been 
demonstrated to have significant impacts on fetal ovarian development, particularly in follicle 
formation and germ cell development (145, 146). 
Leptin. Leptin is primarily an adipocyte secreted hormone important in maintaining energy 
homeostasis. Leptin is highly responsive to nutrition and is critical in the control of body weight 
(147). The genes responsible for leptin production and its receptor are also expressed in a wide 
range of tissues including the ovary (148), pituitary (149), hypothalamus (150),  as well as the 
fetus and placenta (151). In the brain, leptin has been found to facilitate GnRH secretion from 
the hypothalamus (152) and is thought to stimulate both LH and FSH secretion from the 
pituitary (153). Further, these actions potentially occur via a nitrous oxide pathway. In the rat 
ovary, exogenous leptin has been shown to decrease ovulation rate (154). However, in the 
sheep, increased endogenous levels of leptin increases ovulation rate (155, 156). While not 
essential for pregnancy, leptin is thought to play an important role in nutrition during gestation 
(157), and appears important in the onset of puberty and potentially fertility as discussed earlier. 
1.3 Gestational nutrition and postnatal fertility 
Studies examining the effects of gestational nutrition on fertility vary markedly in both the 
methods used and the results. In addition to the species studied, variables to be considered 
include: the type of diet employed (metabolisable energy, calorie restriction, protein 
restriction), the amount of dietary restriction (or amount of overfeeding), control diet 
(maintenance or ad libitum), and the gestational period over which dietary changes are applied. 
In an approach aimed at overcoming these variations, Asmad (158) used meta-analysis on 
thirteen separate studies to examine the effect of maternal nutrition on reproductive 
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development. This analysis showed no effect of prenatal nutrition on postnatal reproductive 
performance based on ovarian weight, follicle counts and LH concentrations. Asmad (159) does 
point out that the analysis used a small number of studies, and that the variables analysed may 
not truly indicate reproductive performance. 
However, numerous studies have shown that alterations to gestational nutrition can affect fetal 
ovarian development and/or postnatal reproductive performance (Table 1.1). While not all 
studies affect the fertility of the offspring, it would appear that under the right experimental 
conditions, postnatal fertility can be impacted. 
There are two likely mechanisms by which gestational nutrition may affect postnatal fertility. 
The first mechanism is via an epigenetic mechanism (160). Epigenetics involves changing the 
structure of DNA (and consequently gene expression) without altering the DNA sequence. 
Epigenetics predominantly involves DNA methylation, histone modification, or binding of 
small RNAs to DNA (161). A well-studied example linking epigenetic changes to ovarian 
development and function is the prenatal exposure to environmental oestrogens, recently 
reviewed by Cruz and colleagues (162). In rats, exposure to methoxychlor (MXC, an endocrine 
disrupting chemical used in pesticides) between day 19 of gestation and day 7 postnatal, 
resulted in increased expression levels of DNA methyltransferases. One result of this increased 
expression was hyper methylation of the promoter region of the oestrogen receptor gene ERβ, 
leading to ovarian dysfunction in the adult rats (163). Lea and colleagues demonstrated in sheep 
that maternal exposure to endocrine disrupting chemicals (EDCs) contained in sewage sludge 
altered the fetal transcriptome. Amongst the genes differentially regulated following exposure 
to EDCs were genes coding for histone and DNA methylation, consistent with EDCs triggering 
altered states mediated by epigenetic mechanisms (164). In sheep, prenatal exposure to 
bisphenol A (BPA, used in the manufacture of plastics) is known to cause disruptions to the 
ovarian cycle (165). Veiga-Lopez and colleagues showed in sheep that prenatal exposure to 
BPA altered the transcriptome of the fetal ovary (166). Expression of miRNAs targeting the 
SOX family of genes, kit ligand, and insulin related genes (all important in ovarian 
development) were affected by BPA exposure. While not definitive in its conclusions, the 
Veiga-Lopez study does nonetheless highlight the potential for altered expression of miRNAs 
to affect postnatal ovarian function.
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Table 1.1 Gestational nutrition and postnatal fertility, synopsis of relevant publications 
 




Long (167) ovine 110% vs. 50% 28-78  ↓progesterone ↓ 
Martin (168) bovine Protein supplementation Late gestation  
↑pregnancy rates 
Higher % calved ↑ 
Asmad (159) ovine Ad lib vs. 
maintenance 
21-140 
↑ type 1 & 2 follicle 
numbers at d100 and 
140 
  
Bernal (169) rat Ad lib vs. 50% Whole gestation  ↓Pi, 2
o, antral follicle 
↑oxidative stress  
Kotsampasi 
(170) 
ovine 100% vs. 50% 0-30  
↑FSH response to GnRH 
Smaller CLs 
Difference in follicle size 
distribution 
 
Lea (171) ovine 100% vs. 50% 
0-30 
0-110 & 66-110 
 
↓Ki-67at d65 
↑BAX at d110 
↑BAX and MCL-1 
  
Borwick (172) ovine 150% vs. 50% 0-47 0-62 
↑germ cells at d47 
↑germ cells at d62 




Reference Species Diet Duration of altered 
nutrition (days) 




Meikle (173) mouse 
Ad lib vs. food 
deprived for 4 out of 
10 days 
Variable  ↓number of pups born from 2nd mating ↓ 
Costa (174) bovine 180% vs 60% 0-60 
↓ovarian wt at d60 
Altered ovarian 
transcriptome at d60 
  
Da Silva (175) ovine High vs moderate 0-103 
↑Pi follicles at d103 
↑ plasma progesterone   
Grazul-Bilska 
(176) 
ovine 100% vs 60% 50-135 
↓ovary weight 
↓proliferation in Po 
follicles at d135 
  
Rae (177) ovine 100% vs 50% 0-95  ↓OR at 20 months ↓ 
Rae (178) ovine 100% vs 50% 0-55 0-65 
↓ ovarian weight at d55 




Evans (179) bovine 100% vs 60% First trimester  ↓AFC  
 
Diet column % relates to a maintenance diet, e.g. 150% is a diet equivalent to 150% of maintenance. ↓ indicates reduction in the lower diet 
group, ↑ indicates increase in the lower diet group. Pi = primordial follicles. Po = primary follicles. 2° = secondary follicles.
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In most mammalian species, paternal genome demethylation occurs immediately after 
fertilisation, followed by remethylation around the blastocyst stage of development. However, 
the sheep appears to be an exception to this pattern (180). In sheep, demethylation of primordial 
germ cells occurs during their migration to the developing gonad (181). The timing of 
remethylation of germ cells is sex dependent. In the female germ cell, remethylation is a gradual 
process and occurs once the germ cells are arrested in meiosis I (181). In the developing sheep 
ovary, this would begin from approximately day 55 of gestation. Alterations to gestational 
nutrition can potentially enhance variations in this epigenetic reprogramming process, leading 
to permanent changes in phenotype which can persist into the F1 (somatic cells and germ cells 
affected) and F2 (germ cells only affected) generations (182, 183).  
Alternatively, nutrition induced changes may be developmental only. Differences in nutrient 
availability may lead to temporal up or down regulation of gene expression. These changes may 
lead to structural alterations in fetal ovarian development while not necessarily affecting DNA. 
Consequently, non-heritable phenotypic differences in the offspring (F1 generation) may be 
apparent. For example, temporal changes to genes regulating germ cell proliferation or germ 
cell death may affect the ultimate size of the ovarian reserve and consequently the fertility of 
the offspring. However, without changes to the DNA (e.g. through methylation, or altered 
miRNA binding), any changes to fertility would not be passed to the F2 generation of animals. 
1.4 Overview and aims 
Results of numerous studies examining the effects of gestational nutrition vary depending on 
species, methodologies used, and the type and timing of the altered nutrition used. Despite these 
investigations, the underlying mechanisms whereby gestational nutrition affects both fetal 
development and postnatal animals have not been identified. Additionally, there is a lack of 
studies utilising the same cohort of animals to examine both fetal development and postnatal 
effects. 
The sheep was selected as the model for the studies presented in this thesis for two reasons. 
Firstly, from an agricultural industry perspective, the sheep is an economically important 
animal. In 2015, Statistics New Zealand estimated the number of sheep in New Zealand at 
approximately thirty million, contributing over three billion dollars to the economy in 2014. 
The challenges facing the sheep industry (climate change and the use of increasingly marginal 
land) have implications for consistently providing adequate levels of nutrition, and therefore 
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maintaining the current levels of fertility. With reproductive patterns being similar between the 
major livestock species, the sheep is an ideal representative model for the livestock industry, as 
it is more cost effective and manageable from an experimental viewpoint. Fertility is a major 
challenge facing the livestock industry as genetic selection for economically valuable traits (e.g. 
milk production, carcass quality) have led to declining fertility, particularly in the beef and dairy 
industries.  
Secondly, fetal ovarian development in the sheep is remarkably similar to humans, as outlined 
in Figure 1.2. While sheep are seasonal breeders, they are none the less a low ovulation rate 
species similar to human. Therefore, results from a trial utilising sheep may have the potential 
to be extrapolated to human biology. 
From a livestock industry perspective, the long term goal of this project is to propose 
management strategies, and/or nutritional supplements during gestation to maximise the 
fertility of female offspring. However, before considering supplementation, a better 
understanding of the relationship between gestational nutrition and postnatal fertility is 
required. 
Two hypotheses guided the work presented in this thesis. 
 Firstly, that restricted maternal nutrition will lead to changes in fetal ovarian gene expression 
and fetal ovarian morphology that have the potential to alter ovarian development. 
Secondly, that restricted maternal nutrition will lead to reduced fertility in female offspring. 
From these hypotheses the specific aims of this study were to: 
• Establish a model in sheep whereby gestational under-nutrition during early gestation 
produced a measurable effect on postnatal fertility. 
• Characterise measurable changes in the maternal environment resulting from reduced 
nutrition. 
• Characterise the postnatal effects on the physiology and endocrinology of mature 
female offspring. 
• Characterise the effects of gestational nutrition on the development of the fetal ovary, 









Chapter 2 . Establishment and Validation of the Animal Model 
2.1 Introduction 
A primary goal of this study was to establish and describe a model in sheep where restricted 
gestational nutrition impacted postnatal female fertility. As highlighted in Section 1.3, many 
studies have reported that restricted gestational nutrition can negatively impact postnatal female 
fertility (168, 173, 177). While some studies report changes to fetal ovarian development (176, 
178, 184), the mechanism(s) underlying the relationship between gestational nutrition and 
postnatal fertility have yet to be clearly identified.  Therefore, in this work both plasma and 
tissue samples were collected for downstream applications to explore any effects observed, and 
to investigate potential mechanisms underlying these observations. These downstream 
applications are reported in Chapters 3, 4, 5 and 6. 
Major considerations for the model were the degree and timing of nutrition restriction. Both 
were based on previous studies and met the guidelines laid out by the institutional animal ethics 
committee. Trials involving indoor restricted nutrition on pregnant ewes had not previously 
been undertaken by research groups within AgResearch. Additionally, trials involving fetal 
collections from large animals are now subject to stringent examination by AgResearch ethics 
committees. For this trial the ethics committee requested that both the period and degree of 
nutrition restriction be set at the minimum likely to produce an effect. 
The timing of nutrition restriction was set for the first 55 days of gestation. This period was 
designed to encompass developmental processes that may be affected by nutrition. This 
included germ cell migration, gonadal sexual differentiation, germ cell proliferation, the early 
stages of meiosis, and germ cell apoptosis (38).  This timing means that the restricted nutrition 
period does not fully cover other important developmental processes within the fetal ovary 
including meiosis (predominantly day 55-75), the peak wave of germ cell atresia (day 75-90) 
and follicle formation (day 75-100). Alterations to these key processes are likely to have major 
impacts on ovarian development and potentially postnatal ovarian function. However, previous 
studies in sheep using nutrition restriction early in gestation (prior to day 55) demonstrated 
alterations to fetal ovarian development (171, 172). Further Rae and colleagues contend that 
the period of maximum sensitivity of the sheep fetus to undernutrition lies between the day of 
mating and day 65 of gestation (178). Impacts in adult offspring from dams exposed to restricted 
nutrition early in gestation have not been fully examined to date. 
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The degree of nutrition restriction was set at 0.6 of a maintenance diet based on metabolisable 
energy intake (with control animals set at maintenance). This was considered the minimum 
degree of restriction likely to produce effects on fetal development and postnatal fertility. While 
a level of 0.5 of maintenance is commonly used in sheep (171, 178), 0.6 has been used 
previously  (176), and is commonly used in cattle (179). 
The selection of a maintenance diet, as opposed to an ad libitum diet, for the control group was 
based on reported effects of obesity and high nutrition on maternal environment, fetal growth 
and development, and effects on the offspring. An ad libitum diet is likely to result in over 
nutrition, substantial maternal weight gain and increased fetal fat deposition. In sheep maternal 
over nutrition has been shown to retard both placental and late fetal growth, as well as increasing 
fetal loss in late gestation (21). Further, feeding at 125% and 150% of maintenance to produce 
overweight and obese animals respectively, results in larger fetuses at mid-gestation (185). 
Maternal obesity from feeding at 150% of requirements has also been shown to produce 
multigenerational effects on the offspring including the failure to display an early postnatal 
peak in leptin, increased adiposity, and increased plasma levels of glucose, insulin, and cortisol. 
(186). Therefore to avoid the potential effects of over nutrition, a maintenance diet was 
employed for control animals. 
The selection of days 55 and 75 to recover fetuses for subsequent studies was based on two 
factors. Firstly, in the context of this project, day 55 would allow determination of any effects 
of the complete period of restricted nutrition on both fetal development, and fetal ovarian 
development. Day 75 would give an indication as to the longevity of any changes noted at day 
55. Secondly, considerable data on sheep ovarian development has been published at both day 
55 and 75 (34, 38). In the context of germ cell development, proliferation is predominant at day 
55, but evidence of meiosis and atresia are also apparent. At day 75, germ cell proliferation is 
markedly reduced, but both meiosis and atresia are prominent. Additionally, the first signs of 
follicle formation are evident at day 75 (38). Examination of both ages, therefore, would allow 
investigation of the key processes in germ cell development. 
The relationship between gestational nutrition and fetal growth and morbidity has been well 
established and is well reviewed by Wu and colleagues (160). As discussed in Chapter 1, the 
literature indicates that nutrition restriction early in gestation is less likely to affect overall fetal 
growth (and morbidity). However, it is important to establish if the nutrition regime used in the 
current study affects fetal growth and morbidity. Thus, the number and weight of fetuses during, 
and at completion of the nutrition restriction, is an essential component of this section of work. 
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Prenatal nutrition has been shown to affect postnatal growth rates (187, 188). Importantly, 
postnatal growth rates can affect the onset of puberty and fertility (189). Thus, if differences in 
growth rates are apparent between the offspring from restricted and maintenance dams, this will 
have implications for fertility data and require appropriate statistical procedures to model this. 
Therefore, postnatal growth characteristics are a required element of this work 
In regard to female offspring, the onset of puberty was considered a useful variable to 
determine. A relationship has been established in humans between gestational nutrition and the 
time of puberty onset (190). However, a least one study in sheep reported no effect of 
gestational nutrition on the timing of puberty onset (191). The key indicators of fertility selected 
to measure were ovulation rate (OR) and AFC. Both variables are proven reliable markers of 
fertility (66, 97, 133). As fertility in pubertal animals differs from mature animals (84), these 
indicators were measured both in pubertal animals and mature animals. 
Animals with a low AFC have been shown to have a poor response to superovulation (63), 
similarly in sheep, low AMH levels have been associated with a poor response to 
superovulation (192). Given this, it was hypothesized that ewes from dams exposed to restricted 
gestational nutrition would display a poor response to a superovulation protocol. To test this 
hypothesis, a superovulation trial was implemented at the end of the offspring’s first breeding 
season.  
2.2 Materials and methods 
All animal trials were undertaken in accordance with the 1999 Animal Protection (Codes of 
Ethical Conduct) Regulations of New Zealand, and with the approval of the Invermay Animal 
Ethics Committee under the applications 12820, 13098, and 13294. To comply with the 
regulations and animal ethics approval, animal manipulations were undertaken only by 
approved users, following standard operating procedures. Internal Drug Administration Orders 
(IDAO) were prepared and veterinary approval obtained before drugs were administered to 
animals. To ensure regulatory compliance, regular inspections were undertaken by both 
representatives of the ethics committee and the Invermay Animal Welfare Officer. 
This work was carried out over a 27-month period on: pregnant ewes (referred to as maternal 
ewes, or dams), day 55 and 75 fetuses, and female offspring up to 19 months of age (referred 
to as peri-pubertal animals around 8 months of age, and adult ewes around 19 months of age). 
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Trials were undertaken at the Invermay Research Centre, Mosgiel, New Zealand (45.9oS, 
170.3oE).   
 
2.2.1 Pre-treatment, selection and mating of animals 
Five-year-old Romney x Texel ewes (n =150) were initially selected for this study. The absence 
of known genotypes affecting fertility was an important consideration in animal selection as 
this has the potential to influence subsequent results. Additionally, animals with a history of 
producing single and twin lambs, but not triplets, were selected. It was considered that the 
metabolic stress of supporting triplet fetuses during a nutrition restriction period, even during 
the first trimester, may have a negative effect on animal welfare. An overview of all trials is 
presented in Figure 2.1. 
Over a three-month period, the pasture management of these ewes was intensively monitored 
with the aim of standardising the ewe’s body condition scores (BCS) and body weights (target 
BCS 3.0 to 3.5, target weight 65 to 70 kg). At the onset of the breeding season (March, 2013), 
50 ewes whose weights were furthest, either side of the mean weight, were discarded from the 
study. 
The oestrous cycles of the remaining 100 ewes were synchronised. Synchronisation is achieved 
through the administration of exogenous progesterone. Exogenous progesterone was introduced 
using intrauterine progesterone releasing devices (0.3 g progesterone, Eazi-Breed CIDR Sheep 
and Goat Insert, Zoetis NZ, Auckland, NZ). Endogenous progesterone is produced by the 
corpora lutea (CL) following ovulation. Continued production of progesterone following 
successful mating (resulting in early embryo development) then maintains pregnancy. The 
resulting extended period of elevated progesterone mimics early pregnancy and prevents 












February-April: Pre-selection and treatment of dams 
March-April: Synchronisation 
April: Mating to intact rams 
April-June: Feed restriction 
June:  Collection of day 55 fetuses 





March-July: Monitoring offspring for onset of puberty 





February-June: Monitoring offspring for onset of estrus  
March-April: Synchronisation 
April: Daily blood sampling throughout oestrous cycle 
April: Intensive blood sampling (every 15 minutes for 8 hours) 
April-May: Laparoscopy and ultrasound scanning 
May: Euthanasia of remaining animals 
 
 




Figure 2.2 gives an overview of the synchronisation method used for the dams. In this instance, 
CIDRs were inserted for 10 days, after which they were replaced with new CIDRs for a further 
3 days. Mating to intact rams to produce pregnancy was undertaken during the second cycle 
following synchronisation. This protocol produces a comparatively loose synchronisation 
enabling subsequent fetal collections to be spread over a 2 to 3-day period. For female offspring 
at 19 months of age, a tight synchronisation was preferred to allow experiments to be performed 
at specific stages of the cycle. To achieve this, at CIDR withdrawal, prostaglandin was 
administered (0.7 mL subcutaneous of Estrumate, MSD Animal Health, Upper Hutt, NZ). 
Prostaglandin causes regression of any CLs present, consequently the removal of both 
exogenous (CIDRs) and endogenous (CLs) progesterone simultaneously results in a tight 
synchronisation. 
Following CIDR removal, vasectomised rams fitted with a mating harness and crayon were 
introduced to the flock, and mating marks were recorded each morning. Day 1 of an animal’s 
oestrous cycle was defined as the day on which a mating mark was first recorded, as mating 
marks result from mating activity in the previous 24 hours. A further 20 animals that either did 
not respond to, or had a delayed response to the synchronisation protocol, were removed from 
the trial. 
Four days following the introduction of vasectomised rams, the flock was introduced to the 
indoor diet. This was incrementally introduced to the 80 remaining ewes over an 8-day period. 
Access to pasture was decreased over 4 successive 2-day periods as the indoor diet was 
increased from 25% to 50% to 75%, and finally 100% of the dietary requirement. A single ewe 
failed to adjust to the indoor diet and, following veterinary advice, was removed from the trial. 
The remaining 79 ewes were ranked by their weights. Odd rankings were assigned to the 
restricted feed group (n = 40), and even rankings were assigned to the maintenance group (n = 
39). Animals were moved indoors and all were fed a maintenance diet for 5 days.  
At the completion of the acclimatisation period, ewes were exposed to intact Texel rams fitted 
with a harness and marking crayon. This exposure occurred during the day. At the end of each 
day, rams were removed and the mating marks recorded. All ewes were mated over a 4-day 
period. In this instance, as the mating marks were the result of mating over the previous 6 to 8 
hours, the day of mating was designated as day 0. From day 0, those animals assigned to the 
restricted feed group (n = 40) were placed on a diet equivalent to 0.6 of maintenance, the 
remaining animals (n = 39) continued their maintenance diets. Assigned diets were maintained 





Figure 2.2 Workflow for maternal ewes from synchronisation until day 55 of gestation. 
CIDR inserted for 10 days in 100 animals
New CIDR inserted for 3 days
CIDR removed. Vasectomised rams 
introduced and mating recorded for 4 days
Indoor diet incrementally introduced over 8 
days to 80 animals
79 animals moved indoors and fed 
maintenance diet for 5 days
Mated to intact rams over 5 days. Animals 
fed maintenance or restricted diet from day 
of mating for 55 days
Feeding restriction ends. Animals returned 




2.2.2 Body weights and body condition scores 
Throughout this trial, both live weight and BCS were recorded. Both measurements are good 
indicators of an animal’s health, and can effectively show changes in an animal’s condition in 
response to a number of factors, including nutrition. While live weight shows an animal’s 
overall response, BCS assesses the level of fat over the skeletal muscle, indicating the animal’s 
energy reserve.  
Weights were measured using scales mounted permanently in a pneumatic crush, and recorded 
on an electronic head set (Tru-test XR3000, Tru-test group, Auckland, NZ). The system has an 
accuracy of ± 1%. To exclude any potential negative effects of the weighing procedure on 
fetuses, pregnant ewes beyond 90 days of gestation were not weighed. 
BCS is assessed by light palpation of the ewe in the lumbar region, on and around the backbone, 
in the loin area immediately behind the last rib, and above the kidneys. Body condition scoring 
involves assessing the fat and muscle cover of an animal by the prominence (sharpness) of a 
number of skeletal features associated with the spine. Body condition scores range from 1 to 5. 
A score of 1 (where it is not possible to detect any muscular or fatty tissue between the skin and 
the bone), indicates an animal is extremely emaciated and on the point of death. A score of 5 
(where the spine cannot be felt) indicates a severely obese animal (194). To minimise variation, 
BCS was recorded by two personnel with extensive experience in this technique. 
2.2.3 Blood sampling 
For both maternal ewes and female offspring, blood samples were collected by jugular vein 
puncture. Vacutainer tubes containing lithium heparin anti-coagulant (Becton Dickinson, 
Franklin Lakes, NJ, USA) were used to collect blood samples. Samples were kept cool and 
within two hours of collection, the blood was centrifuged at 1300 g for 15 minutes (Eppendorf 
5810R, Medi’Ray Ltd, Auckland, NZ). The plasma was recovered and frozen at -20°C until 
required. 
To determine the patterns of gonadotrophin secretion in adult female offspring, the collection 
of serial blood samples was required. For this study, samples were collected every 15 minutes 
over an 8-hour period from a subset of 10 maintenance and 10 restricted female offspring. Each 
animal was fitted with an in-dwelling jugular catheter. Following a 2 mL subcutaneous (sc) 
injection of local anaesthetic (Lopaine, 2% lignocaine hydrochloride, Ethical Agents, 
Auckland, NZ), a sterile stainless steel 12 gauge needle was inserted into the jugular vein. Vinyl 
tubing (SV70, internal diameter 1 mm, external diameter 1.5 mm, Dual Plastics, Auburn, NSW, 
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Australia) was threaded through the needle into the jugular vein. Following removal of the 12 
gauge needle, the tubing was attached to a holding device sutured to the skin of the neck 
overlying the jugular. The end of the tubing was bandaged to an accessible area at the base of 
neck, between the shoulders. Serial blood samples were drawn from the tubing using a 5 mL 
syringe. Following the addition of 0.1 mL of sodium heparin (50 IU/mL) samples were 




2.2.4 Diet calculations 
Diets were based on an animal’s daily metabolisable energy (ME) requirements, which in turn 
is related primarily to the animal’s weight. Based on advice from the AgResearch Animal 
Facilities Unit, Grasslands, Palmerston North, the formula used to calculate an animal’s ME 
requirement was 
0.6 x ewe weight (kg)0 .75 
This formula is in line with other dietary calculations for sheep summarised by Wallach (195) 
and Dryden (196). For the ewes in the current study (average weight of 70 kg), the formula 
estimates the daily ME requirements of each ewe at 14.5 megajoules of metabolisable energy 
(MJME). 
In order to provide both the animal’s daily energy requirements and sufficient fibre to allow for 
healthy rumen function, the diet consisted of a mixture of three commercial products in the 
following proportions. 50% was a silage product (Fibre Eazy, Fibre Fresh Feeds Ltd, Reporoa, 
NZ), 25% was a pellet product (Sheep Pellets, Reliance Stockfoods, Dunedin, NZ) and the 
remaining 25% was lucerne chaff (Sergeant Dan Stockfoods, Gore, NZ).  
Different feeds have different metabolisable energy (ME) content, expressed as mega joules 
(MJ) of metabolisable energy per kg of dry matter. For example, pasture would normally range 
between 8 to 12 MJ ME per kg of dry matter. This value is dependent on the type and quality 
of pasture. Commercial feeds have a more stable ME content. ME values and dry matter content 
for each product were provided by the manufacturer (Table 2.1).  
Table 2.1 illustrates the calculation used to determine the quantity of each feed required to meet 
the daily energy requirements, based on a diet consisting solely of each product. Table 2.2 
shows the quantity of each feed required in the mixed diet for both maintenance and restricted 











Table 2.1 Daily feed requirements  







(kg) for a 70 
kg ewe 
Fibre 
Eazy 8.5 50% (14.5/8.5) x (1/0.5) 3.4 
Sheep 
Pellets 9.7 90% (14.5/9.7) x (1/0.9) 1.7 
Lucerne 
Chaff 8.0 85% (14.5/8.0) x (1/0.85) 2.1 
Daily feed requirements for each type of feed for a 70 kg ewe who’s daily ME requirement is 




Table 2.2 Diet composition from day 0 to day 55 of gestation  








Fibre Ezy 50% 1.7 0.85 
Sheep Pellets 25% 0.42 0.25 
Lucerne Chaff 25% 0.53 0.32 










2.2.5 Housing and feeding 
Ewes were housed in pens containing between 5 and 9 animals of the same group. A minimum 
of 2.5 m2 was allocated per sheep in accordance with the New Zealand Ministry for Primary 
Industries guidelines. Ad libitum access to water was provided for each pen. Ewes were fed 
from bins, with one bin allocated for each ewe. Close monitoring was undertaken during feeding 
to ensure that all ewes received their designated feed allocation. Ewes were fed twice daily 
(morning and afternoon) with pens being cleaned following each feeding. At the completion of 
55 days of restricted or maintenance nutrition, animals were returned to pasture and ad libitum 
feeding. 
2.2.6 Ultrasound scanning 
Trans-rectal ultrasound scanning was performed on pregnant ewes at day 35 to determine fetal 
status. Additionally, the procedure was performed on female offspring to determine both 
ovulation rate (OR), and the number of antral follicles > 2 mm present (AFC). The procedure 
has previously been used to measure both OR and AFC in sheep (197). In accordance with 
animal ethics requirements, the procedure followed the AgResearch standard operating 
procedure (INV036) and was performed by an approved operator. Briefly, animals were 
restrained in a dorsally recumbent position. Following introduction of approximately 50 mL of 
lubricant into the rectum, the transducer was inserted. Ultrasound images indicating pregnancy 
status was determined by manipulation of the transducer.  Trans-rectal ultrasound scanning was 
performed with an Aloka SSD 900 scanner with a 7.5 MHz trans-rectal probe (Hitachi-Aloka 
Medical Ltd, Japan).  
2.2.7 Laparoscopy 
Laparoscopy is a well proven and efficient method of accurately determining ovulation rates 
(198, 199). In accordance with animal ethics requirements, the procedure followed the 
AgResearch standard operating procedure (INV003) and was performed by an approved 
operator. Briefly, food and water were withheld overnight prior to surgery. Animals were 
sedated with 1.0 mL (sc) of Acezine10 (1.4% acepromazine maleate, Ethical Agents, Auckland, 
NZ). Animals were restrained in a dorsally recumbent position. The abdominal area was shaved 
and washed with 70% ethanol. Incision sites were injected sc with 2.0 mL of lopaine local 
anaesthetic (2% lignocaine hydrochloride. Ethical Agents, Auckland, NZ). A trochar and 
cannula were used to penetrate the left side of the abdominal wall and the abdomen inflated 
with CO2. The laparoscope was introduced through the cannula and manipulating forceps 
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introduced through a small scalpel incision made through the right side abdominal wall. 
Following visualisation of the ovary, the incision sites were treated with an iodine solution 
(Vetadine Iodine Animal Wash, Bayer Animal Health, NZ) and animals were returned to 
pasture. 
2.2.8 Euthanasia and fetal sampling 
Pregnant ewes were euthansed at day 55 (n = 24) and day 75 (n = 18) of gestation until at least 
6 female fetuses with a unique dam were recovered from each nutritional group for each age. 
Euthanasia of all animals was by intra-venous barbiturate overdose (Pentobarb 500, Provet NZ 
Pty Ltd, Auckland, NZ) at a dose rate of 0.3 mL per kg of body weight. In the case of pregnant 
animals, the barbiturate was administered slowly (approximately 30 seconds) allowing the drug 
sufficient time to cross the placenta and euthanase the fetuses. Upon expiration of pregnant 
ewes, fetuses were removed. Blood was collected from the day 75 fetuses by cardiac puncture 
using a 20 gauge needle and 5 mL syringe. Sodium heparin (0.1 mL of a 50 IU/mL solution) 
was immediately added to each blood sample. Within 30 minutes, the samples were centrifuged 
and stored as described in Section 2.2.3. Fetal crown-rump lengths and weights were recorded. 
Fetal tissue samples (gonads, kidney and mammary gland) were collected and weighed within 
10 minutes of euthanasia. The ovaries were either fixed in 4% paraformaldehyde at 4°C for 24 
hours (left ovary) and then processed for histology, or snap frozen in liquid nitrogen before 
storage at -80°C until required (right ovary).  
2.2.9 Lambing 
Thirty seven animals progressed through to produce 34 female lambs (13 from dams exposed 
to restricted nutrition and 21 from maintenance dams). Assigning lambs to the correct mother 
was a critical aspect of this study. Throughout the lambing period, ewes were monitored twice 
daily by an experienced shepherd. The number, sex, and weight of lambs was recorded. Lambs 
were assigned to mothers and tagged for ongoing identification. 
2.2.10 Onset of puberty in female offspring 
Prior to the onset of the first breeding season (March, 2014), vasectomised rams fitted with a 
mating harness containing a marking crayon were introduced to the ewes. Ewes were checked 
twice weekly for mating marks to indicate the onset of puberty. Twice weekly checks continued 




2.2.11 Superovulation of female offspring 
The superovulation trial of female offspring was undertaken towards the end of the first 
breeding season (July, 2014) so as the administration of drugs would not to affect the natural 
cyclicity of animals during the onset of puberty. The superovulation protocol used in this study 
is a standard procedure (200), and is outlined in Figure 2.3. The procedure involved 
synchronisation of animals as described in Section 2.2.1. At CIDR change, animals received an 
injection of 400 IU Pregnant Mares Serum Gonadotrophin (Folligon, MSD Animal Health, 
Upper Hutt, NZ) followed by eight twice daily injections of 20 mg Porcine Follicle Stimulating 
Hormone (Folltropin V, Bioniche Animal Health) over four days. As the ewes were no longer 
cycling naturally, Pregnant Mares Serum Gonadotrophin (PMSG) was used to help stimulate 
ovarian activity. PMSG also contains higher LH concentrations than commercial FSH products, 
and is often used in conjunction with FSH products to ensure ovulation (193, 200). Follicle 
Stimulating Hormone (FSH) stimulates the growth of more follicles resulting in higher 
ovulation rates. Typically a 4 to 5 fold increase in OR is observed in sheep, although results can 
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With the exception of gene expression data, the same statistical principles and tests were applied 
to the data in each chapter. Statistical approaches to gene expression data are described in 
Chapters 5 and 6. Statistical procedures were performed using the Genstat statistical software 
package (17th edition, VSN International, Hemel Hempstead, UK).  
Where a continuous time variable was present, a repeated measures analysis of covariance 
(RMANCOVA) was applied (e.g. gestational and postnatal weights). On occasions, additional 
variables were also included in the model (e.g. progesterone concentrations throughout the 
oestrous cycle where OR was also included in the model). RMANCOVA also tests for an 
interaction between the variables within the model. A significant age x nutritional group 
interaction indicates age is affecting the variable being analysed differently between the two 
groups. Figure 2.4 illustrates hypothetical weight and age data for two groups. Graph A would 
return no significant interaction, while graph B would return a significant interaction. 
Where a discrete time/age variable was present, a general linear model (GLM) was applied with 
age/time and nutritional group in the model. GLM is a robust test suitable for a wide range of 
data, including unbalanced data and where multiple variables require consideration. Where 
GLM indicated a significant interaction or a trend (p < 0.1), then analysis of variance was 
applied to analyse either groups or ages separately. Multiple range tests are reported sparingly 
as these increase the probability of type 1 errors (i.e. false positives). The Bonferroni multiple 




















Figure 2.4 Hypothetical data illustrating the concept of interactions between variables.  
(A) As age affects weight in both groups in a similar fashion, no interaction would be apparent. 
(B) As age increases, a more pronounced effect on weight is apparent in group 2, and a 








2.3.1 Maternal weights during gestation 
All 79 animals assigned to the gestational nutrition trial mated over a 5-day period, with 
restricted and maintenance nutrition regimes started from the day of mating. At the time feeding 
regimes were introduced, the average weight of the 39 animals assigned to the maintenance 
group was 70.3 ± 0.6 kg (maximum 73 kg, minimum 63 kg) with an average BCS of 3.2. The 
average weight of the 40 animals assigned to the restricted group was 70.4 kg ± 0.6 kg 
(maximum 79 kg, minimum 63 kg) with an average BCS of 3.3. The BCS scores of 3.2 
(maintenance) and 3.3 (restricted) at the beginning of the nutrition regimes indicates that these 
animals were in good condition, showing no signs of either obesity or malnutrition. At cessation 
of the nutrition regimes and return to ad libitum feeding (day 55 of gestation), maintenance 
animals weighed 72.4 kg ± 0.6 (gain of 2.1 kg), and their BCS remained at 3.2. By comparison, 
the restricted animals on average had lost 5.0 kg, completing the restricted nutrition regime with 
an average weight of 65.4 kg ± 0.5 and a BCS of 2.6 (a loss of 0.7 in BCS). Maternal weights 
during early to mid-gestation are presented in Figure 2.5. 
RMANCOVA analysis indicated significant effects of stage of gestation (p < 0.01), and group 
(p < 0.01) on body weight, with a significant group x age interaction (p < 0.05). The interaction 
reflects the marked decline in weights of the restricted animals at the beginning of the restriction 
period and also the post restriction increased growth plane evident in the restricted animals. The 
drop in BCS in restricted animals from 3.3 to 2.6 between day 55 and 75 was significant (p < 
0.05, ANOVA), suggesting increased use of energy reserves in the restricted animals in 
response to the nutrition restriction. 
From day 55, at the completion of restricted nutrition, through until the final recorded 
gestational weight at day 90, restricted animals showed a significantly steeper growth plane 
than maintenance animals. During this period, restricted animals gained an average of 5.9 ± 0.6 











Figure 2.5 Maternal weights during early to mid-gestation. Nutrition restriction began at 





2.3.2 Fetal weights 
The number of fetuses detected by ultrasound scanning at day 35, and the number of fetuses 
recovered at days 55 and 75 are presented in Table 2.3. There was no effect of group or 
gestational age on the number of fetuses present.  
 
Table 2.3 Fetal numbers present during gestation 
Gestational age Maintenance Restricted 
Day 35 1.6 ± 0.1 n = 39 
1.5 ± 0.1 
n = 40 
Day 55 1.5 ± 0.2 n = 7 
1.6 ± 0.1 
n = 8 
Day 75 1.9 ± 0.3 n = 7 
1.5 ± 0.2 
n = 8 
n = number of ewes. Fetuses at day 35 were estimated by ultrasound scanning. Fetuses at days 
55 and 75 were recovered from a subset of animals following euthanasia. 
 
 
Size and weight data for day 55 fetuses is shown in Table 2.4, and for day 75 fetuses in Table 
2.5. There was no effect of group on the crown rump length, fetal weight, or the weights of the 
organs recovered at either gestational age. This is consistent with the concept that the nutritional 
regime had no effect on overall fetal growth at day 55 and 75 of gestation. This also indicates 
that the post restriction compensatory growth shown by those ewes exposed to restricted 
nutrition did not result in increased fetal growth.  
Additionally, there was no effect of fetal sex on the size, or weight of the fetuses, although a 
significant sex effect was observed on gonad weight, fetal testes being significantly heavier 
then fetal ovaries (p < 0.01, ANOVA). This result is consistent with two previous studies in 






Table 2.4 Day 55 fetal and organ weights
 Female Maintenance (n = 7) Restricted (n = 8) 
Crown - rump length (cm) 10.4 ± 0.1 10.2 ± 0.1 
Fetal weight (g) 37.9 ± 0.9 36.5 ± 1.0 
Average gonad (g) 0.0090 ± 0.001 0.0092 ± 0.001 
Kidney (g) 0.24 ± 0.01 0.20 ± 0.02 
Mammary (g) 0.058 ± 0.008 0.046 ± 0.001 
Male Maintenance (n = 8) Restricted (n = 11) 
Crown - rump length (cm) 10.2 ± 0.1 10.4 ± 0.1 
Fetal weight (g) 37.4 ± 1.3 38.4 ±1.3 
Average gonad (g) 0.016 ± 0.001 0.023 ± 0.007 
Kidney (g) 0.212 ± 0.018 0.232 ±0.011 
Values are means and standard errors. 
 
Table 2.5 Day 75 fetal and organ weights
 Female Maintenance (n = 7) Restricted (n = 8) 
Crown - rump length (cm) 18.7 ± 0.2 18.6 ± 0.3 
Fetal weight (g) 232.9 ± 4.8 227.5 ± 8.6 
Average gonad (g) 0.024 ± 0.002 0.026 ± 0.001 
Kidney (g) 1.39 ± 0.05 1.50 ± 0.09 
Mammary (g) 0.65 ± 0.07 0.56 ± 0.09 
Male Maintenance (n = 6) Restricted (n = 4) 
Crown -rump length (cm) 19.0 ± 0.3 18.2 ± 0.5 
Fetal weight (g) 246.4 ± 11.2 219.1 ± 10.6 
Average gonad (g) 0.062 ± 0.005 0.055 ± 0.001 
Kidney (g) 1.42 ± 0.14 1.40 ± 0.010 
Values are means and standard errors. 
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2.3.3 Lambing and postnatal growth 
Following fetal collections, 35 ewes (21 maintenance and 14 restricted) progressed through to 
lambing. No group differences were observed at lambing in either the number of lambs born 
per ewe, weights of the lambs, or the ratio of female:male lambs (Table 2.6).  
Of the 34 female lambs born, 4 did not survive through to puberty. Growth of the 30 remaining 
female offspring from birth to 560 days of age is shown in Figure 2.6. There was a significant 
age effect (p < 0.01, RMANCOVA), but no group effect on weight, and no significant group x 
age interaction, indicating that the restricted nutrition did not have an effect on postnatal growth 
of the female offspring. 
Combined, the results from Sections 2.3.2 and 2.3.3 show that the nutrition restriction had no 
effect on fetal growth, fetal survival or postnatal growth of female offspring. 
 
 
Table 2.6 Number of lambs born and lamb weights
 Group Variable Lambs born Female Male Lambs per ewe 
Maintenance Number 39 21 18 1.86 
 Weight (kg)  5.5 ± 0.3 5.6 ± 0.3  
Restricted Number 26 13 13 1.86 
 Weight (kg) 
 5.4 ± 0.3 5.8 ± 0.2  









Figure 2.6 Postnatal weights of female offspring. Values are means and standard errors for 
17 maintenance and 13 restricted animals. 
 
2.3.4 Onset of puberty 
Of the 30 remaining female offspring (17 maintenance and 13 restricted), 3 maintenance 
animals failed to display estrus, i.e. no mating marks were recorded over the 3-month period 
(March to May, 2014). Of those animals which displayed estrus, there was no difference in the 
time from birth until the first recorded mating mark (p = 0.2, ANOVA). For maintenance 
animals, this was an average of 218 ± 5 days (minimum 185, maximum 241), while for the 
restricted animals, this was an average of 225 ± 3 days (minimum 211, maximum 240). 
2.3.5 Superovulation of female offspring 
A relationship between AFC and superovulation response has been demonstrated previously in 
cattle, with low AFC being associated with a poor superovulatory response (203). Similarly in 
sheep, a correlation between plasma AMH concentrations and superovulation response has 
been demonstrated (192). Given the association between restricted gestational nutrition and 
postnatal AFC, the response to superovulation in offspring from restricted and maintenance 
dams was examined. Following administration of the superovulation protocol, no animals 
displayed estrus. Laparoscopy of 10 randomly selected animals 6 days following the final FSH 
50 
 
injection indicated that all 10 animals had failed to ovulate. It is unclear whether this failure 
was due to issues related to the age of the animals (being relatively young), the timing of the 
experiment (as most animals had moved into anestrus), or a product failure. Laparoscopy of 10 
randomly selected animals showed a high level of follicular activity suggesting that increased 
FSH levels had been achieved. The implication is that the failure is related to PMSG, with either 
an inappropriate dose being administered for these animals or an issue related to product 
quality.  
2.3.6 Indicators of fertility: OR and AFC 
Indicators of fertility were assessed by laparoscopy (OR) and ultrasound scanning (OR and 
AFC) at 8 months of age (pubertal) and 19 months of age (adult). A synchronisation protocol 
was not utilised in the offspring at puberty to ensure a natural onset of puberty. Adult offspring 
were synchronised as described in Section 2.2.1. Measurements were undertaken over 4 
consecutive cycles (laparoscopy on cycles 1 and 3, ultrasound scanning on cycles 2 and 4). The 
day of cycle varied between pubertal animals but was restricted to day 5 or 6 for adult offspring 
to coincide with the emergence of the first follicle wave.  
OR and AFC data is shown in Table 2.7 for peri-pubertal offspring, and Table 2.8 for offspring 
at 19 months of age. Data presented is the combined data for two observations for each 
technique used (laparoscopy and ultrasound scanning). Including data from both ages and 
groups there was a significant age effect and group effect on both OR and AFC (p < 0.05 for 
all comparisons, GLM). There was no significant age x group interaction (p = 0.07 for OR, and 
p = 0.075 for AFC, GLM). While a significant group x age interaction was not recorded the 
presence of a trend (p < 0.1 for both OR and AFC) justifies the use of ANOVA to analyse each 
age separately.  
No significant group differences in AFC or OR were noted in peri-pubertal animals. However, 
in contrast to predicted results, at 19 months of age, ewes from dams exposed to restricted 
nutrition had significantly higher OR and higher AFC when compared to those ewes from 
maintenance dams (Table 2.8). Ewes from restricted dams showed a 26% increase in OR 
(regardless of the technique used) and a 44% increase in AFC. 
Additionally, irrespective of group, peri-pubertal animals had a significantly higher AFC when 
compared to animals at 19 months of age (p < 0.01, ANOVA). In contrast, while the OR rate 
in peri-pubertal animals appeared lower than in adult animals, this did not achieve significance 







Table 2.7 OR and AFC at 8 months of age
 Method Fertility 
indicator 
Maintenance 
N = 17 
Restricted 
N = 13 
P value 
Laparoscopy OR 1.2 ± 0.1 1.5 ± 0.2 0.6 
Ultrasound scanning OR 1.5 ± 0.1 1.4 ± 0.2 0.4 
Ultrasound scanning AFC 17.3 ± 1.3 19.6 ± 2.6 0.8 
Data are means and standard errors for two combined replicates for each technique. P values 





Table 2.8 OR and AFC at 19 months of age 
 Method Fertility 
indicator 
Maintenance 
N = 17 
Restricted 
N = 13 
P value 
Laparoscopy OR 1.6 ± 0.1 2.1 ± 0.1 < 0.01 
Ultrasound scanning OR 1.6 ± 0.1 2.1 ± 0.2 0.02 
Ultrasound scanning AFC 6.8 ± 0.5 9.8 ± 0.6 < 0.01 
Data are means and standard errors for two combined replicates for each technique. P values 






The primary objective of this work was to establish a model where restricted gestational 
nutrition affected postnatal fertility. This objective has been met, although, the results are 
contrary to expectations and to most previous studies. 
An increase in AFC and OR at 19 months of age in animals from dams exposed to restricted 
gestational nutrition is consistent with fertility being increased in these animals. A major 
limitation of this study is that both OR and AFC represent indicators of fertility and not fertility 
per se. While OR is considered a strong indicator of fertility (84), and an association between 
AFC and fertility has been demonstrated (63), direct measurement of fertility requires the 
female offspring to be mated to intact rams and the number of lambs born from these matings 
recorded. While this experiment was considered, it was deemed impracticable, particularly 
given the limited number of animals available. 
The results pose two major questions worthy of discussion. Firstly, why are increased indicators 
of fertility apparent in adult ewes from restricted dams where previous studies report decreased 
fertility? Arguably, the three variables likely to account for the unexpected results in this study 
are: a) the degree of nutrition restriction, b) the timing of nutrition restriction, and c) the post-
restriction diet. 
 Most published studies in sheep use a restriction equivalent to 50% of maintenance (170, 178, 
184), whereas in the current study, dietary restriction was calculated at 60% of maintenance. 
While the difference between 60% and 50% of maintenance may appear small, effects on the 
animal can be profound. In this study, pregnant ewes exposed to restricted nutrition lost 7% of 
their body weight over the 55-day period. Studies using 50% of maintenance over a similar time 
period resulted in a loss of 16% of body weight (178). Potentially, the less severe restriction 
used in this study may not have been sufficient to induce changes that result in negative effects 
on postnatal fertility.  
The timing of nutrition restriction also varies considerably between studies. In this study, 
nutrition restriction ended at day 55 of gestation, just as key germ cell processes such as meiosis 
and apoptosis are becoming prevalent (38). The selection of this time period (day 0 to day 55) 
may therefore have avoided any prospective negative impacts of restricted nutrition on these 
key processes. 
Following the restricted nutrition period, animals in this study were fed ad libitum. The majority 
of published studies either return animals to a maintenance diet (178, 204, 205) or fail to specify 
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the post-restriction diet. The ad libitum diet used from day 55 in this study is likely to have 
allowed the restricted animals to go through a compensatory catch up phase as shown in Figure 
2.5. This compensatory phase is occurring over the critical time period where germ cells 
undergo meiosis, apoptosis is prevalent, and the first follicles are forming. The potential for a 
"growth spurt" from day 55 to have a positive effect on these key processes seems plausible. 
The second major question posed by these results is why are these positive effects on indicators 
of fertility apparent in adult animals and not in peri-pubertal animals? It is a recognised issue 
in the New Zealand sheep industry that mating of sheep at puberty produces poor results when 
compared to adults (206). Studies have shown that poor lambing from these animals is a result 
of lower ovulation rates and lower embryo survival (84), suggesting a difference in the ovaries 
between adults and peri-pubertal animals. These differences may be inherent ovarian 
differences, or driven by differences in gonadotrophin secretion. The concept of differences 
between the ovaries of pubertal animals compared to adult animals is supported by the 
ultrasound scanning results which highlight a higher AFC in peri-pubertal animals compared to 
adult animals. Bartlewski and colleagues reported a rise in AFC just prior to puberty in sheep 
(207), with this rise being attributed to an increase in LH pulse frequency, most likely a response 
to exposure to rams. This is unlikely to be the case in pubertal animals used in this study, as 
initial exposure to rams occurred more than 60 days prior to assessment of AFC.  
While differences in the pubertal ovary compared to the adult ovary may offer some insights 
into why effects are seen in adult but not pubertal animals, the finding of high AFC in pubertal 
animals where fertility is low, seems counter to the studies linking high AFC with high fertility. 
One possible explanation accounting for both the high AFC-low fertility issue in peri-pubertal 
animals, and the lack of nutrition induced differences observed in pubertal ovaries, is the 
proposed dual recruitment of granulosa cell theory demonstrated in rodents (40). This theory 
proposes that during fetal development, granulosa cells are recruited in two waves. The first 
wave corresponds to initial contact between germ cells and somatic cells, equivalent to days 30 
to 50 in the sheep. A subsequent wave of recruitment of granulosa cells occurs later, following 
formation of germ cell nests or cords. This is equivalent to days 50 to 75 in sheep. The theory 
contends that follicles growing before puberty contain granulosa cells primarily from the first 
wave of recruitment. A gradual shift in follicular granulosa cell make-up occurs such that, 
postpuberty, growing follicles contain granulosa cells primarily from the second wave of 
recruitment. A supporting study also illustrates that prepuberty and postpuberty follicle 
dynamics are different, with prepuberty follicles growing significantly faster than postpuberty 
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follicles (85). Should such a theory hold in sheep, then the differences in prepubertal follicle 
dynamics may simply negate or mask the differences observed in adults. The mechanism by 
which AFC is increased in adults from restricted dams may not produce an additive effect to 
the mechanism driving higher AFC in pubertal ovaries. Alternatively, only the postpubertal 
growing follicles may be affected by the changes to gestational nutrition, which by extension, 
suggests prenatal nutritional effects are limited to follicles from the second wave of recruitment. 
As this wave of recruitment largely occurs in the post-restriction period, this would support the 
concept that it is this period of diet change, and not the restriction by itself that may be important 
in establishing the effects observed. 
The gestational nutrition regime used in this study did not have any effect on the growth or 
survival of fetuses, nor on the growth of female offspring. While numerous studies across a 
range of species show differing results, this finding is in agreement with previous studies in 
sheep which use nutritional restriction during early to mid-gestation (178, 204, 205). Effects of 
restricted gestational nutrition on fetal size and postnatal growth are only evident when 
extended periods of restricted nutrition are employed that encompass the later stages of 
gestation (208, 209).  
In summary, the restricted gestational nutrition regime used in this study (0.6 of maintenance 
from day 0 to day 55 of gestation), increased indicators of fertility in adult female offspring at 
19 months of age. As these results are contrary to previous studies, supporting evidence is 
critical to reinforce these findings. Characterisation of hormone profiles in maternal, fetal and 
especially in the female offspring, may provide evidence to support these novel findings and 









Chapter 3  . Measurement of Hormones and Metabolic Factors 
3.1 Introduction 
Hormones and metabolic factors have been related to an array of functions and conditions 
including menopause (210), ovarian function (131), ovarian insufficiency (211), appetite (212), 
and nutrition (213). Thus, the potential of hormone and metabolic profiles to contribute to the 
results observed in this study to date, and to aid our understanding of possible mechanisms is 
without question. 
Hormone concentrations in both fetal and maternal plasma, as well as their metabolic status, 
can illustrate effects of restricted nutrition on both fetal and maternal animals. Further, they 
may provide insights into the effects on the developing fetus, and the fetal ovary which may 
contribute to the observed outcomes in female offspring.  
In maternal plasma, leptin appears a clear choice to measure in these samples. Leptin is a 
hormone whose primary function is regulation of energy homeostasis by inhibiting hunger 
(214). However, it also has a number of roles in the reproductive system (215). In general, leptin 
stimulates at the level of the hypothalamus (152, 216), increasing the pulsatile secretion of 
GnRH. In the ovary, elevated leptin levels are thought to increase ovulation rate in sheep (155, 
217).  Studies have demonstrated naturally elevated maternal leptin levels during pregnancy in 
sheep and primates (218, 219). Additionally, increased nutrition during gestation is associated 
with elevated leptin levels (220), while restricted gestational nutrition decreases expression of 
leptin mRNA (205) in adipose tissue, the major source of circulating leptin.  
Steroids, in particular progesterone, are also important elements found in maternal plasma, with 
progesterone being primarily responsible for the maintenance of pregnancy (221). Decreased 
plasma concentrations of progesterone have been reported in overfed ewes (222), an 
observation thought to be due to increased liver clearance of progesterone (223).  It is unclear 
whether this observation extends to other steroids. Differences in maternal progesterone 
concentrations early in gestation are also associated with embryo survival (141, 142). Given 
these findings, the effect of nutritional restriction on progesterone and other steroid hormones 
(oestrogens and androgens) were considered important to measure in maternal plasma. 
Steroids are also known to play key roles in fetal ovarian development with progesterone and 
oestrogen having been shown to be important in the breakdown of ovigerous cords and in 
follicle formation (224-226). Excess prenatal androgens have been shown to alter expression 
58 
 
of genes involved in germ cell proliferation and apoptosis (227). Further, effects of prenatal 
androgen excess on follicle development and function have been demonstrated in sheep 
(228).These effects are mediated directly by androgens and following their conversion to 
oestrogens. Expression of genes involved in steroid synthesis are evident in the fetal sheep 
ovary from as early as day 30 of gestation (144), and the ovaries are capable of producing 
steroids from this stage of development (33).Thus, steroid concentrations in fetal plasma were 
considered a possible mechanism by which gestational nutrition may affect fetal ovarian 
development and therefore important to measure in fetal plasma. 
Restricted nutrition is known to have effects on the function of a number of organs in adult 
animals including kidney (229), liver (230), and the immune system (231), all of which have 
the potential to impact fetal development. Potential effects on major organ function can be 
evaluated by determining the metabolic status of both maternal animals and fetuses.  
In non-pregnant adult ewes, hormone profiles are used to characterise oestrous cycles (94, 232) 
and ovarian function (94, 233, 234). Therefore, hormone profiles in the female offspring from 
this study will be used to characterise aspects of the oestrous cycle and ovarian function in these 
offspring. Potential differences between ewes from restricted and maintenance dams may 
support the differences reported in Chapter 2 and offer insights into the mechanisms underlying 
the observed differences. 
AMH was considered a key hormone to measure in offspring as it has widely been reported as 
an indicator of AFC, ovarian reserve, and fertility (63, 235, 236). Determination of AMH levels 
at the time of scanning and laparoscopy may support the differences in AFC reported in Chapter 
2. 
Progesterone concentrations in offspring were considered important, not only for its association 
with embryo survival (141), but also to characterise the oestrous cycles in the female offspring. 
While progesterone concentrations do not necessarily correlate with the OR (237), they do 




FSH concentrations provide important information to characterise the ooestrous cycles and the 
ovaries in the offspring (94), particularly as FSH is sensitive to feedback from ovarian follicle-
produced factors such as inhibin and oestradiol (91). Unlike FSH, the pattern of LH secretion 
is not influenced by feedback from inhibin and oestradiol. Therefore, peripheral blood  
concentrations of LH are considered an accurate reflection of hypothalamic GnRH secretion 
(88). Characterisation of the pattern of LH secretion in female offspring is therefore important 
to determine if alterations to the neuroendocrine system contribute to the observed increased 
indicators of fertility in these sheep. 
Thus, the aims of this chapter were twofold: 
Firstly, to determine if altered gestational nutrition affected concentrations of hormones and 
metabolic factors in maternal and fetal plasma which may contribute to the phenotype observed 
in female offspring. 
Secondly, to characterise the oestrous cycles in female offspring from both groups, identifying 
changes which either contribute to, or result from the observed differences in OR and AFC.   
3.2 Materials and methods 
3.2.1 Theoretical basis of assays used in this study 
3.2.1.1 Sandwich enzyme-linked immunosorbent assay for the determination of AMH 
The concept of the AMH assay is illustrated and described in Figure 3.1. The AMH contained 
in the sample is incubated with, and binds to a known amount of a primary antibody (1°Ab, 
anti-AMH) which coats a tube or well. The amount of AMH which binds to the antibody is 
proportional to the amount of AMH present in the sample. A biotinylated secondary antibody 
(2°Ab) is added which also binds to the antigen. The enzyme horse radish peroxidase, 
conjugated to streptavidin (SHRP) is then added. The resulting biotin streptavidin binding 
results in the complex illustrated in Figure 3.1. Addition of a substrate (tetramethylbenzidine) 
results in the production of a coloured reaction product, which was measured at a wavelength 
of 450 nm using a multilabel plate reader (Victor3, Perkin Elmer, Waltham, MA, USA). The 
resultant colour intensities (optical densities or OD) are directly proportional to the 
concentration of AMH within the sample. The OD values are converted to concentrations by 





Figure 3.1 Basis of the AMH ELISA. Enzyme-linked immunosorbent assay (ELISA) plate 
wells are coated with an anti-AMH primary antibody (1°Ab). Antigen (AMH in a sample) first 
binds to a 1° Ab, the amount of binding is proportional to the antigen concentration. An anti-
AMH secondary antibody (2°Ab) conjugated to biotin is added. This antibody binds to a 
different site (epitope) of the antigen. A streptavidin-horse radish peroxidase conjugate (SHRP) 
is added which binds to the biotin moiety of the 2°Ab. Addition of a substrate for the SHRP 
then produces a coloured reaction product, which is measured photometrically using a multi 
label plate reader. The amount of coloured reaction product produced and then measured is 
proportional to the concentration of antigen. 
3.2.1.2 Competitive enzyme-linked immunosorbent assay for the determination of 
testosterone 
The testosterone within a sample and a known amount of testosterone conjugated to the 
detection enzyme horse radish peroxidase (HRP), compete to bind to a 1°Ab which coats the 
tube. The relative amounts of sample testosterone and labelled testosterone that bind to the 
1°Ab are determined by the sample concentration (as the concentration of the HRP labelled 
antigen is standardised). Following removal of excess sample and labelled antigens, only the 
labelled antigen-1°Ab complex produces a coloured reaction product. Thus, the OD of the 
coloured reaction product is inversely proportional to the concentration of sample antigen and 





3.2.1.3 Competitive radioimmunoassay for measurement of progesterone and FSH  
The concept of a competitive radioimmunoassay (RIA) is presented in Figure 3.2 using FSH as 
an example. FSH within a sample, 1° Ab, and a standard amount of radioactively (I125) labelled 
FSH (tracer) are mixed together. Both labelled (I125) and unlabelled (sample) FSH compete to 
bind to the antibody. The amount of each antigen bound is proportional to the concentration of 
sample antigen. A 2°Ab and polyethylene glycol are added to precipitate the bound and 
unbound 1°Ab, enabling separation of the excess FSH by centrifugation. The remaining 
precipitate is counted in a gamma counter (Wallac Wizard 1470, Perkin Elmer) which counts 
the radioactivity present in each tube and converts it to a concentration by comparing the sample 
counts to counts generated from a series of standards of known concentrations. The 
radioactivity counted (I125 labelled antibody-antigen complex) is inversely proportional to the 
concentration of sample antigen-antibody complex. 
For progesterone assays, the primary antibody is pre-coated onto assay tubes, therefore 
following binding between progesterone and the antibody, unbound reagents are aspirated off 
and the dry tubes counted using a gamma counter. 
3.2.1.4 Displacement radioimmunoassay for measurement of leptin and LH  
In the displacement assays, the sample antigen (leptin or LH) and antibody are allowed to bind 
first. Following this binding, I125 labelled antigen is added that then displaces a proportion of 
the previously bound sample antigen. Following separation of unbound antigens by 






























Figure 3.2 Concept of a competitive RIA (FSH).  Binding occurs when sample containing 
FSH, labelled (I125) FSH and 1°Ab are mixed. Both labelled and sample FSH compete to bind 
to the antibody. Separation is achieved by addition of a 2°Ab, followed by polyethylene glycol 
to precipitate all antibodies (bound and unbound). Centrifugation then separates the precipitated 
antibodies from excess antigens (labelled and labelled). Radioactivity is counted, with counts 






























3.2.2 Assay procedures and indicators of assay performance 
Samples of known concentration (QC samples) were interspersed throughout every assay. The 
purpose was twofold. Firstly, the variation between the QC samples within an assay measures 
the intra assay coefficient of variation (CV). QC samples are also used to measure the variation 
between assays (inter assay CV). The second purpose is to determine during validation whether 
assays are stable or if values drift from expected values. Assay drift is defined as significant 
variation between QC samples measured at the beginning of an assay and those at the end. Drift 
can be an issue in large assay formats. 
Individual assays were structured to include approximately equal numbers of samples from both 
nutritional groups, distributed evenly throughout the assay. Duplicates of each sample were 
assayed and the mean value of the two duplicates was taken as the measured value. Where the 
CV between the two duplicates exceeded 15 to 20% (assay dependent), the sample was repeated 
in a subsequent assay. 
A number of assay parameters are calculated to determine the quality of each assay and to assist 
in identifying problems should the assay not perform to expectations. Non-specific binding 
(NSB) represents the amount of antigen which binds to sites other than the 1° Ab, for example 
directly to the tube or well. This is measured by including tubes which contain no sample and 
no primary antibody. Following the standard assay procedure, the amount of radioactivity 
counted in these tubes represents the amount of labelled antigen which has bound to sites other 
than the 1° Ab. The counts obtained for NSB were subtracted from the counts for each sample 
tube so that the remaining counts represent only binding between the antigen and 1° Ab. For 
the ELISAs, NSB had been shown by the manufacturers to be negligible. As uncoated wells 
were not included in the kits, this could not be verified.  
Binding represents the recognition efficiency between labelled antigen and antibody. For RIA, 
the most useful binding value is calculated by dividing the result from a zero standard by the 
total counts from the labelled antigen (tracer) alone. For ELISA, the value of the zero-standard 
divided by that of the maximum standard represents the most useful binding value.  For both 
competitive and displacement assays providing that the NSB was low, low binding values 
generally indicate poor binding of the labelled antigen to the 1°Ab (often indicating damage to 
the labelled antigen as a result of a poor iodination when I125 is attached to the antigen). Poor 
binding of the labelled antigen to the 1°Ab results in low counts or low colour values, thereby 
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reducing assay sensitivity. Conversely, high values indicate high binding of the labelled antigen 
and therefore low binding of the antigen of interest, also resulting in low assay sensitivity. 
Effective dose (e.g. ED50) was described as the concentration at which the compound of 
interest exhibits 50% of its maximum activity. In the case of an FSH RIA for example, it was 
the concentration of FSH which produces 50% of the counts of the zero standard (that is the 
maximum number of counts). An optimal ED50 value was roughly equivalent to the values 
obtained for the unknown samples. This places these values in the middle of the standard curve. 
Assay detection limit was the minimum concentration detectable by the assay. This was 
calculated as two standard deviations above the values obtained for the zero standard replicates. 
Functional detection limits can also be calculated from the plots of serially diluted samples with 
the detection limit being the lowest point where linearity in this plot was maintained. 
 
3.2.3 Analysis of pulsatile secretion of LH  
The LH assay was used to determine the characteristics of LH secretion over an 8-hour period. 
Two software packages, Dynpeak (238) and Autodecon (239), were trialled to analyse the data 
to determine variables such as pulse frequency, pulse amplitude, and basal secretion levels. 
Both packages utilise differing algorithms and have been used to generate published results in 
a variety of species (240-242). Both programs proved unsuitable for this dataset with false 
detection of peaks being prevalent. Given this issue, a standardised manual method was 
developed and applied to analyse the characteristics of LH secretion.  
For each sheep, from the 33 samples measured over the 8-hour period, the average of the 10 
lowest values was taken to be the basal secretion value. The standard deviation (SD) of the 
basal values was calculated. Values over 10 SD above basal values were considered a major 
peak, while values between three and 10 SD above basal values were considered minor peaks. 
To be considered a peak, at least one value had to fit the criteria where the proceeding value 
did not. These criteria eliminated points, such as indicated by the arrow in Figure 3.3, being 
described as a peak. Figure 3.3 shows a typical LH profile for an individual animal. For this 
example, Dynpeak indicated 4 peaks and Autodecon 5 peaks. Applying the manual criteria 
detailed above, 2 major peaks (red stars) and 1 minor peak (purple star) were detected. Variables 
(sum of all 33 values, average of all 33 values, basal level, number of major peaks, average 
major peak amplitude, number of minor peaks, average minor peak amplitude) were counted 







Figure 3.3 Peak selection applied to a typical LH profile. In this example, major peaks (> 10 
SD above basal levels) are indicated by red stars. A minor peak (between 3 and 10 SD above 
basal) is indicated by a purple star. Arrow indicates potential false positive peak eliminated by 
applying the standard criteria. Basal secretion value for this animal was 0.59 ng/mL. 
 
 
3.2.4 Source of assays 
Leptin was measured using a Millipore multi-species RIA kit (Millipore, St Charles,MS, USA. 
Cat XL-85K). This kit uses an iodinated human leptin protein, and a guinea pig antibody raised 
against human leptin. The provided controls and standards are recombinant human leptin.  
Testosterone was measured using the IBL Free Testosterone ELISA (IBL, Hamburg, Germany. 
Cat DB52181). The kit measures free testosterone which represents only 2 to 3% of total 
testosterone. The remaining testosterone in plasma is bound to factors such as steroid hormone 
binding globulin, and albumin (243). A polyclonal anti-testosterone antibody is used along with 





















AMH was measured using the Equine Ovine AMH ELISA (Ansh Labs, Webster, TX, USA. 
Cat AL-115). Details of the antibodies used in this kit are proprietary knowledge. Equine 
standards are used. 
Progesterone in maternal samples was measured using the Siemens coat-a-count RIA (Siemens 
Healthcare Diagnostics, Auckland, NZ. Product discontinued). For 19 month old female 
offspring, progesterone was measured using the IBL progesterone RIA (IBL, Hamburg, 
Germany. Cat MG12171). A polyclonal anti-progesterone antibody is used along with 
progesterone standards in human serum.  
LH was measured using reagents obtained from the National Institute of Diabetes and Digestive 
and Kidney Diseases (NIDDK-oLH-I-4). The kit uses a rabbit anti-ovine LH antibody (OLH-
1), and a sheep anti rabbit second antibody. The method has been published previously (232).  
FSH was measured using reagents obtained from National Institute of Diabetes and Digestive 
and Kidney Diseases (NIDDK-oFSH RP2). The kit uses an anti-ovine FSH antibody, ovine 
FSH standards and a sheep anti rabbit second antibody. Standards were prepared from a highly 
purified ovine LH preparation (CY1085) The method has been published previously (232).  
Liquid chromatography mass spectroscopy (LCMS) is considered the “gold standard” for 
determining steroid concentrations (244). LCMS was undertaken by the laboratory of Professor 
David Handelsman at the ANZAC Research Institute, Sydney, Australia.  The method is 
described in Keski-Rahkonen et al  (245). 
Metabolic factors (albumin, beta hydroxyl butyrate, creatinine, triglycerides, Ca2+, Mg2+, and 
PO43-) were measured by Gribbles Veterinary Labs (Mosgiel, NZ). All assays were photometric 
assays performed using a Roche-Hitachi Clinical Analyser. The laboratory is IANZ accredited 
to NZS ISO/IEC 17025:2005. All assays were performed using standard protocols which meet 
the accreditation criteria. 





3.3.1 Optimisation and validation of assays for sheep samples 
3.3.1.1 Validation procedures 
Assays for leptin, testosterone, progesterone (IBL kit) and AMH had not previously been used 
or validated for analysis of sheep samples. FSH and LH assays required new reagents, in 
accordance with standard laboratory procedures these reagents required validation before use 
with experimental samples. Each assay was validated using two methods. Firstly, serially 
diluted samples were assayed. Beginning with the measured value of an undiluted sample, the 
expected concentration of each dilution is plotted against the measured concentration of each 
dilution. The resulting plot should return linear results running parallel to the line generated by 





Figure 3.4 Leptin serial dilution. Shows minimal deviation (average 5%) between measured 
concentrations (blue) and expected concentrations (red). Experimental samples ranged between 






























Deviations from the expected value (DEV) should remain < 10%. Secondly, spiked samples 
were used. For example, when 100 µL of a sample containing 2 ng/mL of FSH is added to 100 
µL of a standard containing 8 ng/mL, the resulting 200 µL should have a concentration of 5 
ng/mL ((2 + 8)/2). The measured value for this combined sample divided by the expected value 
is the % recovery, which should be close to 100%. Optimisation data including DEV recovery 
rates, inter assay CV, intra assay CV, and detection limits are presented in Table 3.1 
3.3.1.2 Maternal leptin 
For optimum assay performance, the manufacturer’s instructions were modified as follows. 50 
µL of standard and 50 µL of buffer were used as per instructions. Unknown samples and QC 
samples used 100 µL of plasma with no added buffer. The remaining steps were as 
recommended by the manufacturer. Following this modified protocol, serially diluted samples 
showed acceptable parallelism (Figure 3.4). Spiked samples showed recoveries between 91% 
and 104%. Inter-assay CV was 19%, intra-assay CV was 8.5% and the assay detection limit 
was 0.1 ng/mL. 
3.3.1.3 Maternal testosterone 
The assay used in this study posed a dilemma. The manufacturer’s instructions state that 
samples should not be diluted as this process will alter the ratio of free:bound testosterone, 
effectively meaning that the assay cannot be validated by the standard criteria applied to the 
other assays used in this study. Experiments with samples serially diluted using a variety of 
diluents and incubation conditions demonstrated that this was the case, with linearity failing to 
be achieved. Given this, results from this assay are not presented in this thesis.  
3.3.1.4 Maternal progesterone 
The Siemens Coat-a-Count kit used for maternal progesterone samples was validated 
previously for use in sheep following the manufacturer’s protocol. (141). In the current study, 
inter-assay CV was 12% and intra-assay CV was 5%. Assay detection limit was 0.1 ng/mL. 
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Table 3.1 Validation data for assays 
Assay Average DEV Recovery rate (average) Inter assay CV  Intra assay CV  
Detection limit 
ng/mL Assay accepted 
AMH 42% 34% n/a n/a 0.5 no 
Testosterone 50% 144% n/a n/a n/a no 
Progesterone 
(IBL) 5% 102% 7.5% 9.5% 0.2 yes 
Progesterone 
(Siemens) Previously validated in sheep 12.0% 5.0% 0.1 yes 
Leptin 5% 97% 19.0% 8.5% 0.1 yes 
FSH 7% 96% 11.1% 9.2% 0.1 yes 
LH 8% 94% 12.1% 7.8% 0.2 Yes 




3.3.1.5 Female offspring AMH 
Using an overnight primary antibody incubation at 4°C and subsequently following the 
manufacturer’s recommended protocol, serial dilutions in assay buffer produced acceptable 
linearity and parallelism down to a concentration of approximately 0.5 ng/mL. Below this 
concentration, parallelism was consistently lost with deviations between measured 
concentration and expected concentration ranging from 16% to 65%. This indicates the 
effective lower limit of this assay is approximately 0.5 ng/mL. Almost 90% of samples 
measured from this study gave values below 0.5 ng/mL (most falling within the range of 0.05 
to 0.1 ng/mL).  
Additionally, recoveries from spiked samples within a range of concentrations from 0.04 to 5.0 
ng/mL showed average recovery rates of 34%. Variations in sample volume and serial diluting 
samples in an in-house generated ovariectomised sheep plasma (as opposed to assay buffer), 
did not improve validation results. Given these issues, this assay was deemed unsuitable for use 
in this study. 
3.3.1.6 Female offspring progesterone 
The IBL kit had been developed and validated for human diagnostic use, and as such the 
recommended protocol had been designed for a rapid turnaround with the loss of some 
accuracy. Following the manufacturer’s recommended protocol, three issues become apparent: 
serial dilution of samples or standards showed non-linearity and non-parallelism, spiked 
samples resulted in an unacceptable recovery rate of 168%, and significant assay drift was 
apparent with the internal control samples measuring 600% higher at the end of an assay (i.e. 
tubes 95 and 100) when compared to the start of an assay (tubes 19 to 24).  
Validation procedures indicated that an overnight incubation at 4°C, rather than the 
recommended two hours at 37°C, produced acceptable linearity and parallelism from serially 
diluted samples (Table 3.1).  Recovery rate from spiked samples ranged between 87 to 116% 
using the modified protocol. Assay drift was reduced by processing smaller numbers of samples 
in sections. Standard assay procedure is to add sample to all tubes (100 to 200 tubes), and then 
add labelled progesterone to all tubes. Dividing each assay into blocks of 20 tubes contributed 
to a reduction in assay drift with variation between start and end QC samples averaging 7.2% 
following this change to assay setup. Inter assay CV was 7.5% and intra assay CV was 9.5%. 
Assay detection limit was 0.2 ng/mL. 
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Comparisons between progesterone concentrations obtained for the high, medium and low QC 
samples for the Siemens and IBL progesterone assays are given in Table 3.2. While both assays 
have been validated, some variation was apparent between values obtained for the two assays 
particularly at lower concentrations (2 to 3 ng/mL) where most experimental samples from this 




Table 3.2 Comparison between Siemens and IBL progesterone RIAs
QC sample High Medium Low 
Assay Siemens IBL Siemens IBL Siemens IBL 
Concentration 
(ng/mL) 8.24 7.81 5.28 5.52 2.20 3.12 
Differences in values obtained for high, medium and low concentration QC samples are 
shown. Values are averages over 5 Siemens and 8 IBL assays.  
 
3.3.1.7 Female offspring FSH 
Following the standard protocol for this assay, serially diluted samples showed acceptable 
parallelism. Spiked samples returned recovery rates of between 93 to 99%. Inter assay CV was 
11.1% and intra assay CV was 9.2%. Assay detection limit was 0.1 ng/mL.
3.3.1.8 Female offspring LH 
Following the standard protocol for this assay, serially diluted samples showed acceptable 
parallelism. Spiked samples returned recovery rates of between 91 to 96%. Inter assay CV was 
12.1% and intra assay CV was 7.8%. Assay detection limit was 0.2 ng/mL.  
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3.3.2 Assay results 
3.3.2.1 Maternal metabolic factors 
Concentrations of metabolic factors in maternal ewes along with normal ranges for these factors 
in sheep are presented in Table 3.3. In general, average concentrations of metabolic factors 
irrespective of gestational age or group were within the normal range for sheep. There were no 
significant effects of group or stage of pregnancy on the concentrations of beta hydroxybutyrate, 
Mg2+, PO43-, or triglycerides (GLM). 
There were significant effects on albumin concentrations of stage of pregnancy (p < 0.01, GLM) 
and group (p < 0.01, GLM) and a significant stage of pregnancy x group interaction (p = 0.018, 
GLM). At day 55 of gestation, maternal concentrations of albumin were significantly lower in 
ewes on restricted nutrition compared to those on maintenance nutrition (p < 0.01, ANOVA). 
For Ca2+ concentrations a significant effect of group (p = 0.05, GLM) and a significant stage of 
pregnancy x group interaction (p = 0.038, GLM) were noted. Concentrations were significantly 
lower in restricted ewes at day 55 compared to maintenance ewes (p < 0.05, ANOVA). Ca2+ 
concentrations in restricted ewes at day 55 were lower than the normal range for sheep, while 
all other Ca2+ concentrations were within the normal range.  
There was a significant group effect on creatinine concentrations (p < 0.05, GLM) with no stage 
of pregnancy effect or stage of pregnancy x group interaction. Concentrations of creatinine were 
significantly higher in restricted ewes than maintenance ewes at both days 55 and day 75 (p < 
0.05, ANOVA). The levels in restricted ewes were higher than the normal range for sheep at 






Table 3.3 Maternal metabolic factors at day 55 and 75 of gestation 
 Units Normal Range Day 55    Maintenance              Restricted 
Day 75 
     Maintenance             Restricted 
Albumin  g/L 26-37 33.3 ± 0.54* 28.6 ± 1.0 27.8 ± 0.4 27.3 ± 0.9 
Beta-hydroxybutyrate  mmol/L 0-1 0.44 ± 0.04 0.45 ± 0.02 0.4 ± 0.05 0.4 ± 0.07 
Calcium  mmol/L 2-3 2.26 ± 0.06* 1.97 ± 0.07 2.2 ± 0.1 2.2 ± 0.08 
Creatinine  µmol/L 55-77 66.5 ± 2.5* 77.9 ± 3.7 76.3 ± 3.3* 87.5 ± 3.6 
Magnesium  mmol/L 0.85-1.29 0.74 ± 0.03 0.77 ± 0.03 0.8 ± 0.03 0.8 ± 0.05 
Phosphate mmol/L 1.61-2.35 1.42 ± 0.04 1.27 ± 0.07 1.3 ± 0.1 1.5 ± 0.1 
Triglyceride mmol/L n/a 0.16 ± 0.01 0.19 ± 0.01 0.18 ± 0.02 0.23 ± 0.04 
Values are means and standard errors for 10 randomly selected animals for each group at each age. * indicates significant difference between 




3.3.2.2 Day 75 fetal metabolic factors 
No significant effects of nutrition restriction on metabolic factors were observed in day 75 fetal 
plasma (Table 3.4). Normal concentration ranges for metabolic factors in fetal sheep is not 
currently available. When compared to maternal concentrations at the same day of gestation, 
fetal concentrations of electrolytes (Ca2+, Mg2+, and PO43-) were similar. Albumin and 
creatinine were significantly less (p < 0.01, ANOVA) in fetal plasma, and the concentration of 




Table 3.4 Concentration of metabolic factors in day 75 fetal plasma 
Metabolic Factor Units Maintenance Restricted 
Albumin g/L 12.8 ± 0.7 13.0 ± 1.0 
Beta-hydroxybutyrate mmol/L 0.13 ± 0.02 0.16 ± 0.02 
Calcium mmol/L 2.4 ± 0.3 2.6 ± 0.2 
Creatinine µmol/L 27.4 ± 1.6 26.4 ± 1.3 
Magnesium mmol/L 0.77 ± 0.05 0.77 ± 0.04 
Phosphate mmol/L 1.9 ± 0.1 1.9 ± 0.1 
Triglyceride mmol/L 0.30 ± 0.01 0.31 ± 0.02 
Values are means and standard errors for 8 maintenance and 8 restricted fetuses. No 




3.3.2.3 Maternal leptin  
A significant effect of stage of pregnancy was observed (p < 0.01, RMANCOVA), but no 
significant effect of nutritional group, and no group x day of gestation interaction (Figure 3.5) 
were noted on maternal leptin concentrations. The lack of both a group effect and interaction 
demonstrates that in this study, maternal leptin concentrations were not affected by the 
restricted nutritional regime at any stage of pregnancy examined. Given the role of leptin in 
appetite control and energy homeostasis, its production from adipose tissue, and the differences 
in body weight and BCS between groups this result was surprising and will be explored further 
in the discussion. 
 
 
Figure 3.5 Maternal leptin concentrations during early gestation. Values are means and 
standard errors for between 8 and 20 samples per group, per day of gestation. A significant 
effect of day of gestation was detected (p < 0.01, RMANCOVA), but no effect of group or 























3.3.2.4 Maternal steroids 
There was a significant effect of day of gestation (p < 0.01, GLM) and a significant effect of 
gestational nutrition (p = 0.04, GLM), with no group x day of gestation interaction (p = 0.12, 
GLM) on maternal progesterone concentrations. Animals exposed to restricted nutrition had 
increased progesterone concentrations compared to those animals on the maintenance diet 
(Figure 3.6). 
 
Figure 3.6 Maternal progesterone concentrations during early gestation.  Values are means 
and standard errors for between 7 and 20 animals per day of gestation per group. A significant 
effect of both stage of pregnancy (p < 0.01) and group (p < 0.05) were detected with no stage 
of pregnancy x group interaction. 
Maternal steroid concentrations determined by LCMS are shown in Table 3.5. LCMS was 
unable to detect testosterone, dihydrotestosterone, dehydroepiandrosterone, 3α-androstanediol, 
3β-androstanediol, estrone, and androstenedione at either stage of pregnancy (day 55 and day 
75). Oestradiol was detectable in 12 of 22 samples at day 55, and 14 of 15 samples at day 75.  
Where values were below the detection limit, expected values were generated using an iterative 
algorithm according to the method of Gleit (246). There were no differences between groups in 
the proportion of animals with detectable oestradiol concentrations. There was a significant 
effect of stage of pregnancy (p < 0.01, GLM) on oestradiol concentrations, but no effect of 
group and no stage of pregnancy x group interaction. Progesterone was detected in all samples. 
For progesterone concentrations, there was a significant effect of stage of pregnancy (p < 0.01, 



























Table 3.5 Maternal steroid levels measured by LCMS 
Hormone Units Detection limit 
               Day 55 
 Maintenance     Restricted 
               Day 75 
Maintenance      Restricted 
T  ng/mL 0.01 nd nd nd nd 
DHT ng/mL 0.1 nd nd nd nd 
DHEA  ng/mL 0.05 nd nd nd nd 
3a diol  ng/mL 0.05 nd nd nd nd 
3b diol  ng/mL 0.05 nd nd nd nd 
E1  pg/mL 2.5 nd nd nd nd 
ASD  ng/mL 0.025 nd nd nd nd 
E2 pg/mL 0.125 0.28 ± 0.07 0.79 ± 0.24 1.69 ± 0.55 1.04 ± 0.22 
P4 ng/mL 0.05 2.18 ± 0.17 2.81 ± 0.18 4.01 ± 0.53 3.60 ± 0.62 
Values are means and standard errors for 22 samples at day 55 and 15 samples at day 75. nd = 
not detectable. T = testosterone, DHT = dihydrotestosterone, DHEA = dehydroepiandrosterone, 
3a diol = 3α-androstanediol, 3b diol = 3β-androstanediol, E1 = estrone, ASD = androstenedione, 




3.3.2.5 Day 75 fetal steroids  
Using LCMS, dihydrotestosterone, 3α-androstanediol, and androstenedione were not detected 
in the plasma of day 75 fetuses. No nutritional group differences were observed in the 
concentrations of progesterone, oestradiol, estrone, dehydroepiandrosterone or 3β-
androstanediol (Table 3.6). Fetal concentrations of oestradiol were significantly higher (p < 
0.01, ANOVA) than the corresponding maternal samples, while fetal progesterone 
concentrations were significantly lower (p < 0.01, ANOVA) than the corresponding maternal 
samples. 
 
Table 3.6 Day 75 fetal steroids measured by LCMS 
Hormone Units Maintenance Restricted 
Progesterone ng/mL 0.24 ± 0.06 0.21 ± 0.02 
Oestradiol pg/mL 9.98 ± 1.29 8.17 ± 1.34 
Estrone pg/mL 73.07 ± 21.32 56.94 ± 6.48 
DHEA pg/mL 0.16 ± 0.02 0.16 ± 0.05 
Values are means and standard errors for 14 samples. DHEA = dehydroepiandrosterone. 3β-
androstanediol, testosterone, dihydrotestosterone, 3α-androstanediol, and androstenedione 
were not detected in these samples. 
3.3.2.6 Female offspring progesterone 
Progesterone concentrations on each day throughout a complete oestrous cycle of all 30 female 
offspring are presented in Figure 3.7. For this analysis, ovulation rate was included in the model. 
The results indicate a significant effect of day of the cycle (p < 0.01, RMANCOVA), a 
significant effect of gestational nutrition (p = 0.038, RMANCOVA), and no effect of ovulation 
rate (p = 0.29, RMANCOVA) on progesterone concentrations. There was no day of the cycle x 
nutritional group interaction (p = 0.92). Ewes from dams exposed to restricted nutrition during 
early gestation had higher progesterone concentrations when compared to ewes from 
maintenance dams. Multiple range tests (Bonferroni) indicate that these differences were 







Figure 3.7 Daily progesterone levels throughout the oestrous cycle.  Day 0 indicates day of 
mating. Values are means and standard errors for 13 restricted and 17 maintenance animals at 
19 months of age. Significant day of the cycle and group effects were observed, both 
independent of the ewes’ ovulation rate. * indicates significant between group difference at that 




3.3.2.7 Female offspring LH 
Analysis (ANOVA) of the pulsatile pattern of LH secretion using samples collected every 15 
minutes over an 8-hour period did not identify any significant effects, on any of the variables 
analysed, attributable to the gestational nutrition regime of the ewes’ dam (Table 3.7). This 
includes pulse frequency, pulse amplitude, basal secretion levels and total LH secreted over the 




Table 3.7 Characteristics of LH secretion in adult ewes 
Variable  Units Maintenance Restricted 
Sum of all values ng/mL 31.2 ± 5.0 28.6 ± 2.3 
Average all values  ng/mL 0.95 ± 0.2 0.87 ± 0.1 
Basal level  ng/mL 0.54 ± 0.1 0.58 ± 0 .1 
Number of major peaks number 1.3 ± 0.5 1.9 ± 0.3 
Average major peak 
amplitude  ng/mL 3.2 ± 0.5 2.4 ± 0.3 
Number of minor peaks number 0.9 ± 0.4 1.1 ± 0.2 
Average minor peak 
amplitude  ng/mL 0.4 ± 0.2 0.4 ± 0.1 
Values are means and standard errors for 10 maintenance and 10 restricted animals blood 
sampled every 15 minutes over an 8-hour period. No significant differences attributable to 





3.3.2.8 Female offspring FSH 
Using the same criteria (Section 3.2.3) and samples described for LH secretion, analysis did not 
detect significant FSH peaks. A typical FSH profile from an individual animal is shown in 
Figure 3.8. 
 
Figure 3.8 Typical FSH profile over 8-hour period. Typical FSH profile generated from 
samples collected every 15 minutes over an 8-hour period illustrating the lack of discernible, 
regular peaks.  
 
A randomly chosen subset of 12 maintenance and 12 restricted animals were used to determine 
daily FSH concentrations throughout a complete oestrous cycle (Figure 3.9). There was no 
effect of nutritional group (p = 0.2, RMANCOVA), but an effect of day of the cycle (p < 0.01, 
RMANCOVA). However, a significant day of the cycle x group interaction (p < 0.01, 
RMANCOVA) was noted. The presence of a significant interaction indicates that the pattern of 
FSH concentrations throughout the cycle varies between groups. Multiple range tests 
(Bonferroni) demonstrated that ewes from dams exposed to restricted nutrition had lower FSH 











Figure 3.9 Daily FSH values throughout the oestrous cycle. Day 0 indicates day of mating. 
Values are means and standard errors for 12 restricted and 12 maintenance animals. While no 
overall effect of group was noted, a significant day of cycle effect and day of cycle x group 
interaction was noted. * indicates significant differences between groups at that age by multiple 





The results presented in this chapter indicate that the restricted nutrition regime not only 
resulted in lower maternal weights (Section 2.3.1), but also affected the metabolism of the 
pregnant ewes. Additionally, differences observed in hormone concentrations of 19-month-old 
female offspring expand on the 45% increase in AFC and 30% increase in OR observed in the 
animals from restricted dams compared to those from maintenance dams (Section 2.3.6). 
However, results of steroid and metabolic analysis of fetal plasma at day 75 have not 
demonstrated significant difference attributable to the restricted nutrition regime. 
Results of the metabolic panel in maternal ewes follow a predictable pattern. Decreased albumin 
levels in restricted maternal ewes at day 55 of gestation are consistent with the literature. While 
albumin concentrations are often used as a test for liver function, low levels are associated with 
decreased nutrition as demonstrated in sheep by Caldeira and colleagues (247). Increased 
concentrations of creatinine reported in restricted maternal ewes have been reported previously 
in sheep on sub-maintenance feeding (247, 248). Increased creatinine concentrations are often 
an indication of decreased kidney function, however animals in the Caldeira study (247) and in 
the current study, showed no signs of significant kidney dysfunction. Given that chronic kidney 
disease is known to have negative fetal and maternal outcomes during pregnancy (249), the 
observation that all restricted animals that progressed to lambing did so normally, with no 
additional fetal loss, suggests that major issues related to kidney function had not developed in 
the animals on the restricted nutrition regime. While Caldeira and colleagues (247) reported 
differences in triglyceride concentrations, these differences were only evident when comparing 
animals with extreme differences in BCS (BCS 1 compared with BCS 4). The restricted animals 
in the current study lost < 1 BCS, therefore the absence of differences in triglyceride levels is 
in agreement with the Caldeira study. Similarly, the absence of differences in beta-
hydroxybutyrate in the current study is also in agreement with the Caldeira study.  
Of the electrolytes measured, only Ca2+ concentrations differed between the nutritional groups, 
with concentrations being lower in restricted ewes at day 55. Given the similarities in electrolyte 
levels between maternal and fetal plasma at day 75, one might expect to see a similar difference 
in day 55 fetal plasma. While this remains to be examined, should lower Ca2+ concentrations be 
found in plasma from restricted fetuses, this may have implications for fetal ovarian 
development, as Ca2+ is involved in a number of key cellular processes including cell death 
(250), and cell proliferation (251). 
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Three aspects of maternal leptin measurements made in this study are contradictory to what 
was expected. Firstly, no differences in leptin concentration were observed between nutrition 
groups from mating until day 75 of gestation. This result is somewhat surprising given the role 
of leptin in appetite control, and is in contrast to the study of Sosa which indicated that 
underfeeding produced differences in leptin levels in pregnant ewes (252) and the studies of 
Recabarren and colleagues (83), and also Delavaud and colleagues (253) in non-pregnant sheep. 
Secondly, leptin levels at day 55 were lower than those at day 35, whereas most studies, 
including those in sheep, report elevated leptin levels during gestation (218). Finally, following 
the change from restricted or maintenance feeding to ad libitum feeding (at day 55), leptin levels 
did not rise in either group as one may have expected. 
In the sheep study by Sosa and colleagues, nutrition restriction began 14 days prior to mating 
with nutritionally induced differences in leptin levels apparent 9 days before mating. These 
differences were maintained until completion of the nutritional restriction at day 15 of 
pregnancy. Further, sheep were fed once daily with blood samples collected 1 hour prior to 
feeding and a nutritionally induced difference (maintenance compared to 50% of maintenance) 
in leptin levels was apparent.  
In the current study, samples were collected approximately 1 hour following feeding. Thus, 
potentially a rapid leptin response to feeding in both nutritional groups may account for the lack 
of group differences. This concept may be supported by the fact that leptin secretion is episodic 
in nature as demonstrated in sheep by Recabarren and colleagues (83), although what regulates 
the episodic nature of leptin secretion is unknown. In humans following overnight fasting leptin 
continues to fall for 2 hours before rising to peak levels 8 hours following a meal (254). In 
contrast Weigle and colleagues conclude that food consumption does not increase plasma leptin 
levels. The response in sheep under extended maintenance and restricted nutrition is likely to 
be substantially different from those reports in humans, given both the restricted nature of the 
diet and the change in eating pattern from all day grazing. In the study of Recabarren and 
colleagues, nutritionally induced differences were reported in mean leptin levels, as well as the 
number and amplitude of pulses. However in contrast to the current study, Recabarren and 
colleagues performed their work on non-pregnant adolescent sheep, comparing maintenance to 
ad libitum feeding, and the timing and the relationship between feeding and blood sampling 
was not described. 
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Ehrhardt and colleagues reported an 80% rise in leptin levels from pre-breeding to mid-
pregnancy in sheep (218) on a maintenance diet. In the current study however, a decrease of 
nearly 50% in leptin concentrations in both groups between day 35 and day 55 of gestation was 
observed. Concentrations then plateaued through until day 75. Similar to the current study the 
animals in the Ehrhardt study were fed twice daily although maintenance diets were introduced 
20-40 days prior to mating. Thus differences in the length of maternal restriction between the 
two studies may explain some of the results. However, the study of Thomas and colleagues in 
pregnant adolescent sheep showed a pattern of maternal leptin concentration similar to the 
current study. While the study of Thomas showed increasing leptin concentrations for ewes on 
a maintenance diet from the day of mating until day 25 of gestation, a decline in leptin from 
day 25 was evident in the same ewes (220). In contrast ewes on a maintenance plus diet showed 
increasing leptin concentrations between day 50 and 70. Additionally the Thomas study showed 
changing from a moderate to a high diet at day 50 of gestation increased leptin levels while 
changing from a high to a moderate diet at day 50 decreased leptin levels. 
Arguably the most plausible explanation for the surprising leptin results (and potentially the 
variation in results from previous studies) may relate to the assay used for measurements. This 
was the Millipore Multispecies leptin assay. This assay has published results in cattle (255), 
bats (256), voles (257), pigs (258), seals (259) and sheep (260). Further, the assay was validated 
for use with our samples, in that serial dilutions produced linearity, and spiking of samples gave 
good recoveries. While the study of Delavaud and collegues (253) demonstrated differences in 
leptin between nutritional groups, they also compared an ovine specific RIA with a multi-
species RIA similar to the Millipore Multispecies assay. The multispecies assay returned values 
less than half those of the ovine specific assay. Further, the post-restriction comparison in leptin 
values was substantially less using the multispecies RIA and required using pre-trial values as 
a covariate to achieve significance.  
In an interesting review Chilliard and colleagues raise some questions on the use of multispecies 
leptin assays in ruminants. Using a ruminant specific RIA, a rise in leptin levels was apparent 
immediately prior to parturition in cattle. Further, differences were apparent between high, 
medium and low nutritional groups in the same animals. Using a multispecies kit, the pre 
parturition rise in leptin was not apparent and differences between the medium and low nutrition 
groups were also not apparent (261). Thus for unknown reasons there appears to be an 
interaction between RIA tools and the physiological status of ruminants that potentially 
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precludes the use of nonspecific leptin RIAs in ruminants.  While the reasons for this are 
unclear, it may be related to differences in ratio of free leptin to bound leptin (i.e. bound to a 
soluble receptor) (261) in animals under certain physiological conditions. 
Thus, results for leptin in sheep during pregnancy and/or under differing nutritional planes 
varies considerably. Some factors appearing to contribute to this variation include the assay 
employed, the level of nutrition (over or underfeeding), timing of alterations to nutrition with 
respect to mating, and the age of animals. The potential effect of changes in feeding pattern and 
timing of blood sampling in relation to feeding may also contribute to variation between studies. 
Given that leptin is primarily produced in adipose tissue, differing fat composition of sheep 
breeds may have an effect on leptin levels and the response to nutritional challenges. Therefore, 
the breed of animals used and the metabolic status of animals prior to entering any nutritional 
experiment may also have an effect on leptin. 
It is of interest that while the RIA results reported a significant group effect for maternal 
progesterone concentrations, the LCMS data did not report this difference. These seemingly 
divergent results most likely reflect the greater number of samples (and ages) used for the RIA. 
Further, if an ANOVA, as opposed to a GLM, is applied to the day 55 LCMS data, then a 
significant group difference is observed (p = 0.012). The differing outcomes between the two 
techniques highlights an important principle in interpretation of statistical data. Where 
statistical tests report no significant effects, this does not mean that values are the same. But, 
given the data, an effect was unable to be demonstrated. Given this, it appears that gestational 
nutrition may be affecting maternal progesterone concentrations.  
Similar differences in progesterone concentrations observed using RIA in the current study have 
been reported in previous studies. These differences are thought to be, at least to some extent, 
due to nutritionally induced differences in blood flow through the liver. This results in 
differences in the metabolic clearance of progesterone (262). Differences in maternal 
progesterone concentrations are unlikely to have direct effects on fetal gonadal development. 
While a close association exists between progesterone metabolites in fetal and maternal 
circulations, there is no such correlation in progesterone concentrations (263). However, the 
observed differences in progesterone concentrations in maternal plasma do illustrate that the 
restricted nutrition does have a metabolic impact on the maternal ewes. These differences may 
provide a useful tool in future studies to measure the impacts of different nutritional regimes.  
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Rasby (264) reports elevated oestradiol levels late in gestation following early gestational 
nutritional restriction. There is no evidence from the current study to suggest nutritionally 
induced differences in maternal oestradiol concentrations. Using LCMS analysis, oestradiol and 
progesterone were detectable in maternal plasma at days 55 and 75 of pregnancy, with 
oestradiol detectable in only a proportion of animals. Progesterone concentrations measured by 
LCMS were approximately three fold higher than those obtained by RIA. However, the same 
pattern was observed with restricted animals having higher concentrations than maintenance 
animals.  
Analysis of steroid concentrations in day 75 fetal plasma using LCMS did not detect any 
differences between nutritional groups. While the fetal sheep ovary does  produce steroids from 
relatively early in gestation (33, 144), the high levels of estrone measured in fetal samples 
indicates that these steroids are predominantly placental in origin (265). The observation that 
maternal progesterone concentrations are higher than fetal concentrations, whereas fetal 
oestradiol concentrations are higher than those in the maternal system, likely reflect the source 
and regulation of these steroids. At day 75 of gestation, most maternal progesterone is produced 
by the CL of the ovary. Only at day 90 does the placental progesterone contribution reach parity 
with the CL (266).  Placental oestradiol production is regulated by FSH, whereas progesterone 
production is regulated by prostaglandins (267). The high levels of oestradiol in fetal plasma 
compared to maternal plasma at day 75 may represent an earlier up-regulation of placental 
oestradiol compared to progesterone. The absence of correlations between maternal and fetal 
progesterone and oestrogen(s) concentrations demonstrates partitioning between maternal and 
fetal steroids in line with previous studies (268, 269).  While steroids are known to play critical 
roles in fetal ovarian development (146, 226, 270), there is no evidence that differences in 
steroid concentrations contribute to the findings observed thus far. However, analysis of fetal 
plasma at day 55 of gestation, at the completion of the restricted nutrition period, would have 
provided a more complete picture. Further, the data does not discount autocrine effects of 
ovarian produced steroids.  
A number of studies show a link between high progesterone concentrations and increased 
embryo survival, with this link particularly evident early in gestation (141, 142). The significant 
early rise in progesterone concentrations, evident in adult ewes from restricted dams, suggests 
that the increased OR and AFC observed in these animals (Section 2.3.6) has the potential to 
be accompanied by increased embryo survival. This would add another increased indicator of 
fertility to these animals. The early rise in progesterone in ewes from restricted dams is 
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independent of the OR rate in these animals, an observation also consistent with a likely 
increase in embryo survival in ewes from restricted dams.  
The observed pattern of FSH secretion throughout the oestrous cycle in this study follows the 
typical pattern observed in sheep (94). Transient rises in FSH occur throughout the cycle, with 
these rises corresponding to the emergence of follicle waves (207). The most significant 
differences between the ewes from restricted or maintenance dams occur following the 
emergence of the first follicle wave (days 3 and 4). The first follicle wave is known to be 
especially active in the production of oestradiol and inhibin (271), both inhibitors of FSH 
secretion. Given that more antral follicles are observed in adult ewes from restricted dams, the 
inference is that the lower concentrations of FSH observed at the beginning of the oestrous 
cycle are the result of increased feedback from higher levels of follicle produced oestradiol 
and/or inhibin.  
Sheep generally exhibit three or four follicle waves per cycle. Sheep with four follicle waves 
per cycle have both elevated progesterone levels, and lower average FSH levels throughout the 
cycle (94), both of these characteristics being evident in ewes from restricted dams. Close 
examination of FSH concentrations throughout the oestrous cycle (Figure 3.9), shows a rise in 
FSH concentrations in ewes from maintenance dams, indicative of the emergence of a new 
follicular wave, on days 0, 5 and 10. In ewes from restricted dams, increases in FSH 
concentrations are apparent on days 1, 6 and 9, with an additional small rise on day 14. While 
this may be interpreted as ewes from restricted dams having four follicle waves per cycle as 
opposed to three in maintenance animals, more intensive ultrasound scanning of follicle 
populations throughout the cycle is needed to confirm this. 
Analysis of FSH from serial blood samples, collected every 15 minutes over an 8-hour period, 
did not show the presence of clearly distinguishable peaks (see Figure 3.8). This is a common 
feature of FSH secretion. While FSH pulses can be detected in hypophyseal portal blood (272), 
they are difficult to detect in peripheral plasma. This is thought to be due to the long circulating 
half-life of FSH and additional secretion of FSH pulses between observed pulses of GnRH 
(273). Additionally, multiple isoforms of FSH with differing half-lives further complicates 
detection of pulses (274). Thus, no conclusions regarding effects of dam nutrition on the 
pulsatile pattern of FSH secretion in female offspring can be drawn from the current study. 
No differences were observed in the pattern of LH secretion. The finding of low pulse frequency 
at this stage of the cycle (1 to 2 pulses over the 8-hour period) is in line with expectations (275). 
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Progesterone and oestradiol feedback maintain this low pulse frequency thereby preventing 
final follicle maturation early in the oestrous cycle. With the pattern of LH secretion more 
accurately reflecting the pattern of GnRH secretion by the hypothalamus (88), the lack of 
differences between the groups is consistent with the concept that neuroendocrine control of 
follicle development in the female offspring has not been directly affected by the alterations to 
the dams gestational nutrition. 
Two assays trialled in this study could not be validated to a level where the results were 
acceptable. The free testosterone assay specifically stated that samples should not be diluted, 
thereby making the key serial dilution validation impossible. During validation procedures, 
results from a number of maternal samples demonstrated free testosterone values of 11.3 pg/mL 
at day 55 and 4.3 pg/mL at day 75. These values are significantly higher than the manufacturer’s 
guidelines for human females (95% percentile 0.2 to 1.3 pg/mL) and are similar to expected 
values for human males (95% percentile 2.6 to 9.8 pg/mL). Given that the assay measures only 
free testosterone which accounts for < 5% of total testosterone (243), this would suggest total 
testosterone values of around 214 pg/mL at day 55, and 81 pg/mL at day 75. However, total 
testosterone measured by LCMS, considered the gold standard for steroid measurement, could 
not be detected in the same samples. Given the detection limit of 10 pg/mL for the LCMS 
method, considerable doubt exists as to validity of the free testosterone assay for use in sheep. 
The AMH assay, despite being marketed as an equine/ovine assay, could not be validated in 
our laboratory. The sensitivity of the assay, as indicated by serial dilutions, did not extend into 
the concentration range where most samples fell. Measurement of AMH has been problematic 
in most ruminants with the issues being best described by Arouche and colleagues(276). 
Arouche contends that to gain the sensitivity required to measure ruminant AMH, antibodies 
need to be produced against a ruminant AMH protein. Additionally, the epitope (the antigen 
site recognised by the antibody) may well be critical in determining binding and therefore the 
sensitivity of the assay.  With the association between ovarian reserve, AFC, fertility, and AMH 
being widely accepted, determination of AMH concentrations in the female offspring from this 
study would add considerable strength to the current findings. Therefore, development of an 
appropriate assay such as the BOC ELISA described by Arouche will continue to be explored. 
Overall, the results are consistent with the restricted gestational nutrition regime affecting 
progesterone concentrations in the pregnant ewes. Limited studies in fetal plasma have yet to 
identify any differences between hormone or metabolite concentrations in fetuses exposed to 
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either restricted or maintenance gestational nutrition. Differences in progesterone and FSH, but 
not LH, in adult female offspring suggest that the differences in indicators of fertility are ovarian 
driven. Whether these ovarian driven differences are a consequence of altered fetal ovarian 

















Chapter 4 . Fetal Ovarian and Germ Cell Development 
4.1 Introduction 
The current study offers the rare opportunity to examine fetal ovarian development in the same 
cohort of animals in which gestational nutrition has been shown to affect indicators of fertility 
in female offspring. While most other studies have highlighted the negative effects of restricted 
gestational nutrition, in the current study, multiple indicators of increased fertility (OR, AFC, 
progesterone concentrations) have been observed in female offspring of dams exposed to 
restricted gestational nutrition. The underlying assumption, from both previous studies and the 
current study, has been that alterations to gestational nutrition has affected fetal ovarian 
development. The effects on ovarian development result in changes to the structure and/or 
function of the postnatal ovary, with the consequence of these changes being the observed 
alterations to fertility indicators. Of the many processes in the developing ovary, germ cell 
development seems the most likely aspect to be affected. Germ cell development involves a 
range of developmental processes (mitosis, meiosis, apoptosis, follicle formation and growth), 
is subject to complex regulation, and also has the potential to affect the ovarian reserve which 
is a key determinant of adult fertility (63). 
Reported effects of gestational nutrition on fetal ovarian/germ cell development in sheep are 
not without precedent. Borwick and colleagues reported increased numbers of germ cells in day 
42 and day 62 fetal ovaries from nutritionally restricted dams when compared to overfed dams 
(172). While it is difficult to determine whether this effect is from underfeeding or overfeeding, 
it does none the less establish a link between gestational nutrition and germ cell development. 
Asmad showed that ad libitum feeding during gestation increased numbers of primordial 
follicles, but decreased numbers of primary follicles at day 100 of gestation (159). The Asmad 
study is confounded by the differing weights of the ewes at mating, but it also highlights the 
link between gestational nutrition and germ cell development. Lea demonstrated that 
underfeeding from mating until day 30 of gestation reduced germ cell staining for the 
proliferation marker Ki-67 at day 65 of gestation (171). The same study also reported a 
prospective relationship between underfeeding from day 30 to day 65, and increased expression 
of the pro-apoptosis regulator BAX in germ cells. 
Links between gestational nutrition and the ovarian reserve in female offspring in species other 
than sheep have also been reported. In cattle, Mossa and colleagues demonstrated that nutrition 
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restriction early in gestation decreased the ovarian reserve in female offspring (65).  Similarly 
in the rat, offspring born to under fed mothers throughout gestation showed decreased 
primordial, secondary, and antral follicle numbers (169).  
In addition to effects on germ cell development, restricted gestational nutrition has been shown 
to have effects on other cells in the sheep fetal ovary. Restricted nutrition from 20 days prior to 
mating through until day 135 of gestation, significantly reduced proliferation rates of follicular 
granulosa cells (176). The study of Lea and colleagues (171) showed under feeding from the 
day of mating until day 30 of gestation significantly increased granulosa cell proliferation at 
day 110 of gestation. This study also showed restricted nutrition from either mating until day 
110, or from day 65 until day 110, also increased granulosa cell staining for BAX at day 110 of 
gestation (171). 
While some studies have shown effects of gestational nutrition on the hypothalamic-pituitary-
gonadal (HPG) axis, the timing of nutritional restriction in these studies commences later than 
the regime employed in the current study (170, 277). This timing is consistent with the work of 
Thomas (278), who showed the first appearance of pituitary cells positive for the FSHβ subunit 
at day 100 of gestation. Thus, complete hypothalamic-pituitary development in the sheep fetus 
occurs well after the restriction regime employed in this study ended. Given this, any effects on 
the reproductive system produced by the nutritional regime used in this study are likely to be 
direct effects on the developing ovary, and not as a consequence of effects at the level of the 
developing hypothalamus or pituitary. This contention is supported by the lack of significant 
differences in the pattern of LH secretion in adult female offspring reported in Chapter 3. 
The aim of the work described in this chapter was to determine whether the restricted 
gestational nutrition regime employed had affected the morphological development of the fetal 
ovary. The focus of this work is targeted at quantifying germ cell development, particularly the 
key processes of proliferation, autophagy, and apoptosis. These processes largely determine the 




4.2 Materials and methods 
4.2.1 Histology 
Following overnight fixation in 4% paraformaldehyde, ovaries were rinsed overnight in 70% 
ethanol. The ovaries were then processed and embedded in paraffin following a standard 
processing schedule (Appendix B). To facilitate subsequent immunohistochemistry, a low 
melting temperature wax (Shandon Paraplast X-tra, melting point 50 to 54°C. Thermo Fisher 
Scientific, Auckland, NZ. Cat 503002) was employed for processing and embedding of all 
samples. Ovaries were sectioned on a rotary microtome (Leica RM2135) at 5 µm with all 
sections retained. Every 10th and 11th section was stained with Haematoxylin and Eosin 
(Appendix C) for stereology and assessment of gross morphology (presence/absence of mitotic 
germ cells, meiosis, apoptosis, ovigerous cords, and ovarian rete). 
4.2.2 The basis of stereological techniques applied in this study 
Previous studies examining germ cell development in fetal ovaries from nutritionally restricted 
dams have utilised cell densities (or number of cells per unit area) as an indicator of germ cell 
numbers. While in general this is a reasonable approach, it fails to account for two sources of 
error. The first of these potential errors related to the reference volume. Using cell densities 
assumes that the volume of the ovary containing germ cells (or the ovarian cortex) is similar 
between the two groups being compared. This method is often justified on the basis that ovarian 
weights are similar between the groups. However, as germ cells are only located in the ovarian 
cortex, differences in the development or volume of the ovarian cortex may not necessarily be 
reflected in ovarian weights. Secondly, a size bias is introduced. The larger the cells being 
counted, the more likely they are to appear in an individual histological section (279).  
To account for these type of errors, the current study uses stereological methods to provide 
accurate, unbiased estimates of total germ cell numbers within the ovary (279). The method 
first estimates the volume of the ovary or ovarian cortex using Cavileiris’ principle. Cavaleiri 
estimates the area of interest by counting points which overlay these areas, on regularly spaced 
sections. The areas are converted to volumes by multiplying the total area by the distance 
between the sections counted. For germ cell number, the ovarian cortex was used as the 
reference volume as all germ cells which go on to produce follicles are located in the cortex 
(34). The number of cells per unit volume of ovarian cortex is then estimated using a physical 
dissector. The physical dissector involves overlaying a counting frame of known area over an 
image containing ovarian cortex. Cells of interest are counted within the frame which were not 
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present in the same area of the preceding section. Combining the two values gives a reliable 
estimate of the number of cells per ovarian cortex (or effectively the ovary, as developing germ 
cells are only located in the ovarian cortex) (38, 279).  
These methods take account of any differences in cortical volume between the two groups being 
examined, and potential differences in germ cell size between the groups. Stereological methods 
have been previously used to examine fetal ovary development in sheep (38).  
In all stereological studies, the sampling strategy employed is critical to produce unbiased, 
accurate estimates. The sampling strategy used in the current work was based on previous 
stereological studies of fetal ovaries (38, 280). Sections were chosen using an independent 
uniform random sampling strategy (i.e. systematically from a random start). Areas to count 
were selected using a double random number method. Initially, a computer generated random 
number between 1 and 12 was generated, with the area selected to count being where the 
random number appears on a clock face. A second random number between 1 and 3 was 
generated to select the zone to count within the ovarian cortex, relative to the ovarian surface. 
This principle is illustrated in Figure 4.1, with an ovary inserted inside a clock face. Where the 
first random number is 8 and the second number is 2, the area to be counted is represented by 
the red square.   
When applying stereological techniques (both Cavaleiri and dissector) to quantify cells within 
an organ, the important variables to consider are the number of sections used, and the actual 
number of cells counted in the nucleator volume. Gundersen and Jensen recommend that 
provided the sampling strategy is appropriate, then counting more than 200 cells does not 
improve the accuracy of the estimation (281). In the current study, between 80 and 120 germ 
cells were counted in each day 55 ovary, and between 100 and 160 germ cells in each day 75 
ovary. The physical dissector was applied to an average of 10 section pairs for each day 55 
ovary, and 16 section pairs for each day 75 ovary.  
Each germ cell counted was classified as either an oogonia or oocyte based on morphological 
criteria (38). Oogonia, were smaller than oocytes, possessed an intact nucleus with a smooth 
well defined border and a heterogeneous staining pattern. Oocytes (germ cells that had entered 
meiosis) had either a homogeneous nucleus with an irregular border, or no nuclear membrane 
but with thread like chromatin material. Oocytes were, on occasions, enclosed in isolated 






















Figure 4.1 Principle of area selection for germ cell counting. Two random numbers are 
generated. The first number was between 1 and 12, which corresponds to the numbers on a 
clock face and indicates the area of the section to be examined. The second number was between 
1 and 3 and corresponds to the zone of the cortex to be examined. Where the first number is 8 




4.2.3 Application of stereology to fetal ovaries 
The equation used for Cavaleiris’ volume estimations was 
V = (A)2 x ∑P x D 
V = reference volume (for this study the ovarian cortex)                                                           
A = the area of each point (for this study 0.04 mm2 allowing for magnification)                           
∑P = the total number of points counted                                                                                               
D = distance between sections (for this study every 50th 5µm section was counted, therefore D 
was 250 µm, or 0.25 mm) 
 
For the physical dissector, firstly the volume used for counting on each pair of sections 
(nucleator volume) is calculated using the equation 
v = (a x d) x n 
v = volume in which cells were counted                                                                                       
a = area of the counting frame (for this study 0.12 mm2 allowing for magnification)                         
d = distance between adjacent sections counted (for this study 5 µm)                                                        
n = number of counting frames examined. 
 
The number of cells per ovary was then calculated using the equation  
N(gc) = (V/∑v) x n 
N(gc) = total number of number of germ cells                                                                           
V = reference volume (for this study, the cortex volume)                                                         
∑v = sum of nucleator volumes used                                                                                            




4.2.4 Basis of immunohistochemistry for identification of germ cell proliferation, 
autophagy and apoptosis 
Immunohistochemistry (IHC) for both proliferation and autophagy utilised the Dako 
EnvisionTM system (Dako EnvisionTM + Dual Link system-HRP DAB+. Cat K4065. Dako 
North America, Carpenteria, CA, USA). The envision system eliminates the use of biotin and 
streptavidin in the IHC process, thereby simplifying the protocol, reducing background 
staining, and increasing sensitivity. This is achieved by directly conjugating the HRP enzyme 
and secondary antibody (goat anti-mouse) to a dextran polymer. The concept of the Envision 
system is illustrated in Figure 4.2.  
 
 
Figure 4.2 Concept of the Dako Envision system.  Following incubation and binding of the 
1° Ab (Ki-67 for proliferation or MAPLC3 for autophagy) to the antigen in the section, the 
polymer (conjugated to the 2° Ab and HRP) is added. The 2°Ab then binds the 1°Ab. Addition 





Proliferative cells were identified using immunohistochemistry (IHC) against Ki-67, a protein 
present in the nuclei of some cells in the G1 phase of the cell cycle, and in all cells in the S, G2 
and M phases of the cell cycle. Quiescent cells in the G0 phase do not express the Ki-67 antigen. 
This makes Ki-67 a reliable means of assessing the fraction of proliferating cells within a large 
population of cells (282). 
Autophagy, often referred to as type 2 programmed cell death, is a process where cell 
components are degraded within membrane bound vesicles. IHC detection of MAPLC3 
(involved in expansion and fusion of autophagosomal membranes) used in the current study, is 
the most effective and widely accepted marker, largely because of its specificity compared to 
other autophagy markers  (283). 
Detection of apoptotic cells used the Terminal deoxynucleotidyl transferase dUTP nick end 
labeling reaction (TUNEL). TUNEL detects DNA fragmentation present during the final stages 
of apoptosis. dUTPs conjugated to biotin are enzymatically incorporated into the fragmented 
DNA and subsequently visualised using a streptavidin-HRP based detection system. Positive 
control sections were generated by incubation with a nuclease enzyme, supplied with the kit, 
and performing the labelling reaction. The nuclease enzyme generates breaks in the DNA in the 
section, and following completion of the protocol, all cells in the nuclease treated sections 
should stain positive indicating nicked DNA, mimicking apoptosis. Negative controls were 
created by omitting the terminal deoxynucleotidyl transferase (TdT) enzyme from the labelling 
reaction. This enzyme catalyses the insertion of biotinylated dUTP into breaks in the DNA. 
Following completion of the protocol, these sections should exhibit no staining. 
All IHC protocols were preceded by deparaffinisation followed by hydration steps. Following 





4.2.5 Immunohistochemistry for proliferating cells (Ki-67) 
Antigen retrieval was performed at 95°C in 10mM EDTA pH 8 for 20 minutes (2 x 10 minute 
incubations). After cooling for 20 minutes, a 5-minute peroxidase block was performed with 
0.3% hydrogen peroxide in methanol at room temperature (RT). Incubation with the 1°Ab  (1:50 
dilution in antibody diluent, Dako North America, Carpenteria, CA, USA. Cat S3022) was for 
30 minutes at RT, followed by a 30-minute RT incubation with the peroxidase labelled polymer 
(supplied ready to use). Following a 10-minute RT incubation with 3, 3 diaminobenzidine 
(DAB)/chromogen/substrate solution, cells were counterstained with 2% aqueous methyl green 
for 30 seconds. The primary antibody used was a monoclonal mouse anti-human Ki-67 (type 
IgG1), clone MIB1 (Dako, North America, Cat M7240). The negative control antibody used 
was Dako negative control mouse IgG1 (Dako, North America. Cat X0931). Sections of mature 
sheep ovaries containing numerous ovarian follicles, fixed and processed following a similar 
protocol, were included as positive control sections.  
4.2.6 Immunohistochemistry for autophagy 
Antigen retrieval was performed at 95°C in 10mM citrate buffer pH 6.0, for 10 minutes. 
Subsequent steps were identical to those used for proliferation (Section 4.2.5). The primary 
antibody used was mouse anti MAPLC3β monoclonal antibody (Santa Cruz Biotechnology, 
Dallas, TX, USA. Cat sc271625) of the IgG2b isotype at a 1:100 dilution. The negative control 
antibody used was Dako negative control mouse IgG2b (Dako, North America. Cat X0944).  
4.2.7 Immunohistochemistry for apoptosis (TUNEL) 
Apoptotic cells were detected using the Trevigen TACS 2 TdT-DAB In situ Apoptosis 
Detection kit (Trevigen, Gaithersburg, MD, USA. Cat 4810-30-K). The kit was optimised for 
sheep histological sections following the manufacture’s guidelines. Sections were then 
incubated in a 1:50 proteinase K solution for 15 minutes at 37°C (as per the manufacturer’s 
instructions). Following a 5-minute (RT) endogenous peroxidase block in 0.03% hydrogen 
peroxide in methanol, the labelling reaction was performed at 37°C for 60 minutes. The 
labelling reaction mix required the addition of one of three cations. Manganese at the 
recommended dilution was shown to produce optimal results and was included in all assays. 
Sections were subsequently incubated with SHRP complex for 10 minutes at 37°C. Following 
a 4-minute RT incubation in DAB, sections were counterstained with 2% methyl green.  
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4.2.8 Quantification of immunohistochemistry 
While stereology is appropriate for total germ cell numbers, the frequency of positively stained 
cells using IHC is relatively low, making the application of stereological methods to these 
samples impracticable. For these samples, either staining intensity or positive cells per area of 
ovary were used as an indicator of their relative number.  
Sections for IHC from each ovary were randomly selected based on computer generated random 
numbers, and the number of positive staining germ cells in each section were counted. To 
estimate the area of the ovary on the section, a 100 µm grid was superimposed over the image 
and the number of points over the ovary were counted. Three to four sections from each ovary 
were counted, with the values for the sections from an individual ovary being averaged prior to 
analysis. The number of positive staining cells were then divided by the number of points, with 
the result being expressed as the relative number of proliferating germ cells per unit area of 
ovary (volume from Cavaleiri Section 4.2.3).  
For autophagy, due to the widespread pattern of staining, an alternative strategy was employed 
to quantitate positive staining cells. Three micrographs were taken from randomly selected 
fields for each fetal ovary. Micrographs were taken at the same magnification (250x) under 
identical illumination conditions. The micrographs were assessed by three independent persons, 
with each micrograph being assigned a score between 1 and 5 based on the extent of staining. 





4.3.1 Ovarian morphology 
No gross differences in the morphology of fetal ovaries attributable to maternal restricted 
nutrition were evident at both days 55 and 75. At day 55 of gestation, development of ovigerous 
cords was well advanced. Within the ovigerous cords, germ cell proliferation was noted by the 
presence of mitotic figures. Some germ cells showed the lack of a discrete nucleus but the 
presence of thread like chromatin material, illustrating that meiosis had been initiated in these 
cells (Figure 4.3 C and D). The presence of small eosinophillic germ cells with darkly staining 
condensed nuclei indicated that apoptotic germ cells were also present (Figure 4.4 A and B). 
At day 75, the frequency of apoptotic bodies and meiotic germ cells was more prevalent than 
observed at day 55. Additionally, a small number of follicles were observed in all day 75 ovaries 
(Figure 4.3 E and F). A typical developmental gradient of germ cells was present with the most 
advanced germ cells (follicles) being evident in the inner most regions of the cortex (Figure 4.3 
E and F), while the least developmentally advanced (oogonia) were predominantly located 
towards the periphery of the cortex (Figure 4.3 D). 
Atresia of germ cells displayed a range of morphologies in both restricted and maintenance 
groups. Some germ cells displayed small dark condensed nuclei, often, although not always, 
accompanied by an eosinophilic cytoplasm. Other germ cells showed nuclei that had 
disintegrated, these cells in general did not show eosinophilia. A further morphology associated 
with germ cell atresia showed the presence of extremely large cytoplasmic vacuoles, these cells 
were often, but not always, associated with condensed nuclei.  Some cells displaying atretic 
morphology did not stain for TUNEL, while others, also displaying atretic morphology, did not 






Figure 4.3 Ovarian morphology in H&E stained sections. (M) = maintenance ovary, (R) = 
restricted ovary. (A) Day 55 (M) and (B) Day 75 (M). Showing presence of ovigerous cords 
(black arrows). In (B) expansion of the cords in the innermost regions of the cortex makes 
delineation of individual cords difficult at this magnification (white arrows). (C) Day 55 (R) 
and (D) Day 75 (M). Showing well defined cords partially outlined in red. Black arrows indicate 
germ cells showing a variety of nuclear morphologies representing differing stages of 
meiosis/mitosis. White arrows indicate pre-granulosa cells. (E) Day 75 (R) and (F) Day 75 (M). 
Showing examples of forming follicles (black arrows) and formed, isolated follicles (white 




Figure 4.4 Morphologies associated with germ cell atresia. (M) = maintenance ovary, (R) = 
restricted ovary. (A) Day 75 (M). Germ cell with condensed heterogeneous nuclei and 
eosinophilic cytoplasm (black arrow) and germ cell with pale heterogeneous nuclei and pale 
cytoplasm (white arrow). (B) Day 75 (R). Germ cells with condensed nuclei and eosinophilic 
cytoplasm (black arrows) and germ cells with extremely large cytoplasmic vacuoles (white 
arrows). (C) Day 75 (M). MAPLC3 staining. Germ cell with condensed nuclei showing no 
staining for MAPLC3 (black arrow). (D) Day 75 (R). MAPLC3 staining. Germ cells with large 
cytoplasmic vacuoles showing no staining for MAPLC3 (black arrows). (E) Day 75 (M) 
TUNEL. Adjacent germ cells with large cytoplasmic vacuoles (white arrows), left hand cell 
showing no staining, while right hand cell shows some staining. Black arrow shows germ cell 
with disintegrated nuclei showing no staining for TUNEL. (F) Day 55 (R) TUNEL. Black arrow 
shows germ cell with disintegrated nuclei showing no staining for TUNEL. 
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4.3.2 Ovarian volumes and germ cell numbers 
To test the accuracy of the sampling strategy used for stereology, two ovaries at each age were 
counted using twice the number of sections i.e. volumes on every 10th section, and cell counts 
on every 25th section. Results were then calculated for every 10th and 25th section and compared 
to results for the same ovaries calculated from every 20th and 50th section. For each of the two 
ovaries, the results did not differ by more than 10%, indicating the sampling strategy of every 
20th section for volumes and every 50th/51st section for cell counts was sufficient to produce 
reliable estimates. To ensure the consistency of the methodology, once all ovaries had been 
counted, one ovary at each age was recounted, with the duplicate values not differing from the 
original counts by more than 10%.  
The pattern of germ cell development in maintenance ovaries is similar to that reported by 
Smith and colleagues (38). From day 55 to day 75, total germ cell numbers increased 2.4 fold, 
with numbers of oogonia remaining static and oocyte numbers increasing 11 fold, see Table 
4.1. 
The effects of gestational nutrition on germ cell numbers and ovarian volumes are presented in 
Table 4.1. Significant effects of gestational age (p < 0.01, GLM) and group (p < 0.05, GLM) 
were noted for ovarian volume with no significant gestational age x group interaction. Similarly 
for cortex volume, effects of gestational age (p < 0.01, GLM) and group (p < 0.05, GLM) were 
noted with no gestational age x group interaction. There were no significant differences between 
nutritional groups at day 55 of gestation for ovarian or cortex volumes (ANOVA). At day 75, 
ovaries from fetuses exposed to restricted nutrition were significantly larger (p < 0.05, 
ANOVA), with a larger cortex volume (p < 0.05, ANOVA) when compared to ovaries from 
fetuses exposed to maintenance nutrition.  
Germ cell numbers, showed significant effects of gestational age (p < 0.01, GLM), and group 
(p < 0.01, GLM) with a significant gestational age x group interaction (p = 0.02, GLM). At day 
55 of gestation, there was no significant difference between nutritional groups in germ cell 
numbers (ANOVA), an observation also reflected in similar numbers of both oogonia and 
oocytes between the groups. At day 75 of gestation, ovaries from fetuses exposed to restricted 
nutrition contained 46% more germ cells when compared to ovaries exposed to maintenance 
levels of nutrition (p < 0.01, ANOVA). When examined further, the increase in germ cell 
number in day 75 restricted fetal ovaries was reflected in both significantly more oogonia (p < 
0.05, ANOVA) and more oocytes (p < 0.05, ANOVA). Germ cells classified as oocytes also 
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included the relatively small number of germ cells which were enclosed in isolated follicles. 
The number of follicles present was insufficient for accurate quantification. 
 
Table 4.1 Germ cell numbers and ovarian volumes estimated by stereology 
Volume or 
Cell number Age Maintenance Restricted 
Number of 
ovaries 
Day 55 6 7 
Day 75 8 7 
Ovary volume 
(mm3) 
Day 55 1.70 ± 0.19 1.93 ± 0.19 
Day 75 5.23 ± 0.37 6.39 ± 0.30* 
Cortex volume 
(mm3) 
Day 55 1.34 ± 0.13 1.53 ± 0.14 
Day 75 3.81 ± 0.26 4.74 ± 0.24* 
Germ Cell 
number 
Day 55 317,461 ± 37,367 333,484 ± 42,472 
Day 75 766,344 ± 19,070 1,122,285 ± 87,235** 
Oogonia 
Day 55 274,217 ± 31,414 256,789 ± 28,677 
Day 75 293,499 ± 32,810 453,904 ± 32,810* 
Oocytes 
Day 55 43,243 ± 6,486 76,696 ± 21,649 
Day 75 472,845 ± 41,190 668,381 ± 71536* 
Data are means and standard errors. * indicates p < 0.05, ** indicates p < 0.01 for between 




4.3.3 Germ cell proliferation 
Sections from the 28 fetal ovaries used for germ cell counts were used for all IHC protocols. 
Negligible staining was observed in both the negative controls (Section 4.2.4) (Figure 4.5 A) 
indicating that staining using the Ki-67 antibody was specific. Positive control sections of adult 
ovarian tissue showed extensive staining in follicular granulosa cells (Figure 4.5 B). Positive 
staining for proliferating cells was predominantly confined to germ cells, particularly those 
located towards the outer most regions of the ovarian cortex (Figure 4.5 C and D). Positively 
stained germ cells often occurred in groups or clusters (Figure 4, 5 C, E and F). Occasional cells 
of the ovarian surface showed positive staining (Figure 4.5 C and D). Pre-granulosa cells within 
the cords showed no staining (Figure 4.5 E and F). Considerable variation was noted in the 
number of stained cells between sections. Despite this variation, overall mean results were 
similar between most groups and ages. The densities of Ki-67 positive germ cells in the ovarian 
cortex are shown in Table 4.2. 
Overall there was no effect of gestational age (p = 0.6, GLM) or group (p = 0.06, GLM) on the 
density of Ki-67 positive staining cells, with no significant gestational age x group interaction 
(p = 0.2). ANOVA reported no significant differences between nutritional groups at day 55, 
however at day 75, the density of proliferating germ cells in ovaries from restricted fetuses was 
one quarter of that observed in maintenance animals (p < 0.01, ANOVA). Comparative 
densities between ages and groups are illustrated in Figure 4.6. 
 
 
Table 4.2 Density of proliferating (Ki-67 positive) germ cells  
Age Maintenance Restricted 
55 0.87 ± 0.43 0.76 ± 0.17 
75 1.01 ± 0.32 0.26 ± 0.09** 
Values means and standard errors of the number of positive staining cells per unit area of 





Figure 4.5 Staining for proliferating cells (Ki-67). (M) = maintenance ovary, (R) = restricted 
ovary. (A) Negative control. Incubated with non-immune serum showing no staining. (B) 
Positive control. Antral follicle from mature ovary showing extensive staining in granulosa 
cells. (C) Day 55 (M) and (D) Day 75 (R). Showing germ cells staining in the outer regions of 
the ovarian cortex (black arrows) with occasional staining in the ovarian surface (white arrows). 
(E) Day 55 (R) and (F) Day 75 (M). Showing staining specific to germ cells, often clustered 




Figure 4.6 Comparative densities of proliferating cells.  (A) Day 55 maintenance 
proliferating cell density approximately 0.9. (B) Day 55 restricted proliferating cell density 
approximately 0.9 (C) Day 75 maintenance proliferating cell density approximately 0.85. (D) 









 4.3.4 Autophagy 
Staining with the negative control antibody was negligible (Figure 4.7, A), indicating that the 
staining observed was specific for MAPLC3. At day 55, staining for MAPLC3 was 
predominantly confined to the ovigerous cords throughout the ovarian cortex (Figure 4.7 C and 
E). Within the ovigerous cords, staining appeared to be exclusively within the germ cells, with 
pre-granulosa cells showing no staining (Figure 4.7 B). At day 75, staining was significantly 
less intense (p < 0.05, ANOVA) and concentrated in the outer regions of the ovarian cortex 
(Figure 4.7 D and F). In general, germ cells that had completed meiosis displayed less intense 
staining than those actively undergoing meiosis, while those germ cells within forming or 
isolated follicles displayed little or no staining.  
With regards to assessment and grading of micrographs, the three independent graders assigned 
identical scores to 46% of the micrographs. For the remaining 54% of the micrographs, two 
graders assigned identical scores, while one grader’s score differed by 1 (e.g. the three scores 
assigned were 3, 3, 4). There was no individual grader who consistently differed in scores from 
the others. While it is accepted that the method applied is subjective, the consistency between 
graders gives a high level of confidence to the mean scores. In Figure 4.7, plates C and E are 
indicative of a score of 5, plate D a score of 3 and plate F a score of 2. The relative staining 
intensities are presented in Table 4.3. 
Table 4.3 Relative staining for autophagy (MAPLC3) 
Age Maintenance Restricted 
55 3.1 ± 0.3 2.9 ± 0.2 
75 2.2 ± 0.4 2.5 ± 0.3 
Relative staining was scored between 1 (light sparse staining), and 5 (intense widespread 
staining). No effect of group was noted.  
A significant effect of gestational age on MAPLC3 staining was noted (p < 0.05, GLM) with 
less staining apparent at day 75 when compared to day 55. No overall effect of group was noted, 
and no gestational age x group interaction was noted (GLM). No group differences in the 
relative staining for MAPLC3 were observed between nutritional groups at either day 55 or day 




Figure 4.7 Staining for autophagy (MAPLC3). (M) = maintenance ovary, (R) = restricted 
ovary. (A) Negative control. Incubated with non-immune serum showing no staining. (B) Day 
55 (M). Showing staining confined to germ cells (black arrows) while pre-granulosa cells show 
no staining (white arrows). (C) Day 55 (M) and (D) Day 75 (M). Showing reduced cortical 
staining at day 75 compared to day 55, the cortical–medullary boundary indicated by dashed 
line. (E) Day 55 (R) and (F) Day 75 (R). Showing both reduced staining area and intensity at 
day 75 compared with day 55 which shows positive staining largely confined to ovigerous cords 




4.3.5 Germ cell apoptosis 
Negligible staining was apparent on negative control slides (removal of the TdT enzyme) 
(Figure 4.8 A), while intense staining over the entire section was observed on positive control 
slides (addition of the nuclease enzyme, Section 4.2.4) (Figure 4.8 B). This indicates the 
protocol is specifically staining breaks in DNA. The pattern of TUNEL staining at both days 
55 and 75 indicated that the majority of apoptotic cells were germ cells located in the ovigerous 
cords of the ovarian cortex (Figure 4.8 E and F). The few exceptions to this observation were 
occasional vascular endothelial cells and cells of the connecting rete in the ovarian medulla. 
There appeared to be no discernible pattern related to the distribution of apoptotic germ cells. 
Positive cells occurred throughout the ovarian cortex both individually (Figure 4.8 C) and 
occasionally in clusters (Figure 4.8 D). The relative densities of apoptotic germ cells are 
presented in Table 4.4. 
No effect of gestational age was noted on the density of apoptotic cells, (p = 0.07, GLM). There 
was no overall effect of group (p = 0.5) and no gestational age x group interaction. There were 
no significant differences in the number of apoptotic cells attributable to nutritional group at 
either day 55 or day 75 of gestation (ANOVA).  
 
Table 4.4 Number of apoptotic cells per unit area of ovary   
Age Maintenance Restricted 
55 2.0 ± 0.5 1.3 ± 0.2 
75 1.6 ± 0.3 1.2 ± 0.1 




Figure 4.8 Staining for apoptosis (TUNEL). (M) = maintenance ovary, (R) = restricted ovary. 
(A) Day 75 (M). Negative control. Without TdT enzyme showing no staining. (B) Day 75 (R). 
Positive control. With addition of nuclease enzyme. (C) Day 55 (M), and (D) Day 75 (R). 
Showing variation and random appearance of apoptotic germ cells (black arrows) throughout 
the cortex. (E) Day 55 (R), and (F) Day 75 (M). Ovigerous cords with positive staining 







Stereology and IHC were used to analyse fetal ovaries exposed to either maintenance or 
restricted nutrition to determine whether the nutritional restriction affected germ cell and 
ovarian development. 
The absence of significant group effects at the cessation of nutrition restriction (day 55), is 
consistent  with the concept that restricted gestational nutrition, at levels used in this study, had 
no direct effect on fetal ovarian or germ cell development as assessed by these morphological 
criteria. The differences in maternal metabolic factors and endocrinology at day 55 of gestation 
reported earlier (Section 3.3.2) do not appear to have directly affected germ cell proliferation, 
apoptosis, or autophagy as evidenced by staining for markers of these processes (Ki-67 for 
proliferation, TUNEL for apoptosis and MAPLC3 for autophagy). It is however, intriguing that 
20 days following cessation of restricted maternal nutrition, germ cell numbers in ovaries from 
fetuses exposed to restricted nutrition were significantly increased when compared to fetal 
ovaries exposed to the maintenance diet. Thus, the observed changes to germ cell numbers may 
not be the result of restricted nutrition, but the result of the change from restricted nutrition to 
ad libitum nutrition. This does not preclude the possibility that the restricted nutrition produces 
delayed effects on ovarian development. Such a scenario has been demonstrated in sheep by 
Rae and colleagues (178) where gestational undernutrition for the first 30 days of pregnancy 
produced an effect on follicle development at day 100 of gestation. However, this period of 
nutrition (mating – day 30) did not affect ovarian development at day 65 of gestation. Thus the 
differences in germ cell numbers reported at day 75 in the current study appear less likely to be 
a delayed response to the earlier undernutrition. Of interest with respect to fetal exposure to 
endocrine disrupting chemicals (EDCs), Lea and colleagues (284) conclude that a change in 
fetal environment appears to be more detrimental than a consistent exposure to EDCs. While 
the current study focuses on differing levels of nutrition, the emerging hypothesis is similar to 
the conclusion of Lea and colleagues in that it is the change in fetal environment which may be 
responsible for the observed effects 
The possibility of the change in nutritional status (from restricted to ad libitum and the growth 
spurt shown by restricted animals) being ultimately responsible for the effects seen in adult 
animals was raised during the discussion in Chapter 2. The germ cell data provides further 
evidence that this change in status may be the key in establishing the observed effects. 
Additionally, the data from Chapter 3 was consistent with the effects seen in adult ewes being 
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ovarian driven. (Section 3.4). The fetal ovary data, showing nutritionally induced changes to 
fetal germ cell development, support the hypothesis that the observed effects thus far are 
ovarian driven. 
Studies to date have relied on germ cell densities (159, 171) when considering germ cell 
numbers, failing to account for ovarian volume and more importantly ovarian cortical volume. 
Germ cells are confined to the ovarian cortex and as the fetal ovary develops and germ cell 
numbers increase, the cortical volume increases to accommodate these additional germ cells 
(38). Following the substantial wave of atresia and the loss of approximately 80% of germ cells 
between days 75 and 90 of gestation, cortical volume decreases (38). This implies that changes 
in fetal ovarian germ cell numbers are unlikely to be reflected in the density of these cells, but 
in the volume of the ovarian cortex. This concept is supported by the observation in this study 
where the increased numbers of germ cells in restricted ovaries at day 75 of gestation is 
accompanied by a corresponding increase in cortical volume. Further, a 1.25 fold increase in 
cortex volume and a 1.5 fold increase in germ cell number implies that the density of germ cells 
between the two groups may be quite similar. In the current study, the 1.5 fold increase in germ 
cell numbers observed at day 75 translates to a 1.18 fold increase in germ cell density based on 
both ovarian volume and cortex volume, potentially making this smaller difference in density 
more difficult to detect. The use of stereological methods in this study overcomes the issues 
associated with cortical or ovarian volumes, and for the first time provides accurate, unbiased 
estimates of germ cell numbers in fetal ovaries exposed to restricted maternal nutrition. 
One aspect of germ cell development not studied in detail in the current study is meiosis. 
Quantification of cells positive for factors such as STRA8 or DAZL, expressed in meiotic or 
arrested germ cells, could establish whether restricted nutrition has affected levels or timing of 
meiosis. However, were alterations to the regulation of meiosis to be the mechanism underlying 
the increased germ cell numbers at day 75, then one might expect to see either increased oogonia 
at day 75 (reduced meiosis), or increased oocytes (increased meiosis) at day 75, but not both 
simultaneously. Restricted ovaries contain 1.5 fold more total germ cells, 1.5 fold more 
oogonia, and 1.4 fold more oocytes. The similarities in these fold changes would suggest that 
changes to meiosis is not the mechanism underlying increased numbers of germ cells. The 
mechanism, be it proliferation, apoptosis, survival, or some other mechanism, by which 
increased germ cell numbers arise in restricted ovaries, may be active in a brief transition period 
following the change in nutrition levels. 
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The finding of lower proliferation rates at day 75, when germ cell numbers are higher, is 
consistent with an advancement in the timing of germ cell development in ovaries from 
restricted fetuses, and that ultimately, germ cell numbers in maintenance ovaries (where 
proliferation rates are higher than restricted ovaries) may reach parity with germ cell numbers 
in restricted ovaries. The similar levels of apoptosis at day 75 would support this contention. 
Conversely, female offspring from the dams exposed to restricted gestational nutrition have a 
higher AFC than those from maintenance dams (Section 2.3.6), and as a relationship has been 
demonstrated between AFC and ovarian reserve, it would seem that the differences in germ cell 
numbers observed at day 75 may lead to differences in ovarian reserve. It remains to be seen 
whether this apparent alteration in germ cell development leads to differences in ovarian 
reserve, or whether germ cell numbers in maintenance ovaries reach similar levels, but at a later 
age. Future examination of fetal ovaries in late gestation would clarify any effects on ovarian 
reserve. Additionally, examination of fetal ovaries between day 55 and day 75 may identify the 
mechanism by which increased germ cell numbers are observed at day 75.  
IHC results for Ki-67 showed wide variation in the numbers of proliferating germ cells between 
individual sections within an ovary. Further, staining often occurred in small clusters. These 
effects may be due to the location of positive cells with respect to structures such as developing 
blood vessels, or concentrations of stromal cells, both possible sources of factors regulating 
germ cell proliferation. The lower density of proliferating germ cells at day 75 is consistent 
with the study of Lea and colleagues who reported decreased levels of Ki-67 staining at day 65, 
following restricted maternal nutrition between days 31 to 50 (171).  
In the same study, Lea and colleagues also suggested a link between restricted nutrition and 
increased expression levels of the pro-apoptotic factor BAX at day 65. This would suggest 
increased apoptosis and consequently fewer germ cells in restricted ovaries, an observation not 
supported by the data presented in this work. In the current study, levels of germ cell apoptosis 
were not different between the groups at either day 55 or day 75. Regulation of apoptosis is 
often considered a balance between a number of BCL-2 family members including the pro-
apoptotic genes (e.g. BAX, BAK, BOK, BLK, BNIP,  BAD, BID, BIM and EGL-1 ), and anti-
apoptotic genes (e.g. BCL2, BCL-XL, MCL-1, A1, BCL-W) (285). Additionally the list of genes 
and factors that contribute to the regulation of apoptosis is considerable (51) with any number 
of these factors potentially being affected by restricted nutrition. Results of the gene expression 
analysis (Chapter 6), will offer more insights into the regulation of apoptosis in these fetal 
ovaries, particularly whether BAX is up-regulated as in the study of Lea and colleagues. 
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The similarities in the levels of apoptosis (as detected by TUNEL) between groups however, 
suggest that apoptosis has not been affected by the restricted nutrition at the ages examined. 
While apoptosis is considered the primary mechanism by which fetal germ cells are lost (286), 
there is the likelihood of alternative mechanisms of germ cell loss not examined in the current 
study. The range of morphologies shown in Figure 4.4 along with lack of staining for TUNEL 
and MAPLC3 for many germ cells showing evidence of cell death would seem to support this 
concept. Both Wartenburg and colleagues (287) and McClellan and colleagues (288) report a 
novel non-apoptotic cell death pathway which may be responsible for a considerable amount 
of germ cell loss. Given this, while levels of apoptosis and autophagy between the nutritional 
groups is similar at both ages, differences in germ cell loss between groups cannot yet be 
discounted as a mechanism underlying the observed difference in germ cell numbers.  
The use of IHC to identify, and quantify autophagy is a novel approach to the assessment of 
experimentally induced differences in germ cell development. The staining pattern observed, 
with staining less intense and less widespread at day 75 when apoptosis of germ cells is 
increasing markedly, appears to fit the findings of Gawriluk and colleagues (289). In the mouse, 
Gawriluk and colleagues concluded that autophagy may be an important regulator of germ cell 
survival prior to the formation of the primordial follicle pool. In the rat however, Escobar and 
colleagues propose a role for autophagy in oocyte death (290) with the majority of dying 
oocytes simultaneously displaying features of apoptosis (TUNEL and caspase 3), and 
autophagy (increased acid phosphatase activity and IHC for LAMP1). The focus of the Escobar 
study appears to be on oocytes within follicles, whereas in the current study and that of 
Gawriluk, the focus is on pre-follicular oocytes.  While some follicles have formed at day 75, 
staining for MAPLC3 in the germ cells in these follicles is not apparent. Further, the germ cells 
within the newly formed follicles do not appear to show apoptosis. This lack of staining in 
follicular oocytes may reflect the low numbers of follicles present at this age. However, it is in 
agreement with the findings of Fulton and colleagues who note low germ cell death following 
follicle formation, a result of a protective follicular environment (48). Both the pattern of 
MAPLC3 staining and expression levels of autophagy associated genes at later gestational ages 
may indicate whether a shift in the function of autophagy is apparent between pre-follicular 
oocytes and follicular oocytes. The relative expression levels of autophagy associated genes has 
been proposed as a method of determining the role (either cell survival or cell death) of 
autophagy in a given tissue. Expression levels of these genes will be examined in Chapter 5. 
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Overall, the results from the analysis of fetal ovaries in this section show no direct or immediate 
effect of nutritional restriction on germ cell development at day 55 as assessed by germ cell 
numbers, proliferation rates, apoptosis rates, and levels of autophagy. However, following 
cessation of nutritional restriction, an increase in germ cell numbers is observed in ovaries 
exposed to restricted nutrition compared to maintenance ovaries. The mechanism by which this 
increase occurs is unclear, and may be active for only a brief period following cessation of 
nutritional restriction.  The emerging hypothesis is that rather than nutrition restriction, it is the 
change from restricted to ad libitum nutrition which has established the effects seen in this 
study.  
Alterations to nutrition are known to have impacts on the gene expression patterns of a number 
of mammalian cell types (291). Restricted gestational nutrition or a change in nutrition (from 
restricted to ad libitum) may affect genes or pathways involved in germ cell development. 
Identification of alterations in gene expression in fetal ovaries may provide some insights into 
the mechanism(s) underlying the observed changes. Additionally, analysis of expression levels 
of autophagy associated genes may help determine the functional role of autophagy in the fetal 















Chapter 5 . Application of RNAseq to Fetal Ovaries 
5.1 Introduction 
The data presented in the preceding chapters demonstrates that the nutritional restriction regime 
employed in this study increased indicators of fertility in adult female offspring, with these 
changes appearing to be ovarian in origin. The increased indicators of fertility observed in 
female offspring are contrary to most published studies in this field (167, 173). These changes 
may stem from differences in fetal ovarian development, given that this is when restricted 
nutrition was applied, and that differences in fetal germ cell numbers are apparent at day 75 
(Section 4.3.2). How nutrition affects events at the cellular level is likely to hold the key to 
understanding the relationship between nutrition, ovarian development, and postnatal fertility. 
Identifying the mechanisms underlying this relationship may pave the way for the development 
of practical applications to improve fertility in domestic livestock. 
RNAseq was considered the ideal method for the current study for several reasons. Firstly, 
RNAseq examines the whole transcriptome. Providing sample size and sequencing depth are 
adequate, data will be generated for all genes that express mRNA (292). Secondly, while not a 
focus of this study, RNAseq will provide expression data for gene splice variants. 
The data from the current study and previous studies suggest alterations to germ cell 
development may underlie the effects of gestational nutrition (10, 159). This study uses whole 
fetal ovaries to examine gene expression. Isolation and characterisation of germ cells is feasible 
for a study of this nature, however such a strategy would ignore the potential roles of other 
ovarian cell types. Additionally, the acute cell stress resulting from any isolation process is 
likely to alter gene expression from the native state. 
At day 55 of gestation, pre-granulosa cells are in close contact with germ cells (34). It is thought 
that additional pre-granulosa cells are being recruited from cells near the ovarian surface (28, 
29), with these cells most likely derived from GREL cells (28). In the rodent it has been shown 
that the mesonephros or mesonephros-derived cells are critical for producing the signal(s) 
initiating germ cell meiosis, primarily retinoic acid (44). At day 55 in the sheep fetal ovary, 
migrating mesonephric cells form a large distinct structure in the ovarian medulla. Both pre-
granulosa and mesonephric derived cells seem likely to play a significant role in germ cell 
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development. Thus, the strategy of using whole fetal ovaries will allow the possible roles of 
these cell types to be considered. 
While the focus of this study is on differential gene expression between fetal ovaries from 
maintenance and restricted dams (presented in Chapter 6), analysis of expression of autophagy 
related genes may help to determine whether autophagy is involved in cell survival or cell death 
in sheep fetal ovaries at the ages examined in the current study (day 55 and day 75). The same 
proteins/genes are involved in both the cell death and cell survival aspects of autophagy. 
However, Tsujimoto and Shimizu (293) concluded that the level of expression of the autophagy 
associated genes ATG5 and ATG6 can distinguish between the cell death and cell survival 
processes. During the cell survival process, the expression levels of ATG5 and ATG6 remain 
low, but are highly up-regulated during autophagic cell death when compared to other 
autophagy related genes (293). While the evidence from Section 4.3.4 suggests that autophagy 
is playing a role in cell survival, expression levels of autophagy related genes may provide 
further supporting evidence for this contention. 
Therefore, the aim of the work presented in this chapter was to use RNAseq to generate high 
quality data describing the expression of genes in day 55 and 75 fetal ovaries. This data will be 
related to developmental processes previously discussed in this thesis. Analysis of the data 
generated for differential gene expression will be presented in Chapter 6. 
5.2 Materials and methods 
5.2.1 The concept of RNAseq 
The fundamental concept of RNAseq involves the alignment of short, sequenced fragments of 
cDNA generated from sample mRNA to a reference genomic database (292). A reference 
genomic database is a complete nucleic acid sequence of DNA from a particular species. Over 
time these databases become increasingly annotated (where particular sequences within the 
database are assigned to specific genes). Therefore, sample sequences aligned to database 
sequences can be assigned to specific genes.  
The process from a fetal ovary to gene expression data is complex and has been illustrated in 
Figure 5.1. More than one technical option is available to achieve the desired outcome at most 
steps in the process. In Figure 5.1, the steps highlighted in bold font indicate where more than 





Figure 5.1 Diagram outlining workflow from RNA extraction to data analysis.  Items in 
bold indicate steps where more than one protocol was trialled. Differential gene expression and 
data analysis are presented in Chapter 6. 
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5.2.2 Extraction of total RNA 
5.2.2.1 Assessment of RNA extraction procedures 
Selection of a nucleic acid extraction procedure considered isolation of both DNA and RNA 
from a single sample. DNA isolation was included for prospective future epigenetic studies. 
Fetal testes were used to compare the performance of two technologies. These technologies 
were: Trizol-chloroform based extraction procedures (easy-BLUE, INtRON Biotechnology, 
South Korea), and column based extraction procedures (Zymo Duet, Zymo Research, Irving, 
CA, USA). 
For these trials, RNA concentrations, fragment size distributions, and quality were measured 
using a Bioanalyser (Agilent 2100, Agilent Technologies, Santa Clara, CA, USA). The RNA 
6000 pico kit (Agilent Technologies) was used following the manufacturer’s instructions with 
samples diluted 1:200. The Bioanalyser uses miniaturised versions of agarose gels 
(electropherograms) within multi-well chips. Chips and kits are specific for the nucleic acid 
being measured and its expected concentration. RNA quality is reported as a referential integrity 
value (RIN). Figure 5.2 compares electropherogram traces from samples with high quality and 





Figure 5.2 Calculation of RIN values for RNA quality assessment. Electropherogram traces 
showing profiles for high quality RNA (RIN 9.7), and low quality RNA (RIN 6.2). In 
calculating a RIN value, algorithms compare the area, intensities and ratios of the indicated 
areas: A = pro region, B = marker, C = 5S region, D = fast region, E = 18S fragment, F = inter 
region, G = 28S fragment, H = precursor region, and I = post region. 
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RIN values range from 1 (very poor quality) to 10 (very high quality). Reported lower limits of 
RIN values used in RNAseq vary, from as low as 3.9 to as high as 8. However, decreasing RNA 
quality can affect the expression results obtained (294), thus a RIN value of 7 is widely 
considered the minimum required for RNAseq. DNA contamination of RNA samples was 
measured using a Qubit assay (dsDNA BR, Thermo Fisher Scientific, Auckland, NZ) following 
the manufacturer’s instructions.  
5.2.2.2 RNA extraction using Trizol  
Trizol procedures are based on organic extraction resulting in the separation of RNA into an 
aqueous phase, proteins and lipids into an organic phase, and DNA into an interphase between 
the aqueous and organic phases (295, 296).  
Trizol extraction largely followed the manufacturer’s guidelines. Testes were homogenised 
(Ultraturrex, Ika Labotechnik T25) in 600 µL of Trizol (based on 1 mL per 50 to 100 mg of 
tissue). Phase separation was achieved by the addition of 200 µL of chloroform and incubating 
at RT for 3 minutes. Following centrifugation at 13,000 g for 10 minutes at 4°C (Heraeus Fresco 
17, Thermo Fisher Scientific, Auckland, NZ), the upper aqueous layer containing RNA was 
collected. RNA was precipitated by the addition of 400 µL of isopropanol, incubating for 10 
minutes at RT and centrifuged (12,000 g for 5 minutes at 4°C). The pellet was washed using 1 
mL of 75% ethanol, and centrifuged (12,000 g for 5 minutes at 4°C). Following aspiration of 
the ethanol, the pellet was air dried at RT for 5 minutes and dissolved in nuclease free water.  
The narrow interphase layer (between the upper aqueous phase and the lower phenol phase) 
contained DNA. This layer was also collected and the DNA precipitated by addition of 200 µL 
of ethanol and centrifugation at 2000 g for 5 minutes at 4°C. Two washing steps were performed 
by re-suspending in 0.1M sodium citrate in 10% ethanol, incubating for 30 minutes at RT and 
centrifuging (2000 g for 5 minutes at 4°C). The pellet was resuspended in 1.5 mL of 75% 
ethanol and incubated for 15 minutes at RT.  Following a final centrifugation at 2000 g for 5 
minutes at RT, the ethanol was aspirated and the pellet air dried for 5 minutes at RT. The DNA 
pellet was dissolved in 8 mM NaOH. 
Variations to the manufacturer’s protocol tested included alterations to reagent volumes to 
increase DNA recoveries or concentrations. Differing ratios of Trizol:chloroform:ethanol used 
were: 600:200:200, 600:400:400, 600:100:100, 600:200:400, and 600:400:600. Secondly, the 
use of an agarose based phase lock gel (PLG Heavy, 5 Prime, Gaithersburg, MD, USA) was 
tested. This gel creates a physical barrier between the aqueous and interphase layers, improving 
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purity of both the RNA and DNA recovered. Following the manufacturer’s protocol, 600 µL of 
phase lock gel was added to the Trizol:chloroform mix. Following centrifugation, the phase 
lock gel formed a barrier between the aqueous and organic phases facilitating the removal of 
each layer. Finally, following the completion of the extraction procedure, purification of RNA 
using column technology was trialled (RNeasy Mini Kit, Qiagen, Hilden, Germany, or Zymo 
spin IIIC columns, Zymo Research Corporation, Irving, CA, USA). The manufacturer’s 
protocols were followed for these post extraction procedures. Trizol protocols and results are 
presented in Table 5.1 (Section 5.3.2).  
5.2.2.3 RNA extraction using binding columns 
Column based procedures utilise the properties of nucleic acids to bind to silica filters under 
specific buffer conditions (297). 
Column extraction used the Zymo Duet kit (Zymo Research Corporation, Irving, CA, USA. Cat 
D7001) initially following the manufacturer’s protocol. In-column DNase digests were 
performed using the supplied reagents following the manufacturer’s guidelines. Additional 
DNase digests were performed using the Ambion DNA-free kit following the manufacturer’s 
guidelines (Ambion, Carlsbad, CA, USA. Cat 1906). Homogenised samples were first 
centrifuged (13,000g for 1 minute at RT, Eppendorf Minispin. Eppendorf, South Pacific, Ryde, 
NSW, Australia) through a DNA binding column with the flow-through then centrifuged 
through an RNA binding column. Nucleic acids were eluted from their respective columns and 
assessed. This kit is designed for use with cell suspensions, and initial results with fetal testes 
led to the columns quickly reaching their maximum binding capacity resulting in low RNA and 
DNA yields, as well as high DNA contamination of the RNA sample. Variations to the 
manufacturer’s protocol were aimed at overcoming this issue, and are described alongside the 
results in Table 5.2 (Section 5.3.2). The most efficient modified protocol is outlined in Figure 





Figure 5.3 Optimised protocol used for RNA extractions.
Each aliquot centrifuged through a DNA 
  
The DNA is double eluted in 55 µL 
The 2 aliquots of DNA are stored  
at -80°C 
Each flow through centrifuged through a 
DNA binding column 
Each flow through centrifuged through a 
RNA binding column 
Homogenisation of 1 tissue  
Sample centrifuged through a QIAshredder 
column  
Sample split into 2 aliquots 
Flow through is 
discarded 
In-column Dnase digest  
The RNA is double eluted in 
55 µL 
Dnase digest performed on each 
RNA sample. The 2 aliquots of 
RNA are stored at -80°C 
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5.2.3 Confirmation of fetal sex by PCR 
Sex determination of sheep fetuses at day 55 and day 75 is a straight forward procedure based 
on the appearance of external genitalia (i.e. the presence of absence of a scrotum). Additionally, 
fetal testes are twice the weight of fetal ovaries at these ages. However, as a further safeguard 
to ensure identification and labelling procedures were correctly implemented, DNA extracted 
from fetal ovaries (Section 5.2.2) was used for PCR based sex determination. Primers were 
designed against ovine SRY and produce a 527 base pairs (bp) PCR product and ovine β-actin 
to produce a 420 bp PCR product (See Appendix E). Primers were sourced from Integrated 
DNA Technologies (IDT Pte. Ltd. Baullkham Hills, NSW, Australia). Samples showing the 
presence of both SRY and β-actin were designated male, while samples showing the absence 
of SRY but the presence of β-actin were confirmed as female. The method has been previously 
described by Lun (33). Briefly, a cocktail was prepared of 12.5 µL PCR master mix (PlatinumTM 
Hot Start Master Mix, Thermo Fisher, Auckland, NZ. Cat 13000013), 1 µL of forward primer, 
1 µL of reverse primer (10 pmol/µL), and 10 µL of DNA sample (20 to 50 ng/µL). Following 
the PCR reaction (Eppendorf Mastercycler. Eppendorf South Pacific, Ryde, NSW, Australia), 
electrophoresis of the PCR products was performed on a 2% agarose gel containing ethidium 
bromide (10 µL of 10 mg/mL of ethidium bromide per 100 mL of agarose). Product sizes were 
determined by comparison to a standard size marker (1kb Plus, Thermo Fisher Scientific, 
Auckland, NZ, Cat 10787018). Electrophoresis gels were visualised on a Bio Rad Gel 
documentation system using Quantity One software (V4.6.3) (Bio Rad Scientific Ltd, Hercules, 
CA, USA). SRY product was sequenced by the University of Waikato sequencing facility 
(WDSF, University of Waikato, Hamilton, NZ). Using the National Centre for Biotechnology 
Information (NCBI) nucleotide blast tool, the sequence was compared to the NCBI nucleotide 
collection. For primer sequences and PCR cycling conditions see Appendix E. 
5.2.4 ERCC spike-in control mixes 
ERCC (External RNA Control Consortium) control mixes are synthetic RNA fragments of 
known sequence, sizes, and concentrations. Two spike-in mixes were used, each mix containing 
92 polyadenylated transcripts. The transcripts within each mix span a wide range of 
concentrations. Subsequent analysis of the known concentration of these controls compared to 
the measured concentration allows an assessment of the dynamic range of the data, (i.e. the 
lower limit of detection and upper limit of detection).  
Each of the 2 mixes contain the same transcripts at defined concentration ratios of 0.5, 0.67, 1, 
and 4 relative to each other. Comparison of the known concentration ratios to the measured 
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concentration ratios allows assessment of the fold change data generated from experimental 
data.  
ERCC control mixes (Ambion ERCC Spike-In Control Mixes, Cat 4456739. Thermo Fisher 
Scientific, Auckland, NZ)) were added to total RNA samples (6 µL of the supplied reagent at a 
1:100 dilution in nuclease free water) prior to mRNA enrichment (Section 5.2.5) with 12 
samples receiving ERCC mix 1, and 11 samples receiving ERCC mix 2. Concentration and fold 
change values for the ERCC control mixes are given in Appendix F.  Analysis was based on 
user guide published by the manufacturer (298). Data for each ERCC transcript (length and 
sequence) were added to the sheep genome reference files used for bioinformatics analysis of 
sequence data alignment (Section 5.2.11) and the generation of expressed gene lists (Section 
5.2.12). This approach allowed the ERCC transcripts to be subjected to the same experimental 
and normalisation procedures as the sample transcripts. Measured fragments per kilobase of 
exon, per million reads (fpkm) values for the ERCC controls could then be plotted against the 
known concentration of each ERCC transcript. Using an iterative approach, outliers with either 
low or high fpkm values were removed until an R2 value of > 0.9 was achieved. This then 
determined the upper and lower limit of detection for gene expression in the fetal ovary dataset. 
5.2.5 mRNA enrichment  
RNA extracted from tissue includes only a small proportion of mRNA (<5%) (299). The 
majority of RNA is rRNA which is involved in translation but does not represent transcribed 
genes. mRNA indicates potential proteins synthesised by the fetal ovary. Additional RNA types 
present, but not of interest in this study include: transfer RNA, micro RNA, small interfering 
RNA, small nucleolar RNA, and Piwi-interacting RNA (300). rRNA must be removed from 
RNAseq samples so that informative mRNA transcripts can be measured at greater sequencing 
depths. rRNA can be removed either by rRNA subtraction, or enrichment of mRNA. Removal 
of rRNA is a more complex method and is generally used where the small RNA types are an 
important component of the study.  In this study, mRNA enrichment was undertaken using the 
Dynabead mRNA Direct Micro kit (Thermo Fisher Scientific, Auckland, NZ), following the 
manufacturer’s directions for samples containing 1 to 50 µg of RNA. The method utilises the 
polyA tail at the 3´ end of the mRNA. This tail binds to an Oligo dT sequence attached to a 
magnetic bead. A magnet is used to capture the Oligo dT/mRNA complexes from the total RNA 
solution. After a buffer wash to remove as much non-specifically bound rRNA as possible, 
mRNA is eluted from the Oligo dT/bead complexes by a 65°C incubation in 10mM Tris-HCl 
for 2 minutes. 
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5.2.6 RNA fragmentation  
RNAseq platforms sequence relatively short lengths of mRNA, with the ideal length being 
platform dependent (292). In this instance, the platform used was the Ion Proton which can read 
fragments up to 200 bp in length. mRNA was fragmented with an RNaseIII digestion at 37°C 
(RNase III included in Ion Total RNA-Seq kit V2. Thermo Fisher Scientific, Auckland, NZ). 
A digestion time of 3 minutes was found to give mRNA fragments of the appropriate size. The 
distribution of fragment sizes was determined using the Bioanalyser (RNA 6000 pico kit, 
Agilent 2100, Agilent Technologies, Santa Clara, Ca, USA), as described in Section 5.2.2, at a 
dilution in nuclease free water of 1:20. 
5.2.7 Library preparation 
Current sequencing technologies are unable to directly sequence RNA fragments, therefore, 
mRNA is converted to cDNA followed by amplification prior to sequencing cDNA. 
Additionally, adaptors, barcodes, primer sites, and calibration sequences are all ligated to the 
cDNA fragments to make the sequencing library. Figure 5.4 illustrates the structure of an 
individual cDNA fragment following library construction with references to sections that 
explain the roles of each library adaptor component. 
Libraries were constructed using the Ion Total RNA-Seq kit V2 (Thermo Fisher Scientific, 
Auckland, NZ) as per the manufacturer’s instructions for fragmented poly (A) RNA up to 5 µg.  
A 3 µg aliquot of each mRNA enriched sample was used for library construction. The quality 
and concentration of each completed library was assessed with the Bioanalyser, using the 














Figure 5.4 Components of each fragment of a completed cDNA sequencing library.   References to thesis sections explains the functions of each 





5.2.8 Emulsion PCR and enrichment of Ion Sphere Particles 
Emulsion PCR is the chemical cloning of individual library fragments and the attachment of 
numerous cloned copies of unique fragments to sequencing beads (Ion Sphere Particles or 
ISPs). This process is shown in Figure 5.5, and is reviewed by Kohn et al (301).  
In Figure 5.5 A, an emulsion is created by the addition of oil, PCR reagents, Ion Sphere Particles 
(ISP´s), and a library sample. The purpose of the emulsion is to create aqueous droplets within 
which the chemical cloning reactions take place. The size of the aqueous droplets (termed mi-
cells or micro-reactors) in this emulsion are critical. This size distribution follows a Poisson 
distribution and is dependent on the ratio of the individual reagents, as well as the degree of 
agitation the emulsion is subjected to. The optimally sized micro-reactor will contain one ISP, 
one library fragment, and PCR reagents (Figure 5.5 B). The adapter (“hook”) previously ligated 
to the 3ʹ end of the fragment, binds to a complimentary sequence with which the ISP is coated. 
Repeated PCR amplification cycles then detach the fragments, amplify them using the primer 
sites (also previously ligated to the library fragments) and reattach clones of the original 
fragment to the ISP (Figure 5.5 C). Following repeated cycles, the emulsion is broken using a 
detergent buffer, creating a suspension with millions of ISPs, each with up to 30,000 clones of 
a unique fragment (templates) attached (Figure 5.5 D).  
In practice, most ISPs do not contain templates, so an enrichment step is required. A primer 
(complimentary to adapter 2, Figure 5.4) conjugated to biotin, binds to the end of the bead 
attached templates. Streptavidin coated magnetic beads are added (Figure 5.5 F), and following 
the streptavidin-biotin binding reaction, ISPs that are coated with template can be separated 
from the mixture magnetically. The template containing beads are centrifuged onto a multi-
welled chip (Ion PI v2, Thermo Fisher Scientific) and subsequently sequenced. The goal is to 
achieve a chip that has a single ISP in each well. The sequence of the fragments (up to 30,000) 
in each well is identical, while the sequence of the fragments in individual wells differs from 
well to well. In reality, between 20 to 50% of wells contain more than one ISP, and these 
polyclonal wells are automatically removed from the analysis by the Ion Torrent software.  The 
emulsion PCR and enrichment process were performed using the Ion One Touch 2 System and 












Each RNAseq platform uses different technologies for sequencing. The Ion Proton technology 
used in this study is referred to as “sequencing by synthesis” and measures changes in pH when 
nucleotides are incorporated into a complimentary sequence.  In each well of the Ion PI v2 chip, 
DNA strands are synthesised complimentary to the template fragments anchored to the ISP. 
The Ion Proton sequentially flows single nucleotides across the chip. If the next base in the 
template is complimentary to the base flowing over the chip, it is incorporated into the 
sequence. The incorporation releases an H+ ion, resulting in a pH change, which is recorded by 
semiconductors at the base of each well. Each incorporation reaction occurs up to 30,000 times 
in each well, corresponding to the number of cloned fragments attached to the ISP. 
For this study, the term Ion Proton run is defined as the sequencing from a single chip. The 
sequencing process is illustrated in Figure 5.6. The pH range for a single base incorporation for 
each well is determined using the calibration sequence (A-T-C-G) ligated at the beginning of 
each fragment template during the library construction process. As the number of fragments 
attached to the ISP may vary from well to well, calibration of each well is critical. The first 
bases sequentially added (T-A-G-C) are complimentary to the calibration sequence. This allows 






Figure 5.6 Principles of Ion Proton sequencing by synthesis. Individual bases are added 
sequentially and a complimentary DNA strand is synthesised. If the next available base in the 
fragment sequence is complimentary to the added base, incorporation occurs, which releases an 
H+ ion resulting in a pH change which is detected by the instrument. 
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As sequencing progresses, subtle changes to the measured pH profile, reaction chemistry, and 
template integrity causing drift from the expected profile become apparent. These errors 
contribute to the generation of a Phred score for each base call. 
Phred scores indicate the probability of each base call being correct and are presented on a log 
scale. A Phred score of 20 indicates a 99% probability of the base call being correct, while a 
score of 30 indicates a 99.9% probability of the base call being correct. It is usual for per base 
Phred scores to decline towards the end of each fragment read. In part, this is due to errors made 
during the sequencing process. For example, if a base call on an individual fragment is skipped, 
then that fragment becomes out of phase with the other fragments in that well. As these errors 
compound during the sequencing process and the number of fragments affected increases, then 
the probability of the base call being correct increasingly declines. Phred scores are based on 
platform dependent adaptations to the original methods described by Ewing et al (302). 
The insertion of the library specific barcode during library construction allowed multiple 
libraries to be sequenced simultaneously (i.e. up to 12 libraries sequenced during each Ion 
Proton run) with data generated for each library being separated based on its barcode. Technical 
variation between each sequencing run could then be assessed by comparing data for each 
library from each of the runs in which that library was sequenced. Given the same starting 
quantity of cDNA library, each run should produce a similar number of reads. The same 
quantity of DNA from each library was added to each run i.e. a run of five libraries would 
contain 5 x 100 pmol/L. This means, all things being equal, each library in a run should produce 
a similar number of reads. In addition, read length and GC (guanine-cytosine) content are good 
indicators of sequencing quality (303, 304).  Therefore, for each library, variation in read length 
and GC content between sequencing runs are appropriate measures of technical variation. 
The outputs from a sequencing run are computer data files in FASTA format, where one file 
for each library sequenced in that particular run is generated. Beginning with these files, the 
remaining steps for analysing gene expression were computer based processing and analysis of 
the sequenced data output. 
5.2.10 Pre-processing of reads following the Ion Proton sequencing 
The main objective of pre-processing is to remove bases or complete reads with a low Phred 
score (< 20), particularly those bases toward the end of a sequence. Pre-processing is performed 
on each output file generated by the Ion Proton. If a library was sequenced in four independent 
runs, then the four output files were processed separately. For this study, the Fastx Tool Kit (v 
0.0.14) was used, with two basic functions, Quality Filtering and Quality Trimming, being 
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utilised. Both functions utilise user defined variables p, q, and l (described below). To achieve 
optimum results, various combinations of values p, q and l were trialled with the optimum 
values (based on number of reads remaining, their length, and average Phred score) determined 
to be p = 40, q = 25, and l = 25. Filtering removed complete reads that have greater than p% of 
bases with a Phred score lower than q. Trimming trims sequenced reads on quality threshold. 
This tool trims the sequences from the end of a read if the quality of a base drops below the 
given threshold q. Trimming also removes sequences shorter than a pre-determined length l. 
The concept of pre-processing is a balancing act between retaining as many sequences (and 
sequence length) as practicable, while ensuring an adequate sequence quality.  
It was thought that the order of application of these two functions (trimming and filtering) may 
affect the number and length of the reads remaining following pre-processing. By removing 
bases with a poor Phred score first (trimming), this would improve the % of bases (p value) 
remaining with the designated acceptable Phred score (q value). Therefore, fewer reads would 
be removed when subsequently filtering the data. To test this hypothesis, a comparison was 
performed where output files were trimmed then filtered, with these results compared to pre-
processing by filtering then trimming. Results of this comparison are presented in Section 5.3.5. 
5.2.11 Sequence alignment 
Sequence alignment is a procedure where two or more sequences are compared to each other 
to determine if those sequences are homologous. In the context of this study, the comparison 
was between the sequences generated from the Ion Proton, and the sequences within the 
reference genome  Ovis Aries 3.1 (OAR3.1, GCF_000298735.1) (305).  Through this process, 
the data generated from the study becomes annotated, i.e. where reads align to a reference 
sequence known to be associated with a particular gene, the sequence is tagged with the 
associated gene identifier. Further, the number of reads which align to a given feature or gene 
gives an estimate of the abundance of that gene in the sample. 
A number of software packages are available for alignment, and while each uses subtly different 
approaches, most rely on variations of the Smith-Waterman algorithm (306). In this study, a 
comparison of two software packages, Tophat (307) (v2.1.0) and STAR (308) (v2.3.0.1) 
demonstrated that STAR was the more efficient alignment package for this dataset (Section 
5.3.5). Both Tophat and STAR also report the number of splice sites. These are defined as 
sequence elements in the mRNA that are recognised by splicing factors (309). The number of 
these sites gives an indication of the level of alternative splicing in the samples. Default settings 
for STAR were used with one exception, reads which mapped to more than 1 site in the 
reference genome were excluded from the output files.  
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5.2.12 Generation of gene lists using Cufflinks 
To produce files of a manageable size, the Samtools (V 0.1.19-44428cd) software package was 
used to convert FASTA files from the Ion Proton output to SAM (sequence alignment map) 
files and subsequently compressed BAM (binary alignment map) files. Files corresponding to 
each individual library from different sequencing runs were then merged so that the data for 
each library (i.e. each fetal ovary) was contained in a single file. These files were then analysed 
using the Cufflinks software package (v2.2.1).  Cufflinks takes the aligned reads and assembles 
them into individual transcripts, then matches these transcripts to specific genes within the 
reference genome. Where annotation data is available, it also identifies splice variants of the 
same gene. The expression level for each gene is calculated from the number of generated 
sequences that align to a gene. 
The number of sequences that align to a gene is not solely dependent on the expression level of 
the gene but, based on probability, also upon the number of fragments in that library, and the 
length of the gene mRNA concerned. A library with a high number of sequences is more likely 
to have sequences align to a gene than a library with a low number of fragments. Additionally, 
longer sequences are more likely to align to a gene than shorter sequences.  To allow for this, 
the raw number of aligned fragments is divided by the known length of the gene mRNA, then 
multiplied by the number of mapped reads from the library (310). The resulting value is 






5.3.1 Confirmation of fetal sex by PCR 
While 24 samples were processed to the gene expression analysis stage, examination of the 
expressions profiles from each library revealed one outlier (day 75 restricted). For this sample, 
high expression of genes associated with testes development of INSL3, INHA, INBA, STAR, 
HSD3B, CYP11A1, CYP17A1, and STAR was noted. Similarly, low expression of oocyte genes 
such as ZP2, ZP3, ZP4, GDF9, and FIGLA were noted. PCR demonstrated the presence of a 
band at 527 bp in known male samples (fetal and adult), and also in the outlier sample. Sanger 
sequencing of these bands showed 100% homology with ovine SRY, thus confirming the outlier 
sample as a male (Figure 5.7). Results for this sample were removed from the remaining 
analysis for this thesis. Figure 5.7 shows an image from a DNA gel containing this sample (lane 




































Figure 5.7 DNA electrophoresis gel showing sex determination using PCR.  Upper gel 
shows SRY, lower gel shows β-actin. Lane 1 adult male control, lane 2 fetal male control. Lane 
3 contains a sample thought to be female, but the presence of SRY confirms this sample as a 
male. Lanes 4 and 5 contain fetal samples confirmed as female. Lane 6 contains controls with 




5.3.2 RNA and DNA extraction 
Nucleic acid extraction procedures were optimised using day 55 and 75 fetal testes (unless 
specified otherwise, Tables 5.1 and 5.2). Nucleic acid extraction with Trizol based protocols 
produced average RNA concentrations of 176 ng/µL with an average RIN value of 8.7 (Table 
5.1). While RNA with these specifications is suitable for RNAseq work, the DNA 
contamination (as measured by Qubit assay) remained relatively high. Further, the techniques 
for extracting DNA from the samples did not prove effective, with no detectable DNA being 
present following extraction and purification. 
Results obtained during optimisation of the Zymo Duet extraction protocol are shown in Table 
5.2. Beginning with the manufacturer’s recommended protocol (Table 5.2 Protocols A to C), 
the method was progressively refined until sufficient RNA and DNA of high quality was 
recovered. Protocols A to C show satisfactory RNA and DNA yields, however DNA 
contamination of the RNA samples prevented a RIN number being generated and indicated that 
these samples would not be suitable for RNAseq work. Serial elutions (Table 5.2 Protocols E 
and F, columns were eluted multiple times using fresh elution buffer for each elution) showed 
that a single elution was not sufficient to elute all the bound RNA and DNA off their respective 
columns. This result was reinforced by double elution results (Table 5.2 Protocol D, columns 
re-eluted with the initial flow through). The implication was that the columns were at their 
maximum binding capacity, allowing excess nucleic acid to flow through the columns. 
Increasing the extraction volume and processing multiple aliquots as individual samples (Table 
5.2 Protocols H to K), not only increased the RNA and DNA yield (by providing multiple end 
samples), but also substantially reduced DNA contamination in the RNA sample. 
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Trizol chloroform  55/Male 116.1 350 304 n/a 17.8 225 < 1  
Trizol chloroform  
Qiagen RNA column 65/Female 421 50 200 9.0 9.0 4.83 < 1  
Trizol chloroform 
Qiagen RNA column 
phase lock 




55/Male 106 50 82 8.5 3.7 2.21 < 1  
Trizol chloroform  











Table 5.2 Results of column based extraction procedures 












A Manufacturer’s protocol 55/M 576 282 n/c 22.8 823 187 
B Manual homogenisation 55/M 130 194 n/c 9.6 767 168 
C Ovary manufacturer’s protocol 65/F 275 309 n/c 20.5 239 264 
D Double elution 55/M 862 434 8.4 28.9 386 81.6 
E1 2 elutions, elution1 55/M n/a 620 n/c 24.2 950 197 
E2 2 elutions, elution2 55/M n/a 295 n/c 11.5 437 62.4 
F1 Serial elution1 (for both RNA and DNA) 55/M 840 738 n/c 32.1 472 802 
F2 Serial elution2 (for both RNA and DNA) 55/M 760 574 n/c 25 580 282 
F3 Serial elution3 (for both RNA and DNA) 55/M 38.6 44 8.5 1.9 19.7 55.6 
F4 Serial elution4 (for both RNA and DNA) 55/M 27 <20 8.4 1.2 6.6 37.5 
G 2x ex vol  55/M 428 (x2) 394 (x2) n/c 19.7 218 63 
H 4x ex vol (mean of 2 aliquots) 55/M 712 209 8.3 69.6 79.3 101 
I 4x ex vol, DNase (mean of 2 aliquots) 55/M 404 (x4) 262 (x4) 8.8 21.8 53.3 91.4 
J 2x ex vol (mean of 2 aliquots) 55/M 460 (x2) 184 (x2) 8.1 40.8 175 108 (x2) 
K 2x ex vol DNase (mean of 2 aliquots) 55/M 538 (x2) 215 (x2) 8.3 47.6 107 81.6 (x2) 
 For the following trials, each sample/aliquot was centrifuged through 2 DNA columns, the first column retained for DNA extraction 
L1 4x ex vol, 2 elutions, elution1 55/M 287 (x4) 93 (x4) 9.7 37.2 4.3 94.4 (x4) 
L2 4x ex vol, 2 elutions, elution2 55/M nd nd nd nd nd nd 
M 4x ex vol, 2 elutions, DNase elution1 55/M 300 80 8.4 32.0 2.1 82.6 
N 2x ex vol, DNase, double elution 55/M 435 (x2) 358 8.4 44 5.5 145 (x2) 
O 2x ex vol, DNase x2, double elution 55/M 619 (x2) 233 9.95 52 4.4 145 (x2) 
In the method synopsis column, double elution indicates the first eluent was re-centrifuged through the column yielding one sample. Two elutions 
indicates columns were eluted twice yielding two separate samples. Ex vol refers to the extraction volume, for example 2x ex vol indicates the 
sample was homogenised in 2x the recommended extraction volume with the sample subsequently split in two and each aliquot processed 
separately. DNase refers to the recommended in-column DNase digest, while DNase x2 refers to an in-column and a final DNase digest. nd indicates 
not detectable, n/a indicates not measured, and n/c indicates value not able to be calculated.
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By centrifuging each aliquot from a single sample through two consecutive DNA columns 
(Table 5.2 Protocol L), DNA contamination was reduced further. Both an in-column DNase 
digestion (Table 5.2 Protocols N to O) and a DNase digestion of the final RNA sample (Table 
5.2 Protocol O) ensured low DNA contamination. The results indicated that Protocol O 
produced the most efficient recoveries of both RNA and DNA. This protocol was then applied 
to the fetal ovary samples obtained at day 55 and 75 of gestation. 
Using optimised Protocol O, a total of 30 fetal ovaries were used to extract nucleic acid for 
RNAseq library construction, with each ovary yielding 2x 50 µL RNA samples and 1x 50 µL 
DNA sample. The average concentrations of DNA and RNA recovered for each age and group 
are presented in Table 5.3. At day 75 of gestation, significantly more DNA was extracted from 

















10.3 ± 0.9 104.5 ± 13.5 < 12.8 103.6 ± 10.6 
Day 55 
restricted 
10.1 ± 0.7 135.4 ± 18.7 < 11.8 109.0 ± 10.1 
Day 75 
maintenance 
23.9 ± 1.3 332 ± 14.8 < 12.7 204.7 ± 15.0 
Day 75 
restricted 
24.9 ± 1.3 302.1 ± 35.9 < 15.8 116.4 ± 10.8 
Results are expressed as means and standard errors. For DNA contamination, most values were 
below the detection limit of the assay (10 ng/mL). For these samples, a value of 10 ng/µL was 









5.3.3 mRNA enrichment, fragmentation and library preparation 
Individual libraries were constructed from a total of 24 fetal ovaries (6 from each group at each 
age). The average RNA concentration and molarities for 23 of the completed libraries (as the 
male sample has been removed) are shown in Table 5.4 for each age and group. 
Throughout the process, a Bioanalyser was used to control for the efficiency of RNA extraction 
by checking the concentrations and size range of total RNA, mRNA, fragmented RNA, and the 
completed cDNA library. Bioanalyser outputs are shown in Figure 5.8 illustrating the 
progression through these stages of a typical sample. For this example, 3 µg of total RNA 
produced 10 µL of mRNA at a concentration of 35.6 ng/µL, 7 µL of fragmented mRNA at a 
concentration of 13 ng/µL, and 15 µL of cDNA library at a concentration of 4 ng/µL. Figure 
5.8 B shows that prior to fragmentation most mRNA has a length between 3000 to 4000 nt. 
Following fragmentation, length was reduced to approximately 150 bp (Figure 5.8 C). This 
resulted in the cDNA library consisting of fragments < 200 bp in length (Figure 5.8 D), within 








 molarity pmol/L 
Day 55 maintenance 13.8 ± 1.9 130,023 ± 18,815 
Day 55 restricted 13.5 ± 2.0 135,134 ± 17,086 
Day 75 maintenance 14.5 ± 2.4 119,265 ± 17,932 
Day 75 restricted 18.3 ± 1.9 165,325 ± 11,975 










Figure 5.8 Total RNA to library Bioanalyser outputs for a typical sample. (A) Total RNA 
1:200 dilution showing the predominance of 5S, 18S and 28S rRNA. The 28S:18S ratio gives 
an indication of the sample quality with a value of 2.4 being ideal. (B) mRNA 1:20 dilution 
following poly(A) enrichment. Most mRNA is greater than 2000 nucleotides in length. (C) 
Fragmented mRNA 1:20 dilution, most mRNA is now in lengths < 200 nucleotides following 
enzymatic fragmentation. (D) Completed library with fragment length averaging 150 bp. For 
this library, the concentration (the sum of the reported peaks, 2 and 3, lying between the marker 





5.3.4 Sequencing of cDNA libraries 
To reduce bias introduced by technical variation between individual Ion Proton runs (see 
Section 5.2.9), 15 separate sequencing runs were performed. Each run contained between four 
and 12 libraries, with the data generated for each library separated based on its unique barcode. 
Each library was sequenced in 3 to 4 separate Ion Proton sequencing runs and different 
combinations of libraries were run together. Total reads, average sequence length, and Phred 
score for each library is shown in Table 5.5. 
For each library, the average between-run variation in read length was 5.0%, and the average 
variation in GC content was 4.0%. Each run generated an average of 59.3 million reads, with a 
between-run coefficient of variation of 4.0%. Within each run, the contribution of each library 
within that run varied by an average of 12%. Combined, this data illustrates minimal technical 





















1 4 32,841,230 72 51 24 
2 4 30,659,552 90 50 24 
3 4 41,021,163 102 51 24 
4 4 39,843,036 85 50 25 
5 4 38,562,731 95 50 24 
6 3 36,100,278 84 48 24 
7 3 37,453,728 69 51 24 
8 3 43,055,898 109 51 25 
9 3 48,833,617 70 48 24.5 
10 3 37,396,828 110 48 24 
11 4 36,417,753 64 49 24.5 
12 3 37,526,440 81 50 24 
13 3 34,683,455 112 50 24 
14 4 33,572,057 72 48 24 
15 4 33,916,331 74 46 24.5 
16 4 41,548,809 70 49 25 
17 4 35,057,583 67 49 25 
18 4 43,452,171 95 48 25 
19 4 31,816,559 69 48 24 
20 3 35,793,410 83 49 24 
21 3 37,175,362 79 48 24 
22 4 36,794,741 85 49 25 






5.3.5 Pre-processing of the sequencing data 
Pre-processing involved the application of trimming and filtering algorithms to remove 
complete reads or individual bases with low Phred scores. Comparison of the order in which 
pre-processing was performed indicated that trimming followed by filtering had no effect on 
average read length or average Phred score for each library when compared to filtering followed 
by trimming. However, as hypothesised (Section 5.2.10), trimming followed by filtering 
yielded 2.8% more reads for subsequent alignment and analysis. This order of pre-processing 
was used for all data files, from all 23 libraries.  
The effects of pre-processing on a typical read are presented in, Table 5.6 and Figure 5.9. Figure 
5.9 illustrates pre-processing successfully resolved the issue of declining Phred scores towards 
the end of a read. In this example, from around 130 base pairs into the 270 bp read, Phred scores 
below 20 become increasingly apparent (Figure 5.9 A). Following pre-processing, the average 
read length was reduced to 230bp, but Phred scores remained above 20 throughout the length 
of the read (Figure 5.9 B). In Table 5.6 following pre-processing, the average number of reads 
for each library was reduced from 36.4 million to 24.5 million, the average read length dropped 









length (bp) Phred score 
Before 
pre-processing 36,355,953 83 24 
Post 






Figure 5.9 Effect of pre-processing on average Phred score. Graphs show Phred score on 
the vertical axis and position in the read (bp) on the horizontal axis. Central red line is the 
median value, the yellow box represents the inter-quartile range (25-75%). Upper and lower 
whiskers represent the 10% and 90% points. The blue line represents the mean quality. (A) 
Typical fall in Phred score towards the end of the read with a number of yellow blocks entering 
the red zone (Phred scores < 20). (B) Following pre-processing, while the read length is slightly 
shorter, those reads with a Phred score of < 20 have been removed with no yellow blocks 




5.3.6 Sequence alignment 
As outlined in the introduction, sequence alignment involved aligning the reads from the dataset 
to the reference genome OAR3. Based on the literature, a target of at least 10 million aligned 
reads for each library was set to provide sufficient sequencing depth for differential gene 
expression analysis. Using a subset of the output files (one file from each library) from the Ion 
Proton, the efficiency of two alignment software packages (STAR and Tophat) were compared. 
For this comparison, default settings were used for both packages. STAR reported 147 million 
aligned reads to the reference database OAR3, while Tophat reported 120 million aligned reads.  
On this basis, STAR was used to align all files to the reference database.  
Alignment data for each library is shown in Table 5.7. For each of the 23 libraries the alignment 
target of 10 million aligned reads per library was met, with an average of 18.4 million aligned 
reads per library being achieved. The average alignment was 71% of reads. While human (311) 
and rodent (312) datasets generally produce a higher percentage of aligned reads, the results 
obtained here are typical for ovine datasets (313) and merely reflect the level of annotation in 
the reference database. The number of annotated splice sequences was similar between all 
groups and ages, and this indicates there is no evidence supporting global differences in 
alternative splicing either between groups or between ages. The average per base mismatch rate 
over all libraries was 0.18%. This is an indication of the quality of the libraries as the STAR 




Table 5.7 Alignment data for individual libraries 
Age Group Mapped reads (unique) 
Splices 
(annotated) 




55 M 20,490,076 5,267,172 26 78.66 
55 M 17,017,427 4,744,158 28 72.04 
55 M 21,622,908 5,230,303 24 77 
55 M 19,010,334 4,323,653 23 76.79 
55 M 17,716,890 3,224,167 18 69.1 
55 M 17,567,118 3,418,153 19 74.03 
55 R 16,625,245 4,192,715 25 55.57 
55 R 20,740,905 5,901,219 28 74.62 
55 R 16,742,319 3,343,464 20 79.79 
55 R 19,595,662 4,379,325 22 75.32 
55 R 26,701,979 8,736,796 33 71.5 
55 R 16,452,178 3,585,972 22 76.4 
75 M 15,842,191 5,229,425 33 76.28 
75 M 24,210,139 4,745,838 20 68.42 
75 M 17,186,999 3,622,344 21 63.06 
75 M 14,083,531 4,297,927 31 62.29 
75 M 18,115,690 3,554,793 20 71.93 
75 M 12,244,221 3,899,005 32 67.2 
75 R 18,099,890 4,679,378 26 70.33 
75 R 20,826,235 4,777,067 23 75.2 
75 R 17,583,577 4,588,105 26 67.64 
75 R 23,058,823 4,190,384 18 73.48 
75 R 16,775,211 3,428,710 20 66.59 
152 
 
5.3.7 Determination of the lower limit of detection (LLD) from the ERCC spike-in 
controls 
ERCC controls spiked into each total RNA sample during library construction were processed 
so limits of detection of the experimental data could be interpreted with confidence. The 
average measured fpkm value for each detectable ERCC transcript was plotted against the 
known concentrations of that transcript. Outliers were removed from the analysis until an R2 
value of > 0.9 was achieved. Transcript ERCC0074 consistently returned the highest fpkm 
reading, being at least 2 fold higher than the next highest value. For fpkm plots to achieve an 
R2 value > 0.9, it was necessary to remove this value from all libraries. When raw counts were 
plotted against the known transcript concentration, removal of the value for transcript 
ERCC0074 did not affect the R2 value (Figure 5.1 A). This implies that the normalisation 
procedures have a major impact on the fpkm values calculated for ERCC0074 and this impact 
will be explored in the discussion. 
Figure 5.10 shows the edited average fpkm values for each transcript plotted against the known 
concentrations of the same transcript. In this plot, all measured fpkm values < 0.1 were removed 
to achieve an R2 value > 0.9. The only value > 0.1 which was removed was the value for 
ERCC0074. The linear relationship achieved between measured and known concentrations 
indicates that for assessing gene expression in this dataset, fpkm values > 0.1 are a reflection of 



















Figure 5.10 Concentrations of ERCC transcripts for a typical library. (A) Plot of unedited 
raw counts plotted against known concentrations. An R2 value > 0.9 was achieved without 
removal of the data for the highest measurable ERCC transcript. (B) Plot of edited fpkm values 






5.3.8 Generation of gene lists using Cufflinks 
The number of transcripts identified by Cufflinks with an fpkm value > 0.1 are presented in 
Table 5.8.  The aligned transcripts are split into those that align to known genes and those that 
align to unannotated sequences within the reference database. 
Irrespective of nutritional group, for fetal ovaries at day 55 of gestation, 61% of aligned 
transcripts had an expression level > 1 fpkm, a cut off value commonly used in RNAseq studies. 
Using the LLD indicated from analysis of the ERCC transcripts, 99% of aligned transcripts 
showed an expression level > 0.1 fpkm. At day 75, 66% genes had an expression level > 1 
fpkm, and 98% showed an expression level > 0.1 fpkm. The distribution of fpkm values at both 
day 55 and 75 is presented in Figure 5.11. 
 
Table 5.8 Number of aligned transcripts with expression > 0.1 fpkm 
Age            Genes with fpkm > 0.1     Maintenance           Restricted 
Unannotated genes with fpkm > 0.1 
    Maintenance            Restricted 
Day 55 14,834 14,530 3,406 3,788 
Day 75 15,038 15,009 3,567 3,562 
 
 
Applying the criteria that fpkm values > 0.1 represent true expression and 0 fpkm represent no 
expression (values in between 0 and 0.1 could potentially be either no expression or low 
expression), then the number of transcripts that are either switched on or off between day 55 
and day 75 of gestation can be estimated. These transcripts are presented in Table 5.9.  
 
Table 5.9 Number of transcripts switched on or off between day 55 and day 75 of gestation 
Change in expression from 
day 55 to day 75 Maintenance Restricted 
Switched on 
from fpkm 0 to fpkm > 0.1 476 401 
Switched off 






Figure 5.11 Distribution of expression values. Expression values (fpkm) are for transcripts 











































5.3.9 Expression levels of autophagy related genes 
Prior to differential gene expression analysis, the data generated in this chapter has the potential 
to provide insights into the metabolic and functional activities with the fetal ovaries. While in 
general these are not directly related to goals of this study, one relevant example is the 
expression of autophagy related genes. Tsujimoto and Shimizu proposed the relative expression 
of the autophagy associated genes ATG5 and ATG6, when compared to other autophagy related 
genes, are an indicator of the functional role of autophagy in a given tissue (293).  Where 
autophagy is involved in cell death, the expression of ATG5 and ATG6 are highly up-regulated 
compared to other autophagy related genes. To clarify the MAPLC3 IHC results (Section 4.3.4), 
the RNAseq data related to autophagy associated genes are presented in Table 5.10. Relative to 
other autophagy related genes, ATG5 and ATG6 are not highly up-regulated. Based on this 
result, and the work of Tsujimoto and Shimizu (293), it is likely that autophagy in the day 55 
and day 75 fetal ovaries is playing a role in cell survival rather than cell death. 
 
 
Table 5.10 Expression levels of autophagy associated genes in fetal ovaries 
Gene 
                    Day 55 
 Maintenance      Restricted 
         fpkm                fpkm 
                 Day 75 
Maintenance    Restricted 
      fpkm                fpkm 
MAPLC3 392 434 483 545 
ATG5 9 9 10 9 
ATG6 61 63 60 57 
ATG10 15 13 14 12 
ATG12 34 32 38 32 
ATG3 84 88 74 84 
Values in red relate to genes reported as highly up-regulated during autophagic cell death. 
Expression levels of ATG5 and ATG6 are similar to the other autophagy related genes 






Based on the assessment of RNA quality, library quality, sequencing data, alignment data, and 
the LLD as determined by analysis of ERCC transcript expression levels, the data obtained is 
of high quality and ideally suited for analysis of gene expression patterns. While this chapter is 
predominantly focused on technical aspects of RNAseq, the data generated gives insights into 
the biological processes within the fetal ovary. 
The finding of one male sample as indicated by PCR was unexpected. This sample was derived 
from a set of twins, one female and one male. The weight data for this gonad clearly indicated 
the sample as female, histological sections of the contralateral gonad also confirmed the 
presence of an ovary. Given the PCR result and the pattern of gene expression, the conclusion 
is that this resulted from an error in sample labelling of frozen gonads at the time of collection. 
PCR confirmed the sex of the remaining samples as female. It is important to note that this error 
had no impact on the results presented throughout this thesis as data from this sample was 
removed from all analysis.  
The control of variation, both technical and biological, in RNAseq studies is an important 
consideration. Analysis of the number of reads generated for each sequencing run, read length, 
and GC content following sequencing, indicates a low level of technical variation in this dataset.  
Biological variation (variation between individual animals) is controlled for by arguably, the 
most important considerations in designing an RNAseq experiment: the number of biological 
replicates to use, and the number of aligned reads achieved per sample (sequencing depth). 
Recommendations vary between studies and depend on the software being used for analysis, 
the goal of the study, and the fold changes in gene expression being targeted.  In experiments 
where fold changes of two or more are the goal, Schurch and colleagues recommend a minimum 
of three biological replicates (314), with this number increasing for more sensitive 
requirements. Overall, Schurch and colleagues recommend six biological replicates as suitable 
for most studies. Using a human cell line, Liu and colleagues show a trade-off between 
biological replicates and sequencing depth (defined as the number of aligned reads). Lui and 
colleagues showed that increasing sequencing depth beyond 10 million aligned reads per 
sample gives diminishing returns on the ability to detect differentially expressed genes, whereas 
addition of biological replicates improves this return (315). Further, they contend that a 
sequencing depth of 10 million reads for between two and six biological replicates is sufficient 
in the majority of cases. Diminishing returns beyond 10 million reads was also reported by 
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Wang and colleagues, although increasing to 30 million reads allowed detection of all annotated 
genes compared to 80% of genes at 10 million reads (316). A similar broad conclusion was also 
reached by Hart and colleagues (317). The current study is based on five or six biological 
replicates per group with an average of 18.4 million aligned reads per library, which clearly 
meets the recommendations from the literature. 
The range of fpkm values that represent real expression varies between studies. As a general 
guide, provided that sequencing depth is adequate (minimum of 10 million aligned reads per 
sample), a conservative cut off value of 1 fpkm is often used, although values as low as 0.2 
fpkm have been shown to represent true gene expression (318). In the current study, analysis 
of the ERCC control mixes indicates that values of 0.1 fpkm show a linear relationship with 
transcript concentration and therefore are likely to represent real gene expression. In this dataset 
< 1% of fpkm values fall below 0.1 fpkm. 
The analysis of the ERCC transcript levels also highlighted an issue with ERCC0074, the ERCC 
transcript which consistently returned the highest fpkm values. The fpkm values generated for 
this transcript did not fit the linear relationship between measured fpkm values and transcript 
concentration. However, the raw counts (non-normalised) did appear to fit the relationship 
suggesting that the normalisation procedures used by the software had a major impact on the 
fpkm values for this transcript. The Cufflinks software (and CuffDiff used in Chapter 6) apply 
a number of normalisation procedures to the raw data to generate fpkm values. One of these 
normalisation procedures is the application of a scaling factor to highly expressed genes, as 
results for these highly expressed genes can skew the data for those genes with low expression 
(319). Given that fpkm values for ERCC0074 were two fold higher than any other transcript, it 
is thought that this normalisation procedure may be contributing to the non-linearity of this 
transcript. 
The number of transcripts that are switched on or off between day 55 and day 75 likely indicates 
the changing developmental status of the fetal ovaries as outlined in Section 1.1. For example 
at day 75, dissolution of ovigerous cords and formation or follicles is observed, processes not 
apparent at day 55. 
A relevant example of how the data generated in this chapter (without progressing to differential 
gene expression analysis) can add to a study is the expression levels of the autophagy related 
genes. Analysis of the autophagy associated genes ATG5 and ATG6 provides evidence that at 
the gestational ages studied, autophagy is playing a role in germ cell survival and not cell death, 
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based on the work of Tsujimoto and Shimizu (293). This result is consistent with the IHC data 
reported in Section 4.3.4 and supports the findings of Gawriluk and colleagues (289). While 
autophagy appears not to be affected by restricted gestational nutrition, the data adds another 
dimension to the debate surrounding the role of autophagy in the developing ovary. 
In summary, the RNAseq techniques applied in this study have generated quality data with high 
sensitivity ideally suited for the analysis of differential gene expression which will be presented 







Chapter 6 . Differential Gene Expression in Fetal Ovaries 
6.1 Introduction 
To understand the potential mechanisms underlying the effects observed in this study to date, 
the data generated in the Chapter 5 has been used to analyse differential gene expression in fetal 
ovaries exposed to restricted gestational nutrition. Nutrition is known to regulate gene 
expression through different mechanisms including transcription initiation, RNA splicing, and 
mRNA stabilisation (291), all of which may be reflected in RNAseq results. 
The mechanisms underlying the effects observed in the current study, and also in the literature, 
remain elusive. The evidence implicates germ cell development, a complex process involving 
a multitude of genes and pathways. Additionally, it remains unclear whether the nutritionally 
induced effects act directly on the germ cells or are mediated via pre-granulosa cells or other 
ovarian cell types.  
While the data generated in the current study is from whole fetal ovaries, a wealth of literature 
is now available describing the cell specific expression pattern of genes in the fetal ovary. The 
most comprehensive of these studies describes the expression pattern of over 12,000 genes in 
the developing mouse ovary (320). This study used transgenic mouse lines with fluorescent 
reporters to enable fluorescent cell sorting of digested ovaries to separate germ cells, supporting 
cells, stromal cells, and endothelial cells. Microarray analysis was performed to examine gene 
expression in each cell population. Extensive use of data from the developing mouse ovary 
(320) is made throughout this chapter. 
The use of RNAseq to study the effects of nutrition on ovarian development has been reported 
in one other study to date. In cattle, Costa and colleagues reported nutrition induced changes to 
the transcriptome of the fetal ovary (174). While these changes to the transcriptome supported 
developmental changes to the ovary, the functional implications of the changes were not 
discussed. The possibility of relating changes in gene expression to morphological, endocrine, 
and physiological changes already observed in maternal animals, fetuses, and offspring from 
the same cohort of animals, highlights the advantage of the multi-disciplined approach adopted 
in this thesis. The prospect of relating nutritionally induced changes in gene expression to 
functional changes is enhanced by the use of pathway analysis (IPA, QIAGEN Redwood City, 
USA) and Gene Ontology (GO) terms (321). Identification of affected pathways may lead to 
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strategies targeting these pathways to either overcome the negative effects of under-nutrition, 
or to induce the positive effects observed in this study. 
Therefore, the aim of the work described in this chapter was to use RNAseq to identify changes 
in gene expression and functional pathways in fetal ovaries exposed to restricted gestational 
nutrition. New hypotheses to explain the observed relationship between gestational nutrition, 
ovarian development, and postnatal fertility will then be developed from this data. 
6.2 Materials and methods 
6.2.1 Detection of differential gene expression between groups 
The Cuffdiff (307) (v 2.2) software package was used to determine those genes differentially 
expressed between groups at each gestational age studied. Before calculating fold changes 
between groups and assigning significance to these changes, Cuffdiff first applies a number of 
normalisation procedures to the data (307).  Firstly, as described in Section 5.2.9, to allow for 
variations in the number of fragments within a library, and variations in transcript size, raw data 
is converted to fpkm values. Secondly, a common feature in RNAseq data is that a small fraction 
of highly expressed genes usually accounts for large proportions of the sequenced reads. 
Further, small expression changes in these highly expressed genes can skew the results for 
genes with low expression. To address this, a scaling factor is applied based on number of 
aligned reads. For each library the median read count is divided by the geometric mean for all 
genes (319). To address an issue termed over dispersion (where the variance in gene expression 
between biological replicates is often greater than the mean expression level for that gene), 
Cuffdiff models the data to a negative binomial distribution (319). Finally, tests for significant 
fold changes between groups are based on t tests. As thousands of between-group tests are 
performed (in this case over 16,000), using a p value to indicate significance would result in a 
high false discovery rate (FDR). Cuffdiff utilises the Benjamini-Hochberg procedure (322) to 
manage the FDR and control the expected proportion of tests which reject the null hypothesis 
(i.e. that there is no difference between treatment groups). Ultimately, significance is assigned 
based on a q value rather than the p value generated from the t test. 
Figure 6.1 illustrates the effect of applying the Benjamini-Hochberg procedure to the day 55 
gene expression data. The number of differentially expressed genes (red dots, p < 0.05 for A 
and q < 0.05 for B) is substantially reduced following removal of what are deemed to be false 




Figure 6.1 Day 55 volcano plots illustrating effect of FDR procedures. (A) Differentially 
expressed genes (red dots) are reported using an unadjusted p value (p < 0.05). (B) 
Differentially expressed genes are reported following application of a FDR procedure and using 
an adjusted p value (q value) of q < 0.05 to indicate significance. 
 
6.2.2 Data analysis 
To determine potential biological pathways, and the functional significance of differential gene 
expression reported by Cuffdiff, three approaches were used for analysis: Ingenuity Pathway 
Analysis software (IPA, QIAGEN Redwood City, USA), GO terms (321), and literature 
searches.  
IPA was employed to examine pathways affected by differential gene expression. In 
combination with the q value, IPA also utilises the magnitude of fold changes between groups, 
the number of genes associated with the pathway being analysed, and current knowledge 
relating to the pathway concerned (e.g. rate limiting steps) to give strength to its pathway 
predictions. Results are expressed as p values and activation (z) scores. The p values are based 
on the number of focus genes (genes with a significant fold change between groups based on 
the q value) in the dataset, and the total number of genes known to be associated with that 
function or pathway. A significant p value for a given pathway indicates that the pathway has 
more focus genes associated with it than would be expected by chance. The z score is similar, 
but takes into account the direction of fold changes in the data, and compares this to information 
from the literature regarding the dynamics of the pathway concerned. A z score of < 2 indicates 
Log 2 fold change Log 2 fold change Log 2 fold change 
















that the pathway is likely to be down-regulated, while a z score of > 2 indicates the pathway is 
likely to be up-regulated. IPA classifies pathways as either canonical or functional. In general, 
a canonical pathway encompasses a broad category e.g. acute phase response signalling, 
whereas, functional pathways are more defined e.g quantity of oocytes. IPA also includes an 
extensive reference database describing the roles of each pathway, and unless specifically 
referenced, functional descriptions of pathways have been sourced from this database.  
Some aspects of the data required adjusting before IPA analysis. Where the expression value 
reported by Cuffdiff for one group was 0, and the second group being compared was reported 
as > 1, Cuffdiff reports the fold change as infinite or –infinite (as the denominator in the 
calculation is 0). Based on bioinformatics advice (Mr Paul Maclean, AgResearch, Lincoln), 
where instances such as this occurred, an arbitrary value of 100 was assigned to the fold change 
so that the data was compatible with the software packages used. 
Where available, GO terms have been assigned to genes of interest. GO terms describe what is 
known about a gene or a gene product. GO terms fall into three major categories: molecular 
function, biological processes, and cellular components. Terms are based on published 
literature and computer projections based on the known structure of the molecule. For this 
study, GO terms were largely sourced using AMIGO2 (321). An extensive literature search was 
used to provide further information regarding roles of genes and pathways of interest in fetal 
ovarian development. 
6.2.3 Validation of RNAseq data 
Nanostring technology was employed to validate the differential gene expression data obtained 
from the RNAseq procedures. In contrast to RNAseq which uses mRNA and several 
normalisation steps for raw counts (i.e. number of transcripts aligned to a gene), Nanostring 
uses total RNA and results are direct counts of identified gene sequences normalised to 
housekeeping genes. 
The concept of Nanostring is outlined in Figure 6.2. A code set is produced comprising of a 
reporter probe and a capture probe. Each probe recognises a complimentary, adjacent, 50 bp 
sequence of the RNA transcript of interest. Both probes are hybridised to the sample RNA 
forming a complex. The reporter probe has a sequence of coloured fluorescent tags attached, 
with the order of these coloured tags uniquely identifying the transcript (gene) of interest. The 
purification sequences (one for all reporter probes, and one for all capture probes) are used to 
bind the probes and complexes to magnetic beads with complimentary sequences. Two 
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purification steps are then performed. Firstly, beads with nucleotides complimentary to the 
capture probe purification sequence are added. This binds both the probe/transcript complexes 
and the excess capture probes. The excess reporter probes are removed. Secondly, magnetic 
beads with nucleotides complimentary to the reporter probe purification sequence are added. 
These bind only the probe/transcript complexes, and excess capture probes are removed. The 
purified probe/transcript complexes are then eluted off the beads. The capture probes have a 
biotin moiety attached which is used to anchor the complexes to a streptavidin coated glass 
plate during an electrophoresis step. This process straightens the probe/transcript complexes so 
that the instrument (nCounter MAX, Nanostring Technologies, Seattle, WA, USA) can 
recognise and count the number of complexes based on the number of specific fluorescent tag 




Figure 6.2 Concept of Nanostring technology. Reporter and capture probes bind to 
complimentary sequences of the gene of interest. Following purification and electrophoresis, 
the probe/gene specific sequence of fluorescent tags are counted by the instrument using a 





For this study, the Nanostring nCounter XT gene expression assay was used (Nanostring 
Technologies, Seattle, WA, USA). The manufacturer’s protocol was followed using 2 µL of 
total RNA. This protocol was then repeated using 4 µL of total RNA. Genes considered below 
the detection limit of the assay failed to show an increase in counts when the higher quantities 
of RNA were used in the assay. Counts were normalised to housekeeping genes and analysis 
performed using the Nanostring N solver software (v2.6). Based on RNAseq gene expression 
data, genes with a range of fold changes, a range of significance levels associated with fold 
changes, a range of expression levels, and genes of particular importance in ovarian 
development were selected for Nanostring analysis. A total of 48 genes were selected which 
included the housekeeping genes YWHAZ, SDHA, GAPDH, and G6PD. Code sets (reporter and 
capture probes) were synthesised by Nanostring Technologies. A full list of genes and target 
sequences can be found in Appendix G. The target sequences are 100 bp in length, 50 bp being 
complimentary to the reporter probe and the remaining 50 bp complimentary to the capture 
probe. 
6.3 Results 
Throughout this section, numerous references are made to fold changes in gene expression. 
Fold changes refer to expression levels in restricted fetal ovaries when compared to 
maintenance fetal ovaries. Therefore, up-regulation, or a positive fold change, indicates higher 
expression levels in restricted ovaries compared to maintenance ovaries. Conversely, down-
regulation, or a negative fold change, refers to lower expression in restricted ovaries compared 
to maintenance ovaries. 
6.3.1 Analysis of ERCC control mixes for fold change validation 
As described in Section 5.2.4, two separate ERCC control mixes were added to the total RNA. 
The two mixes contain identical transcripts, but at different concentrations.  Comparison of the 
known fold change in concentration between the two mixes compared to the measured fold 
change indicates the accuracy of the measured fold change. Plotting known fold changes against 
measured fold changes (Figure 6.3) should result in a linear relationship with an R2 value > 0.9. 
Repeating the procedure described in Section 5.2.4, beginning with values < 0.1, values were 
removed until an R2 value > 0.9 was achieved. To achieve the result illustrated in Figure 6.3, 
all values < 0.3 fpkm were removed. This indicates that for reliable fold change comparisons 






Figure 6.3 Comparison of fold changes for ERCC transcripts. Values were calculated for 
each transcript from mean fpkm values for all libraries. To achieve an R2 value  > 0.9, transcripts 































Log2 expected fold change
168 
 
6.3.2 Differential gene expression in fetal ovaries 
Six libraries, each representing one fetal ovary were compared for day 55 maintenance and 
restricted groups, and the day 75 maintenance group. Five libraries were available for 
comparisons in the day 75 restricted group.  
6.3.2.1 Overall differential gene expression 
A summary of the genes differentially expressed between the ovaries from maintenance and 
restricted fetuses at both days 55 and 75 is presented in Table 6.1 and Figure 6.4. Complete lists 
of differentially expressed genes, Ensembl gene id (ENSOARG numbers), expression levels, 
fold changes, and significance levels are located in Appendix H for day 55 genes and Appendix 
I for day 75 genes. For all differentially expressed genes, at least one group had an fpkm value 
> 1. 
Cuffdiff analysis reported 69 differentially expressed sequences at day 55. Of these, 34 were 
down-regulated in restricted animals and 35 were up-regulated in restricted animals. Of the 69 
transcripts, 14 assembled contigs with genomic alignment remain unassigned to a gene. This 
left, by coincidence, 55 assembled contigs at day 55 which aligned to annotated genes. At day 
75, 145 sequences were differentially expressed. Of these, 49 were down-regulated in restricted 
animals and 96 were up-regulated in restricted animals. Of these 145 transcripts, 23 assembled 
contigs with genomic alignment remain unassigned to a gene. Figure 6.4 presents the gene 
expression data as volcano plots for day 55 (A) and day 75 (B). Comparison of the two plots 
show fewer genes are differentially expressed at day 55, but larger gene expression fold changes 
are evident at this age between maintenance and restricted groups when compared to day 75. 
 
Table 6.1 Summary of differentially expressed genes at days 55 and 75 
Differentially expressed sequences Day 55 Day 75 
Total  69 145 
Unassigned to a gene identifier 14 23 
Known genes common to both ages 16 
Known genes unique to each age 39 106 







Figure 6.4 Volcano plots illustrating fold change vs FDR (q value). (A) Day 55 genes, (B) 
Day 75 genes. Differentially expressed genes are represented by red dots and genes not 





Kilberg and colleagues (291) describe the classical mechanisms regulating gene expression in 
response to nutrient deprivation as being chromatin structure, transcription initiation, RNA 
splicing, nuclear export of mRNA, and mRNA stabilisation. Many of the differentially 
expressed genes are involved in these categories (Table 6.2) illustrating at least some 
predictability to the altered pattern of gene expression. RNA binding proteins have been shown 
to play a role in RNA stabilisation (323). 
 
Table 6.2 Differentially expressed genes fitting classical nutrition response categories 
GO annotation Gene 
Chromatin remodelling TADA2A, HIST2H2BF 
Transcription FIGLA, TADA2A, FOXR1 





FUS, PNLDC1, DHX40, TDRD15, TDRD10, 
ZNF19, WDR87, RPS27L, ARMc2, MAEL2, 
OOEP, TDRKH, TFB1M, DHX58, RPL13, 
RPL31 
Differentially expressed genes have been assigned to the four categories highlighted by Kilberg 
and colleagues (291) as being responsive to nutrient deprivation. 
 
6.3.2.2 Differential gene expression at day 55 
The most represented canonical pathways affected by nutritional restriction at day 55 (Table 
6.3) fall into three categories: lipid homeostasis, the citrulline-nitric oxide-Ca2+ relationship, 
and environmental/DNA damage signalling. Lipids are critical to the production of steroids 
which play an essential role in germ cell development and follicle formation (146, 270, 324). 
Both citrulline and nitric oxide are products of Ca2+ dependent arginine metabolism. Citrulline 
is involved in post-translational protein modification and therefore has the potential to affect 
many cellular and organ processes (325). Nitric oxide and Ca2+ are also involved in a wide 
range of cellular functions. Acute phase response signalling and GADD54 signalling are 




Table 6.3 Canonical pathways at day 55 affected by gestational nutrition 
Pathway Activation Function/significance 
LXR/RXR activation downregulated 
Nuclear receptors involved in lipid 
homeostatsis 
FXR/RXR activation napa 
Nuclear receptors involved in lipid 
homeostatsis 
Acute phase response 
signalling napa 
Signalling responses to a variety of 
stressors including under nutrition. 
Many of the negative acute phase 
response proteins bind hormones 
such as cortisol and retinol  
Biotin-carboxyl carrier 
protein assembly napa 
Involved in fatty acid and lipid 
biosynthesis 
Protein citrullination napa 
Dependent on the pathway involved 
citrulline production is a Ca2+ 
dependent process  
Citrulline-nitric oxide 
cycle napa 
Citrulline and nitric oxide are 
products of arginine (process can be 
reversible) 
nNOS signalling in 
skeletal muscle napa 
Control of blood vessel dilation and 
muscle contraction 
Super pathway of 
citrulline metabolism napa 
Citrulline is involved in post 
translational protein modification 
Calcium transport 1 napa 
Intracellular Ca2+ transport, 
involved in cell signalling, vitamin 
and mineral metabolism 
GADD54 signalling napa  
GADD45 signalling is in response 
to environmental stressors (e.g. 
under-nutrition)  
DNA damage induced 
14-3-3σ signalling napa 
Controls cell cycle checkpoints in 
response to DNA damage 
napa = no activity pattern available. Napa indicates that IPA cannot determine whether a 




Of the 17 most represented functional pathways affected by nutritional restriction at day 55 
(Table 6.4), 6 relate to lipid and carbohydrate metabolism, or ion transport/homeostasis. Three 
relate to inflammatory response, and 4 relate to reproductive ovarian development. The majority 
of differentially expressed genes involved in the four pathways related to reproductive/ovarian 
development have been shown to be expressed specifically or preferentially in oocytes. These 
genes are ALB, GDF9, FIGLA, NOS1, TMED2, and ZP3 (Tables 6.4 and 6.5). 
The prominence of germ cell development is further reinforced when IPA overlaps the 
canonical pathways as a network. Five pathways relating to stem cell differentiation or 
pluripotency are highlighted as being affected by restricted gestational nutrition (Figure 6.5). 
These pathways are impacted by the down-regulation of two germ cell specific transcription 
factors NANOG (-2.4 fold) and POU5F1 (-1.9 fold). 
 
Figure 6.5 Network diagram illustrating stem cell pathways affected. Colour intensity 
indicates the degree to which the pathway has been affected, based on the number differentially 









p-value Activation score 
Differentially expressed genes 
involved in pathway 
Quantity of oocytes 4.04E-06 1.980 FIGLA, GDF9,  NOS1,  ZP3 
Activation of 
macrophages 5.85E-03 -1.974 AGT, APOH, GC, VTN 
Inflammation of 
body region 1.07E-02 1.844 
AGT, ALB, AMBP, APOH, 
CA5A, FUS, GC, HPX, TNNI3 
Transport of 
molecules 1.13E-02 -1.652 
AGT, ALB, APOH, ATP2C2, 
FGB, FUS, GC, GDF9, HPX, 
NOS1, TMED2, ZP3 
Inflammatory 
response 5.04E-03 -1.424 
AGT, AHSG, APOH, GC, NOS1, 
SERPINA1, VTN, ZP3 
Conversion of lipid 9.31E-04 1.413 ALB, AMBP, HPX, NOS1 
Binding of cells 4.61E-03 -1.407 AGT, APOH, FETUB, SERPINA5,VTN, ZP3 
Fibrosis 8.56E-03 -1.297 AGT, ALB, HPX, NOS1, TNNI3, VTN 
Development of 
reproductive system 3.73E-03 1.199 
AHSG, ALB, DNAH9, FIGLA, 
GDF9, SERPINA5, TMED2, 
ZP3 
Gonadogenesis 1.71E-03 1.199 AHSG, ALB, DNAH9, FIGLA, GDF9, SERPINA5, ZP3 
Quantity of 
carbohydrate 1.50E-03 -1.154 
ACACB, ACVR2B, AGT, ALB, 
AMBP, CA5A, NOS1 
Mass of gonad 4.04E-03 1.067 AGT, GDF9, NOS1, ZP3 
Activation of cells 6.37E-03 -1.053 AFP, AGT, ALB, APOH, ERC2, GC, SERPINA1, VTN, ZP3 
Flux of Ca2+ 2.29E-04 -1.026 AGT, ALB, ATP2C2, ERC2, GC, VTN 
Cellular 
homeostasis 7.20E-03 -1.031 
ACACB, AGT, ALB, ATP2C2, 
ERC2, GC, GDF9, HPX, NOS1, 
SERPINA1, TNNI3, VTN 
Ion homeostasis of 
cells 2.45E-03 -1.026 
AGT, ALB, ATP2C2, ERC2, GC, 
TNNI3, VTN 
Cell movement 7.01E-03 -1.006 
AFP, AGT, AHSG, ALB, CDK1, 
CHL1, DNAH1, FGB, GC, 
GDF9, NOS1, SERPINA1, 
SERPINA5, VTN, ZP3 
Pathways are ranked by activation score (Section 6.2.2).  Genes in bold are expressed either 
specifically or preferentially in germ cells, referenced from, ALB (327), GDF9 (327), 





Extensive examination of the literature revealed that of the 55 known genes identified at day 
55 as differentially expressed by Cuffdiff, the cell specific expression pattern of 35 genes has 
been published. Of these 35 genes, 13 are expressed in all ovarian cell types including germ 
cells, and 16 are expressed preferentially, or solely in germ cells (Figure 6.6 and Table 6.5). 
Four of the genes are reported to be expressed specifically in adult oocytes, and only 2 have 
been shown not to be expressed in germ cells. Of these 55 genes, 20 with an unknown 
expression pattern are involved in functions such as reproductive development, gonadogenesis, 
as well as basic cellular functions including homeostasis, and ion/molecule transport. It seems 
likely that some of these 20 genes are expressed in germ cells. Collectively, this data is 
consistent with a marked effect on germ cell gene expression at day 55 by the nutritional 





Figure 6.6 Cell specific expression pattern of differentially expressed known genes at day 
55 of gestation. Segment size represents proportion of the 55 differentially expressed genes. 
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Table 6.5 Cell specific expression pattern of differentially expressed genes at day 55   
Cell specific expression Genes 
Germ cell specific or 
preferential (fetal) 
Total = 16 
ALB(329), CDC2(331), FETUB(332), FIGLA(330), 
FOXR1(330), GDF9(327), HSP70 (I and II)(333, 334), 
NEFH, NOS1(328), PADI6, PNLDC1(330), RIBC1, 
TADA2A, TMED2(329), ZP3(327) 
Oocyte specific or 
preferential (adult) 
Total = 4 
ACAB, ATP2C2(335), SERPINA1(333), WDR87(335) 
Expressed in all cells 
Total = 13 
ACVR2B(121), AGT(320), BAIAP2L1(320), CHL1, 
DHX40, FAM3C, FUS, GC, KIAA1324L, RPS27L, 
SERPINA5, SPCS3, TNNI3 
Minimal germ cell 
expression 




Total = 20 
AFP, AHSG, AMBP, APOH, C1orf112, CA5A, CALY, 
CRTAC1, DNAH1, DNAH9, ERC2, FGB, HIST2H2BF, 
HPX, ITIH2, SAMD15, SPESP1, SPP2, TDRD15, 
ZNF19 
Unless indicated, cell specific expression is based on Jamieson and colleagues (320). * 





The importance of germ cell specific gene expression is illustrated when the ten most up-
regulated genes at day 55 are examined (Table 6.6). Of these 10 genes, 7 are known to be 
specifically or preferentially expressed in germ cells. The cell specific expression of the 
remaining three is unknown in fetal ovaries. The GO annotations of these ten genes can largely 
be assigned to two categories: nucleic acid binding, and ion transport. Of the exceptions to this, 
SAMD15 has no assigned functional annotation, and the role of GDF9 in fetal ovaries has yet 




Table 6.6 Ten most up-regulated genes at day 55 of gestation in response to nutritional 
restriction 




change GO annotation(s) 
ZP3 germ cell 0.1 58.4 ion transport 
FOXR1 germ cell 0.3 18.3 transcription factor, nucleic acid binding 
FIGLA germ cell 0.8 9.8 transcription factor, nucleic acid binding 
PADI6 germ cell 2.5 6.4 ion transport 
KIAA1324L unknown 0.5 6.0 ion transport 
HIST2H2BF unknown 5.3 5.6 DNA binding 
GDF9 germ cell 2.5 3.7 cytokine activity 
NOS1 germ cell 0.4 3.4 ion transport, protein binding 
PNLDC1 germ cell 2.5 3.1 nucleic acid binding 










While examination of the up-regulated genes highlights the importance of germ cell gene 
expression, examination of down regulated genes illustrates that other cells and mechanisms 
may be affected by the nutrition regime. Of these ten genes (Table 6.7), only two, FETUB and 
ALB, have been shown to be specifically or preferentially expressed in germ cells. The ten most 
down-regulated genes can be assigned to only two GO categories: carrier proteins of the 
albumin family, and those with protease inhibitor activity (Table 6.7). 
 
 
Table 6.7 Ten most down-regulated genes at day 55 of gestation in response to nutritional 
restriction 
Gene Expression Maintenance fpkm 
Fold 
change GO annotation(s) 
AFP unknown 30.0 -48.2 carrier protein albumin family 
FETUB germ cell 10.6 -43.6 protease inhibitor 
SERPINA1 unknown 84.8 -25.5 protease inhibitor 
AMBP unknown 7.2 -25.2 protease inhibitor vesicle development 
GC all 5.3 -24.0 carrier protein albumin family 
AHSG unknown 184.8 -17.7 protease inhibitor vesicle development 
ALB germ cell 16.1 -12.0 carrier protein albumin family 
VTN not germ cell 5.6 -11.6 binds to protease inhibitors 
SPP2 unknown 6.4 -10.4 protease inhibitor 





6.3.2.3 Differential gene expression at day 75 
Based on stereological analysis, fetal ovaries exposed to the restricted nutrition regime had a 
1.5 fold increase in germ cell number (Section 4.3.2). As the gene expression data represents 
the whole ovary, this fact must be kept in mind when interpreting the data, i.e. a 1.5 fold increase 
in expression of germ cell specific genes is likely to reflect the increase in germ cell number, 
and not an increased expression in each germ cell. The published cell specific expression of 
genes identified as being differentially expressed by Cuffdiff in fetal ovaries at day 75 is 
presented in Figure 6.7 and Table 6.8. 
Of the 122 differentially expressed genes at day 75, 25 are known to be specifically or 
preferentially expressed in germ cells, 11 are known to be specifically or preferentially 
expressed in adult oocytes, and 34 are known to be expressed in all cells of the fetal ovary 
including germ cells. The ovarian cell specific expression of 39 genes is unknown and 13 are 




Figure 6.7 Cell specific expression pattern of differentially expressed known genes at day 
75 of gestation. Total of 122 genes. Segment size represents proportion of the 122 differentially 
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Table 6.8 Cell specific expression pattern of differentially expressed genes at day 75  
Cell specific expression Genes 
Germ cell specific or  
preferential (fetal) 
Total = 25 
ALB(329), CCDC64, CLIP4, COCH, FIGLA(330), 
FOXR1(330), LHX8(337), LIG1(330), MAEL(338), 
MAP3K15(330), MATER(338),  MVP(334), NETO2, 
NOBOX(332), NOS1(339), OOEP(340), PADI6, 
PNLDC1(330), RIBC1, TDRKH(330),TFB1M, 
TMED2(329), YBX2(330), ZNF541(330), ZP3(327) 
Oocyte specific or  
preferential (adult) 
Total = 11 
ADAMTS14(335), ARMC2(335), ASB11(335), 
C11orf16(335), CHL1(335), HIP1R(335), PLG(335), 
SERPINA1, SLC12A3(335), TTN(335), WDR87(335)  
Expressed in all cells 
Total = 34 
ALDH1A1, APAF-1, BAIAP2L1, CCDC88C, CEP164, 
COX5A, DOCK5, ENTPD4,  FSTL4, GLRX, ITM2B, 
JAG1, JAK3(320), KCTD9, LGMN, MYBPC3, NLRC5, 
PARP2, PCBD1, PGS1, PHTF1, POLDIP2, ROR2, 
RP9, RPL13, RPL31,SEMA3G, SLC25A15, SLC7A6, 
SPON1, TMC4, UBE2Q1, UNC13C, UPF3A  
Minimal germ cell 
 expression 
Total = 13 
CALB2(341), DACH1, FAP, GPRC5B, GREB1, 
HIPCAL1, HSPG2, PLXNC1, PTN, RALB, SLC2A1, 
TKT, GUCY1A3 
Expression pattern  
Unknown 
Total = 39 
ACAB, AFP, AHSG, AMBP, APCDD1L, C20orf27, 
C7orf25, CADPS2, CCL16, CHRDL1, CNR1, 
CNTNAP4, DHX58, DLEC1, DNAH1, EPB41L4B, 
FAM204A, GPANK1, HAX1, HSPA6, IRF8, ISG17, 
MAP7, MOXD1, MX1, MYH15, PRELP, RBM20, 
RYR3, SCD5, SCN1A, SLC12A1, SLC5A6, SLC8B1, 
SPTBN5, TDRD10, TDRD15, TSKS, WIF1  






The pattern of differential gene expression at day 75 becomes clearer when the most up-
regulated and down-regulated genes (based on fold changes) are examined. Of the top ten up-
regulated genes (Table 6.9), 3 are known to be specifically or preferentially expressed in germ 
cells. One is expressed in all cells including germ cells, while the expression pattern of the 
remaining 6 in the fetal ovary is unknown (3 of these 6 are known to be expressed specifically 
or preferentially in adult oocytes).  
The ten most down-regulated genes at day 75 (Table 6.10) bear a similarity to those down-
regulated genes at day 55, with protease inhibitors and carrier proteins of the albumin family 
featuring prominently. The difference in fold change between the two groups at day 75 is much 
less than that observed at day 55, with the exception to this being CCL16. This gene was 
expressed in maintenance ovaries but no expression was evident in restricted ovaries. Therefore 
the fold change reported as -100 is an artificial value (Section 6.2.2). The average fold change 
of the ten most down-regulated genes at day 55 was -25.5 while at day 75 the average fold 
change (excluding CCL16) was -4.2 
 
Table 6.9 Ten most up-regulated genes at day 75 of gestation in response to nutritional 
restriction 
Gene Expression Maintenance fpkm 
Fold 
change GO annotation(s) 
SLC12A3 oocyte (adult) 1.2 2.94 ion transport 
ADAMTS14 oocyte (adult) 5.3 2.52 peptidase activity 
TDRD10 germ cell 21.8 2.29 nucleic acid binding 
MATER germ cell 3.1 2.29 germ cell development 
RBM20 unknown 1.7 2.27 nucleic acid binding 
CHL1 oocyte (adult) 9.7 2.25 protease binding 
SPTBN5 unknown 1.1 2.19 actin binding 
NLRC5 all cells 2.2 2.17 DNA binding 
TSKS germ cell 4.3 2.17 protein kinase binding 





Table 6.10 Ten most down-regulated genes at day 75 of gestation in response to nutritional 
restriction 
Gene Expression Maintenance fpkm 
Fold 
change GO annotation(s) 
CCL16 unknown 2.3 -100 chemokine activity 
AMBP unknown 9.0 -6.5 protease inhibitor 
AHSG unknown 108.9 -5.1 protease inhibitor 
PLG unknown 1.8 -4.7 protease inhibitor 
SERPINA1 oocyte (adult) 57.4 -4.3 protease inhibitor 
AFP unknown 12.5 -4.20 carrier protein albumin family 
ALB unknown 16.3 -4.01 carrier protein albumin family 
HIP1R oocyte (adult) 52.6 -3.84 vesicle mediated transport 
APCDD1L unknown 21 -3.01 membrane component 
MOXD1 unknown 15.7 -2.33 ion transport 
 
 
The top canonical pathways identified by IPA analysis as being affected by restricted 
gestational nutrition at day 75 are presented in Table 6.11. IPA predicts down-regulation of 
both the LXR/RXR pathway as well as production of nitric oxide and reactive oxygen species 
in macrophages. 
In addition to LXR/RXR, the FXR/LXR pathway is also identified as being affected. The 
differentially expressed genes identified in these pathways are the same as those at day 55 
(AHSG, ALB, AMBP and SERPINA1). The analysis identifies the availability of HDL (high 
density lipoproteins) as being critical for these pathways. A relationship between vitamin C 
(ascorbate) pathways, nitric oxide, and protein citrullination (all identified as affected pathways 
by IPA) is also known, with ascorbate reported as inducing production of nitric oxide (342, 
343). 
Functional pathways identified by IPA as being affected at day 75 of gestation are presented in 
Table 6.12. Of the 10 functional pathways, 7 relate to gonadal development, with germ cell 
specific/preferential genes being key to these effects. Based on the gene expression data, IPA 
assigns a z score > 2 to both quantity of oocytes and quantity of cells, predicting up-regulation 
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of these two functional pathways. This result is consistent with the increase in germ cell 
numbers observed by stereology at this age. While quantity of protein in blood is listed as being 
affected, this is based on a global analysis (not ovary specific) and assumes that the observed 
gene expression patterns are similar in most tissues. It is of interest to note that the cell death 
pathway is listed as affected, although the z score of 1 is relatively low (a score of > 2 or < 2 
being required for IPA to predict up or down regulation of function). 
 
 
Table 6.11 Canonical pathways at day 75 affected by gestational nutrition  
Pathway Activation Function/significance 
LXR/RXR activation down-regulated 
Nuclear receptors involved in lipid 
homeostasis 
Production of nitric oxide 
and reactive oxygen 
species in macrophages 
down-
regulated Immune response, infection control 
Acute Phase response 
signalling neutral 
Signalling responses to a variety of 
stressors. May indicate response to post 
restriction compensatory growth 
FXR/RXR activation napa Nuclear receptors involved in lipid homeostasis 
Vitamin C transport napa Involved in growth, proliferation and development 
Ascorbate recycling napa Antioxidant activity and vitamin C metabolism. 
Glutathione redox 
reactions napa Involved in controlling ROS 
Biotin-Carboxyl carrier 
protein assembly napa Fatty acid and lipid biosynthesis 
Tyrosine biosynthesis napa Synthesis from phenylalanine. Involved in cell to cell signalling 
Nitric oxide signalling in 
skeletal muscle napa 
Cardiovascular signalling. Key 
regulator is Ca2+ 
Citrulline nitric oxide 
cycle napa 
Citrulline and NO are products of 
arginine (process can be reversible). 
   
Protein citrullination * napa Post translational protein modification 
 








p-value Activation score 
Differentially expressed genes 
involved in pathway 
Quantity of oocytes 4.67E-06 2.219 
FIGLA, NOBOX, NOS1, YBX2, 
ZP3 
Quantity of cells 2.05E-03 2.157 
AMBP, CADPS2, DACH1, 
FIGLA, ZP3, GUCY1A3, HAX1, 
HSPG2, IRF8, JAG1, JAK3, 
LGMN, LHX8, LIG1, MAP7, 
MYBPC3, NLRC5, NOBOX, 
NOS1, PLG, PTN, ROR2, 
SERPINA1, SLC2A1, YBX2   
Quantity of germ 
cells 1.03E-04 1.969 
FIGLA, MAP7, NOBOX, NOS1, 
ROR2, YBX2, ZP3 
Quantity of protein 
in blood 1.17E-03 -1.305 
ACACB, AHSG, CNR1, DHX58, 
LGMN, NOS1, PCBD1, PLG, 
PTN, SLC12A1, UBE2Q1 
Gonadogenesis 5.00E-04 1.154 
AHSG, ALB, FIGLA, LHX8, 
MAEL, MAP7, NOBOX, PLG, 
PTN, TDRKH, YBX2, ZP3 
Development of 
internal genitalia 8.72E-06 1.091 
AHSG, ALB, FIGLA, LHX8, 
MAP7, NOBOX, PLG, PTN, 
YBX2, ZP3 
Development of 
ovary 4.43E-05 1.091 
ALB, FIGLA, LHX8, NOBOX, 
PLG, YBX2, ZP3 
Folliculogenesis 1.15E-04 1.091 
ALB, FIGLA, NOBOX, PLG, 
YBX2, ZP3 
Adipogenesis 9.75E-03 -1.067 ALDH1A1, CNR1, PLG, ROR2 
Cell death 1.94E-04 1.007 
AFP,  ALB,  ALDH1A1,  
CADPS2,  CHL1,  CNR1,  
COX5A,  DACH1,  DHX58,  
FAP,  FIGLA,  GLRX,  HAX1,  
HIP1R,  HSPG2,  IRF8,  ITM2B,  
JAG1,  JAK3,  LGMN,  LIG1,  
MAEL,  MVP,  MX1,  MYBPC3,  
NOS1,  PARP2,  PLG,  PTN,  
RALB,  ROR2,  RPL13,  RPL31,  
RYR3,  SCN1A,  SERPINA1,  





6.3.3 Validation of RNAseq using Nanostring 
A comparison of fold changes derived from RNAseq and Nanostring is illustrated in Figure 
6.18 and Table 6.13. A good overall correlation between fold changes observed using 
Nanostring and RNAseq was achieved. Figure 6.8 presents the correlation between Nanostring 
and RNAseq results as a Bland Altman plot. Bland Altman analysis plots the mean of two 
values being compared against the difference between the two means, and is extensively used 
to compare agreement between two different techniques (344). The comparison shows good 
correlation between the two techniques with an R2 value of 0.8986. Some divergence in the 
magnitude of the fold changes, but not the direction, was noted. This arose where values for 
individual genes were below the detection limit of the Nanostring assay (Table 6.13) in a 
particular fetal ovary RNA sample. Where this occurred more than once over the 12 day 55 














Table 6.13 Comparison of Nanostring and RNAseq fold changes 
 Day 55 
      RNAseq           Nanostring 
   fold change        fold change 
 
Day 75 
   RNAseq          Nanostring  
  fold change      fold change 
 
HSD3B 1.0 1.0 1.1 1.1 
ACVR2B -1.1 -1.1 1.2 1.1 
AFP -48.2 -12.2* -4.2* -9.9 
AGT -6.6 -18.7* -3.2* -9 
AHSG -17.6 -11.4 -5.1 -8.8 
AHR 1.2 1.2 1.1 1.2 
ALB -12.0 -10.6 -4 -9.3 
ALDH1A1 1.1 1.3 -1.7 -1.9 
AMBP -25.5 -11.5* -5.3 -9.3 
APOA2 -8.0 -13.7 -5.2 -7.7 
APOC3 -13.9 nd -7.2 -10.2* 
APOH -4.0 -5.9 -2.4 -6.0 
BMPR2 1 1 1.1 1.0 
CCNB1 -1 1.1 1.2 1.0 
CRABP2 -1.3 -1.2 1.3 1.1 
CYP11A1 1.1 1.1 1.1 1.0 
CYP17A1 -1.9 -1 1.3 1.0 
DACH1 1 1 -1.1 -1.2 
DAZL -1.0 -1.1 1.0 1.1 
FETUB -43.4 -16.4* -4.5 -7.8 
FIGLA 9.8 12.6* 2.0 2.5 
FSTL4 -1.0 -1.1 1.9 1.9 
GC -23.9 -19.9* -4.5* -9.6 
GDF9 3.7 3.7* 1.6 1.8 
GRIA1 -1.1 -1.7* 1.0 -1.3 
INHBA -1.2 -1.1 1.1 1.0 
ITIH2 -10.2 nd -3.3 -5.5 
LDLR -1.2 1.1 -1.2 -1.1 
LHR -1.2 -1.3 1.1 -1.1 
MGST1 -1.0 1.0 1.0 1.0 
NOBOX 14.4 nd 2.1 1.8 
NOS1 3.4 14.3* 2.0 2.1 
PLAC1 1.2 1.0 1.3 1.0 
RARA -1.1 1.0 1.1 1.1 
RARES2 -1.2 1.0 1.1 1.1 
SERPINA1 -25.5 -10.3 -4.2 -7.9 
SPP2 -10.4 -20.5* -4.5 -10.9* 
STAR 1.1 1.3 1.1 1.0 
ZP3 58.4 nd 2.0 2.1 
ZP2 6.2 39.3* 1.3 1.7 
ZP4 23.4 14* 1.4 1.6 
* indicates one or more values are below the detection limit of the Nanostring assay. PADI6, 





The primary aim of RNAseq was to identify changes in the expression of genes or pathways in 
the fetal ovary following restricted gestational nutrition. Significant changes to the ovarian 
transcriptome are apparent at the completion of restricted nutrition at day 55. 
 Key findings from the gene expression analysis include 
• up-regulation of key germ cell genes associated with nucleic acid binding and ion 
transport at day 55 
• down-regulation of specific carrier protein genes and protease inhibitors at day 55 
• higher ovarian expression of a number of germ cell genes at day 75 reflective of the 
increased germ cell number at this age   
• continued down regulation of protease inhibitors and carrier protein genes at day 75 
although with reduced fold changes than those observed at day 55 
 
At day 55 of gestation, changes in gene expression were evident before morphological changes 
to ovarian or germ cell development were observed by histology. Some of these changes in 
gene expression are still evident at day 75, 20 days following the change to an ad libitum diet 
for all animals, although the fold changes observed are considerably less than those at day 55. 
The largest fold change observed in up-regulated genes at day 75 was a 2.9 fold increase in the 
ion transport gene SLC12A3. Given that many of these genes are germ cell specific or 
preferential in their expression pattern, this suggests that the observed up-regulation of many 
of these genes reflects the increased number of germ cells present in the fetal ovaries from 
fetuses exposed to the restricted nutrition regime. Thus, while the ovary as a whole may be 
expressing more of these genes, it is likely individual germ cells are not. This pattern of fold 
change reflecting the increased number of germ cells is also exhibited by many other germ cell 
genes not reported as being significantly differentially expressed between groups, for example, 
GDF9 shows a 1.5 fold increase, POU5F1 a 1.5 fold increase, and SPO11 a 1.2 fold increase. 
These observations are consistent with changes to the transcriptome in restricted animals being 
temporal, allowing normal ovarian development in a reduced nutrition environment. Following 
the change to an ad libitum diet, the transcriptome gradually returns to a state consistent with 
ad libitum nutrition. This interpretation of the data is consistent with the hypothesis developed 
from Chapter 4 which examined morphological development of the fetal ovary. This suggests 
the change from restricted to ad libitum nutrition, while the transcriptome briefly remains 
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attuned for restricted nutrition, is the critical factor in establishing the observed alterations to 
ovarian development. 
To understand how these reported differentially expressed genes may affect ovarian or germ 
cell development, a number of factors need to be considered. RNAseq has reported differential 
gene expression, however this may not necessarily translate into increased or decreased levels 
of corresponding proteins. Even assuming that protein levels are correlated to mRNA 
expression levels, post translational protein modifications have not been considered. Given that 
citrullination is one pathway affected, and that citrulline is involved in post-translational protein 
modification, it may affect cellular processes independent of differences in gene expression. 
Differences in alternative splicing of genes and consequently differences in isoforms of proteins 
have also not been considered in the analysis thus far. Despite these factors, consideration of 
the genes and their functions may give insights into possible mechanisms whereby restricted 
gestational nutrition may affect ovarian development. Given that the number of differentially 
expressed genes reported is relatively low (69 at day 55 and 145 at day 75), the implication is 
that a specific, targeted mechanism may be involved rather than a broad based affect. 
Of the genes up-regulated at day 55, three are known transcription factors (FIGLA, TADA2A 
and FOXR1). FIGLA in particular is known to regulate expression of the zona pellucida genes 
(345). The analysis reported a significant 58 fold up-regulation of ZP3 at day 55. It is also 
interesting to note that while not statistically significant, the two other zona pellucida genes 
expressed at this stage were also up-regulated. A 6 fold change was reported for ZP2, while a 
45 fold change was reported for ZP4. Electron microscope examination of sheep fetal ovaries 
at day 55 of gestation does not reveal any indications of zona pellucida formation (34). 
However, similar to the results from this study, expression of ZP3 has been observed in human 
ovaries prior to follicle formation (34, 346). GO annotations for ZP3 include both signal 
transducer activity and Ca2+ channel activity. Based on this evidence, it appears likely that at 
this stage of development rather than zona pellucida formation, ZP3 is playing some alternative 
role in germ cell development. The role of ZP3 in Ca2+ channel activity is of particular interest. 
IPA identified ion transport as an affected pathway, and there are at least three other up-
regulated germ cell specific genes involved in ion transport: NOS1, PADI6 and KIAA1324L. 
The importance of Ca2+ availability in the germ cells leads into, arguably, the affected pathways 
with potentially the most consequences for development. These pathways are those relating to 
citrullination, Ca2+, and nitric oxide production by NOS1, with NOS1 expression reportedly  
oocyte specific or preferential (328). Nitric oxide is known to be involved in Ca2+ homeostasis 
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at a number of different levels (347). Additionally, conversion of arginine to nitric oxide and 
citrulline by NOS1 and PADI6, is a Ca2+ dependent reaction (348). This reaction links all three 
pathways (citrullination, Ca2+, and nitric oxide production by NOS1) indicated by IPA as being 
affected by restricted gestational nutrition. The 3.4 fold up-regulation of NOS1 in restricted 
ovaries at day 55 may be in response to changes in insulin levels as a result of restricted 
nutrition. Elevated insulin levels have been shown to increase NOS1 mRNA levels in cerebral 
astrocytes and neurons (349). This reaction is also catalysed by Ca2+ dependent peptidylarginine 
deaminases such as PADI6 (325), an oocyte specific gene differentially expressed at both 
gestational ages.  
Interestingly, three pathways (vitamin C transport, ascorbate recycling, and glutathione redox 
reactions) identified by IPA as being affected by restricted gestational nutrition at day 75 are 
involved in vitamin C metabolism or transport. Vitamin C (ascorbate) is one compound that 
can potentiate nitric oxide synthesis (343). The importance of nitric oxide and citrulline in fetal 
development have been highlighted by Wu and colleagues (160). They emphasise the 
relationship between impaired nitric oxide production and intra-uterine growth retardation 
(350), a relationship that can be reversed by arginine supplementation (351). Further, in sheep 
allantoic fluid, concentrations of citrulline increase 18 fold between days 30 and 60 (352). 
While the emphasis of the Wu review is on placental development, it is notable that maternal 
nutrition restriction decreases fetal plasma arginine concentrations in the pig at day 60 of 
gestation (353). In sheep, restricted maternal nutrition between days 28 and 78 of gestation 
decreases maternal and fetal plasma levels of both arginine and citrulline  (354).  
Citrulline is involved in post translational protein modification. Alterations to post translational 
protein modification has the potential to affect many cellular functions. Determining if this is 
indeed a factor in these ovaries requires an in-depth proteomics investigation to examine the 
structure of proteins susceptible to the effects of citrulline and is beyond the scope of this study.  
The role of nitric oxide in ovarian development is complex as nitric oxide is involved in 
numerous cell and developmental processes, additionally NOS is present in three distinct 
isoforms (348). NOS1 was first discovered in neuronal cells and is often referred to as neuronal 
or brain NOS, while NOS2 or iNOS is referred to as inducible NOS. NOS3 or eNOS refers to 
endothelial cell NOS. Up-regulation of NOS1, and genes involved in ion transport, particularly 
Ca2+, suggest that there are increased levels of nitric oxide in the germ cells of nutrition 
restricted fetuses.  
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Nitric oxide is known to play a role in DNA damage and repair although its precise role is not 
clear. While most studies highlight the negative effects of nitric oxide on DNA damage and 
repair, many of these studies use exogenously administered nitric oxide. However, Phoa and 
Epe (355) conclude that nitric oxide generates DNA damage only inefficiently, and only 
selectively inhibits the repair of oxidative DNA base modifications. Further, Phoa and Epe state 
that nitric oxide can protect against some forms of DNA damage (355). Patel and colleagues 
(356) showed that nitric oxide is required for cell proliferation once DNA damage is repaired.  
Zhang reported that fetal germ cells from mice deficient in NOS3, and exposed to the 
environmental oestrogen bisphenol A, showed an increase in chromosomal errors during 
meiosis (357). As NOS1 is preferentially expressed in the germ cells (328), and is up-regulated 
in restricted fetal ovaries at a time of significant proliferation, apoptosis, and also meiosis, it 
seems likely that this up-regulation may have an effect on the DNA status in these cells. Given 
the opposing views in the literature, it is difficult to determine whether this effect is positive or 
negative. However, the observation that more germ cells are present in day 75 restricted ovaries 
is consistent with a positive effect rather than a negative effect. Given this evidence, it seems 
that nitric oxide may be one mechanism by which restricted gestational nutrition may be 
affecting ovarian development by affording some protection to germ cell DNA or by facilitating 
DNA repair in these cells. 
Nitric oxide is also known to play an important role in angiogenesis, although this function is 
normally attributed to NOS3 (358), which in the fetal ovary is predominantly expressed in 
endothelial cells (320). While Zhang (328) attributes most NOS1 expression to germ cells, 
Jamieson and colleagues (320) attribute the majority of NOS1 expression to the supporting or 
pre-granulosa cells as well as germ cells. The differences between these two studies likely 
reflects differences in the gestational age of the animals. The differences notwithstanding, given 
the expression of NOS1 either adjacent to, or within germ cells, it seems likely that any effect 
of differential expression will be focused in the germ cells. It seems unlikely that the differences 
in NOS1 expression would affect angiogenesis. Expression of NOS1 is relatively low compared 
to NOS3 expression (0.5 fpkm compared to 11.3 fpkm in maintenance fetuses). NOS3 
expression is also concentrated in endothelial cells and therefore likely to control angiogenesis 
(348). 
While the up-regulation of germ cell specific genes is a notable pattern in this data set, the 
down-regulated genes observed are likely to play an important role. The fold changes in these 
genes are significantly greater than those observed in the up-regulated genes. Specifically, 
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expression of genes for carrier proteins of the albumin family change significantly with AFP, 
ALB and GC all showing large negative fold changes. These genes are primarily expressed in 
liver and bind to a number of compounds including steroids and cations such as Ca2+ in plasma 
(359). The expression pattern and role of the members of the albumin family in the fetal ovary 
has yet to be fully investigated. it is therefore difficult to relate the differences in gene 
expression to the changes observed in the fetal ovary. However, the characteristic of members 
of the albumin family to bind Ca2+ may signify an indirect involvement in Ca2+ dependent nitric 
oxide synthesis.  
AFP is considered the fetal equivalent of albumin. Expression of AFP in the fetus declines with 
gestational age as expression of ALB increases. By birth, liver expression of AFP is negligible 
(360). Despite its abundance early in fetal life, AFP is not essential for development. It is 
required for female fertility as AFP null mice develop to adulthood, but are infertile (360). This 
infertility is thought to be due to effects on the hypothalamus-pituitary system where the 
oestrogen binding properties of AFP  have a neuro-protective effect on the fetal brain (361). At 
day 55 of gestation, the hypothalamic-pituitary system has yet to develop in sheep (278), and 
therefore it seems unlikely that differences in AFP expression at this age are producing an effect 
at the hypothalamus or pituitary. However, expression of AFP has been observed in the ovarian 
follicles of pregnant rats and the level of this expression appears related to the health of the 
follicle, suggesting some link between this gene and ovarian function (362).  
Based on the known binding roles of these albumin like proteins, ovarian expression of these 
genes may serve to bind and therefore regulate intra-ovarian or intra-cellular levels of 
compounds that bind to the albumin family (e.g. steroids, Ca2+). Down-regulation of these genes 
may serve to increase the availability of the unbound compounds for cellular functions, 
conceivably an important concept given the important roles of steroids in gonadogenesis, and 
the importance of Ca2+ discussed previously. 
Of particular interest is the down-regulation of protease inhibitors FETUB, SERPINA1, 
SERPINA5, AMBP, AHSG, SPP2, ITIH at day 55, and AMBP, AHSG, PLG, SERPINA1 at day 
75. Proteases and their inhibitors control a wide range of biological processes including cell 
signalling, apoptosis, and inflammation. The process can either be destructive (destroying the 
proteins function) or positive (activation of a function or pathway) (363). Arguably, the most 
relevant proteases to this study are the caspases, as these are critical in germ cell apoptosis. 
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The role of protease inhibitors in fetal ovaries is unclear. Of the protease inhibitors identified 
by Cuffdiff with differential expression levels between groups, none are known to be germ cell 
specific in their expression pattern. Further, the cell specific expression pattern for these 
protease inhibitors has not been published for fetal ovaries. Adding to the enigma surrounding 
protease inhibitors, links between protease inhibitors and apoptosis have been published in 
some tissues (364, 365), but not for fetal ovaries. Decreased expression of protease inhibitors 
in restricted fetal ovaries would suggest an increase in caspase activity, and therefore an 
increase in apoptosis in restricted ovaries, resulting in fewer germ cells. However, germ cell 
numbers are either similar between the groups at day 55, or restricted ovaries actually have 
more germ cells at day 75, indicating that higher levels of apoptosis in restricted germ cells is 
unlikely. While it seems intuitive that decreased protease inhibitor expression leads to increased 
apoptosis, it is interesting to note that in immature rats, at a developmental time similar to late 
gestation in sheep, serine protease inhibitors have been shown to impair follicle development 
(366). This illustrates the potential for a counter intuitive process whereby down-regulation of 
protease inhibitors may have possible beneficial consequences for ovarian development. 
This dilemma may be resolved by the identification of which ovarian cells express genes for 
protease inhibitors. In adult bovine follicles, expression of serpins appeared to be in either 
granulosa and/or thecal cells (367).  Aside from germ cells, invading cells from the regressing 
mesonephros also show significant apoptosis,  and at least some of the protease inhibitors have 
been linked to mesonephric (and metanephric) development (368, 369). Should invading 
mesonephros cells be the site of protease inhibitor gene expression, this would offer an 
explanation for the divergent results between decreased protease inhibitor gene expression, but 
no increase in germ cell apoptosis. 
The fold changes observed at day 75 are less than those observed at day 55, indicating that 
expression levels of genes in restricted ovaries are returning to levels similar to maintenance 
animals. This pattern is the same for down-regulated genes at day 75. While many genes are 
still significantly down-regulated at day 75, the fold changes are much smaller than those 
observed at day 55, with the largest negative fold change at day 75 being -5.1. At least four 
protease inhibitors remain significantly down-regulated (AMBP, AHSG, PLG, and SERPINA1). 
Given the seemingly counter intuitive positive effects that down-regulation of these genes has 
on postnatal follicle development (366), their potential role in follicle formation seems worthy 




Two members of the albumin carrier protein family also remain significantly down-regulated 
at day 75 (ALB -4.0 and AFP -4.2). The possible effects of these down-regulated genes 
previously highlighted at day 55 are likely to still be apparent at day 75. Further, given that 
levels of both meiosis and apoptosis of germ cells are higher at this age, and that follicles are 
being formed, the implications of any effects for ovarian development are likely to be more 
significant at this age. 
This discussion has largely focused on germ cell development thus far.  However, as highlighted 
in Section 2.4, recruitment of granulosa cells during fetal development may play an important 
role in the effects observed at 19 months of age. It is interesting to note that classical granulosa 
cells markers such as FOXL2 and AMH are absent from the list of differentially expressed genes 
at both day 55 and day 75. Many of the differentially expressed genes are expressed in all cells, 
including granulosa cells and pre-granulosa cells (Tables 6.5 and 6.8). Therefore, direct effects 
of differentially expressed genes on pre-granulosa cells is a possibility. Differentially expressed 
oocyte genes also have the potential to affect the granulosa cells, with GDF9 being a good 
example. GDF9 has been extensively studied in adult ovaries, where it has been shown to be 
critical for follicle development and proliferation of follicular granulosa cells (370, 371). In the 
fetal ovary, GDF9 is known to be important in follicle formation. Expression of GDF9 has been 
observed prior to follicle formation in fetal ovaries from human (336) and sheep (372), but its 
function at these relatively early ages is still unclear. In this study, up-regulation of GDF9 at 
day 55, well before follicle formation begins, is likely to be important, but its implications are 
unable to be determined based on the current literature. 
Collectively, this data has identified temporal changes in gene expression due to under nutrition 
and allows the emergence of new hypotheses to understand the relationship between the 
nutrition regime and the results observed, thereby fulfilling the second aim of this study. In 
considering the data and the points raised in this discussion, two potential hypotheses are 
emerging. 
Firstly, the alterations to the pattern of gene expression observed at day 55 appear to be 
mechanisms to allow the ovary, and in particular the germ cells, to survive in a low nutrition 
environment. With a sudden shift from low to normal nutrition, there appears a small window 
(or lag phase), where gene expression remains set for a low nutrition environment. Conceivably, 
during this window or lag phase, germ cells are able to increase in number through a mechanism 
as yet to be identified. The inability to detect this mechanism in this study suggests that this lag 
phase, where the mechanism may be active, lies between the two ages studied, day 55 and day 
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75. One possible mechanism appears to be increased germ cell production of nitric oxide, 
allowing more germ cells to survive through meiosis and apoptosis. 
Secondly, direct effects of differentially expressed genes (e.g. protease inhibitors) on the 
function of ovarian cells up to day 75 may account for the differences observed in the day 75 
ovaries, and potentially flow through to the differences observed in adult animals.  
Further work is required on the cell specific expression pattern and the roles of many of the 








Chapter 7 . Final Discussion 
This study has, for the first time, demonstrated that alterations to gestational nutrition in dams 
can increase indicators of fertility in female offspring. The observed changes in fetal ovarian 
development and fetal gene expression are consistent with the first hypothesis that restricted 
maternal nutrition will lead to changes in fetal ovarian gene expression and fetal ovarian 
morphology. However the finding of increased fertility in the female offspring requires that the 
second hypothesis, that restricted maternal nutrition will lead to reduced fertility in female 
offspring, be rejected.  
However, this result potentially opens a new direction of research in the area of gestational 
nutrition and postnatal fertility. While the focus of current studies is aimed at understanding 
how restricted gestational nutrition negatively impacts postnatal fertility, the concept of 
improving lifetime fertility through manipulating gestational nutrition has major implications, 
particularly in the livestock industry. The results of this study would suggest that this concept 
is feasible. 
Potential reasons why this study has produced results which contrast to previous studies will be 
discussed in Section 7.1. One of the strengths of the current study is the combination of data 
from whole animal physiology, endocrinology (maternal, fetal and adult offspring), 
morphological fetal ovarian development, and differential gene expression in the fetal ovary. 
How these data support each other will be discussed in Section 7.2. Unequivocal identification 
of the mechanism(s) underlying the relationship between gestational nutrition and postnatal 
fertility remain elusive. However, the data offers some insights into the mechanism(s) 
underlying the effects seen in the current study. These will be discussed in Section 7.3. 
Additionally, whether the data offers some insights into the negative effects seen in other 
studies will also be discussed. While the variety of data is a strength of this study, there are 
limitations to this study. These will be discussed in Section 7.4. From the limitations and the 
results, unanswered questions and future directions will be discussed in Section 7.5. 
7.1 Why do the results contrast with previous studies? 
Prior to the current study, work examining gestational nutrition varied markedly (summarised 
in Table 1.1, Section 1.3). Arguably, at a simplistic level, one could suggest that the results 
from the current study represent yet another variation in a field where the number of possible 
variables affecting the outcome is considerable. These variables include the timing of nutrition, 
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amount of restriction (or over feeding), type of restriction (protein, metabolisable energy), and 
species studied. In general, negative effects on the fertility of female offspring have been 
reported where over or underfeeding was imposed in mid or late-gestation. Where nutrition 
restriction has been applied during early to mid-gestation, differences in ovarian development 
have been reported, but negative effects on the fertility of the offspring are generally not 
reported in these studies. Thus, the timing of nutrition restriction in the current study is likely 
to have contributed in some part to the novel results. 
Additionally, the level of nutrition restriction used in this study (60% of maintenance, based on 
metabolisable energy requirement) is less than that applied in most studies, where in sheep, 
50% of maintenance is commonly used. As discussed in Section 2.4, the consequences of this 
seemingly small change in the level of nutrition restriction are substantial for the ewe.  In the 
current study, ewes lost an average of 7% of body weight, while in a similar study using 50% 
of maintenance, ewes lost 16% of body weight (177). While the implications of the differences 
in maternal body weight loss for fetal ovarian development are unclear, it does nonetheless 
represent an additional point of difference between the current study and most other studies in 
sheep. 
The change from 0.6 of maintenance to ad libitum feeding (combined with changing from an 
indoor diet to pasture), also represents a point of difference from most other studies. This factor 
has been highlighted throughout this thesis. 
Without further studies changing the timing and level of nutrition restriction, it is not possible 
to definitively give a reason for the novel results observed in the current study. However, it is 
hypothesised that the combination of the three factors listed above (duration of restriction, 
amount of restriction, and change of diet) have all contributed to the results observed. 
7.2 Re-examination of the data from a global perspective 
Two recurrent themes are present in the data throughout this thesis. 
Firstly, the differences observed appear to be ovarian driven. Differences in OR and especially 
AFC (Section 2.3.6) support this contention. While AFC includes follicles greater than 2 mm, 
and these follicles are gonadotrophin responsive (101), the data is consistent with a strictly 
ovarian response. If differences in AFC were the result of changes to the hypothalamic-pituitary 
system, one may have expected to see higher concentrations of FSH driving the increased 
follicular growth. At the time of ultrasound scanning however, the opposite was true, with lower 
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concentrations of FSH present in ewes from restricted dams (Section 3.4.9). The timing of 
scanning coincided with the appearance of the first follicle wave, with this wave known to be 
particularly active in the production of factors such as inhibin. One interpretation of these 
observations is that the differences observed in FSH may be the result of increased feedback 
from the ovary. Further, differences in the pattern of LH secretion were not observed. With LH 
being a more accurate reflection of GnRH secretion (88), this also suggests that changes within 
the ovary are primarily responsible for the observed differences. Differences in the pattern of 
germ cell development prior to establishment of the hypothalamic-pituitary-gonad system 
(Section 4.3) also suggest the differences are ovarian driven. The differences in fetal ovarian 
development are supported by the gene expression data which highlight a different pattern of 
gene expression between maintenance and restricted fetal ovaries. These differences are 
particularly (although not exclusively) evident in genes which are expressed preferentially or 
exclusively in germ cells. 
The second recurrent theme throughout this thesis is the importance of the change in diet from 
restricted indoor feeding to ad libitum pasture. In Chapter 2, the post restriction “growth spurt” 
observed in restricted ewes following cessation of nutrition restriction has been highlighted as 
a potential contributor to the observed effects. Additionally, in discussing the absence of effects 
in peri-pubertal animals, the concept of waves of granulosa cell recruitment was examined 
(Section 2.4). The possibility was raised that granulosa cells recruited during the first wave of 
recruitment (coinciding with the period of nutrition restriction) may be unaffected, resulting in 
the lack of observable differences in OR and AFC in peri-pubertal animals. Prepubertal growing 
follicles contain granulosa cells predominantly from this first wave of recruitment (40). 
Growing follicles from adult animals, where differences in AFC are observed, are thought to 
contain granulosa cells from the second wave of granulosa cell recruitment. This wave of 
recruitment would occur during the immediate post restriction period, again suggesting that this 
period of diet change and not the actual nutrition restriction alone is the critical factor in 
establishing the observed affects. The importance of the post restriction period is perhaps best 
highlighted in Chapter 4. At the cessation of nutritional restriction, no differences were 
observed in the morphological pattern of germ cell development (Section 4.3). However, 20 
days following the change to an ad libitum pasture diet, differences became apparent, with fetal 
ovaries from restricted dams containing more germ cells than those from maintenance dams. 
While differences in gene expression were noted in fetal ovaries at day 55 (Section 6.3.2.2), the 
absence of measurable morphological differences in the ovaries at day 55 led to the hypothesis 
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that the differences in gene expression were a mechanism to allow normal ovarian development 
to progress in a low nutrition environment. Following the change to an ab libitum diet, gene 
expression takes some time to readjust, with differences (albeit with smaller fold changes than 
observed at day 55) still apparent at day 75 (Section 6.3.2.3). Thus, Chapters 2, 4 and 6 each 
suggest that it is not the restricted nutrition alone which is responsible for the affects observed 
in this study, but the change from restricted nutrition to ad libitum nutrition. 
7.3 Potential underlying mechanisms 
The data from this study is consistent with the observed results being the consequences of 
changes in ovarian development. From the gene expression data, there are a small number of 
potential mechanisms which may underlie the changes. It is accepted that these hypotheses are 
highly speculative. While the data from this study may be consistent with these proposed 
mechanisms, there is no evidence to conclude that the mechanisms discussed are indeed 
responsible for the changes observed in this study. 
Perhaps the most promising mechanism is the arginine to citrulline and nitric acid pathway. 
Nitric oxide is a key compound in many cellular processes. The number of genes identified by 
RNAseq and pathways identified by IPA analysis that may affect the arginine to nitric oxide 
and citrulline reaction, is substantial and are illustrated in Figure 7.1.   
The two key differentially expressed genes regulating this reaction are PADI6 which is germ 
cell specific, and NOS1 which is expressed in either germ cells, pre-granulosa cells, or both 
(320, 328). This is consistent with a germ cell effect. How nitric oxide may facilitate the 
increased germ cell numbers observed is not clear. Many studies have shown that nitric oxide 
can cause DNA damage (373-375). However, one could argue the dose applied in most studies 
is considerable. Phoa and Epe (355) showed no increase in oxidative DNA damage in mouse 
fibroblasts overproducing nitric oxide, and also concluded that nitric oxide actually afforded 
DNA some protection from oxidative damage caused by H2O2. Further, it is not actually nitric 
oxide which causes DNA damage, but the products of the reaction between nitric oxide and 
reactive oxygen species (ROS): N2O3 and ONOO-. Arguably, this is where the vitamin C 













While the nitric oxide pathway seems a possible mechanism to facilitate the effects of 
gestational nutrition on ovarian development, the presence of differential expression of a 
number of protease inhibitors is also of interest as a possible mechanism. The potential for 
protease inhibitors to have profound effects is highlighted when one considers their targets, 
which are proteases. Two classes of proteases with divergent roles in the fetal ovary are the 
caspases, (involved in apoptosis), and the proteins transcribed from the autophagy associated 
genes (ATGs) (376), which appear to be involved in cell survival at the gestational ages studied. 
There are a number of classes of protease inhibitors, those identified as differentially expressed 
in this study are either cysteine or serine protease inhibitors. Intriguingly, caspases are serine 
proteases, while ATG proteins are cysteine proteases. Thus, it is easy to hypothesise that 
differential regulation of protease inhibitors may have marked effects on ovarian development. 
However, little is known about protease inhibitors in the fetal ovary and further work is required 
to understand these compounds, their role, and potential as a mechanism for the effects observed 
in this study. 
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There is no evidence from the current study to suggest mechanisms involving steroids are 
responsible for the effects, despite their critical roles in germ cell survival and follicle 
formation. Steroid concentrations in fetal plasma were not affected by the nutritional regime. 
Further, genes involved in steroid production were not differentially expressed in fetal ovaries 
at either age examined. 
When planning this project, the original aim was to identify possible mechanisms underlying 
the relationship between restricted gestational nutrition and reduced fertility in the female 
offspring, an outcome observed in most studies to date. The question arises then, does the 
current study give any insights into this relationship? One may speculate on the impacts of 
increases in magnitude of the fold changes observed in the current study, in response to a more 
severe nutrition restriction. This assumes that a higher restriction level amplifies the changes 
observed. Further, one could speculate on the impacts of extended differential expression of the 
genes in this study, in response to extended nutrition restriction. This assumes that the same 
genes would be affected in a longer restriction regime. When examining gene expression from 
comparing day 55 and day 75, 390 transcripts are switched off between day 55 and day 75 
(expression value at day 75 > 0.1 fpkm, value at day 75 = 0). Additionally, using the same 
criteria, 476 transcripts are switched on. Any of these 476 transcripts may be differentially 
regulated by an extended restricted gestational nutrition and affect ovarian development. Thus, 
from this study, insights into mechanisms underlying the relationship between restricted 
gestational nutrition and low fertility in the female offspring cannot be drawn with any 
confidence. 
7.4 Limitations of the study 
The studies on adult animals found differences in OR, AFC, progesterone, and FSH. All of 
these measures can be classified as indicators of fertility and not fertility as such. While the 
progression from these indicators of fertility to actual fertility (number of lambs born) may 
seem logical, the potential for changes in gene expression during germ cell development and 
follicle formation to affect this progression is nonetheless a factor. This raises several questions: 
Are the oocytes in adult follicles normal?  Are they capable of being fertilised? And, are they 
capable of producing viable embryos? Additionally, do changes during development lead to 
abnormal assembly of follicles in the fetal ovary? If follicles are abnormal, this may effect 
maturation of the oocyte during follicle growth leading to impaired fertilisation.  While these 
scenarios cannot be discounted, three observations would suggest that fertility is likely to follow 
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the same trend as the indicators of fertility. Firstly, aside from differences in numbers, follicular 
growth appears normal by ultrasound scanning suggesting that major changes to primordial 
follicle assembly are unlikely. Additionally, given the recent paradigm that the oocyte drives 
follicle growth and differentiation (377), this would also suggest that at least during follicular 
growth, oocytes are normal. Secondly, hormone profiles are only subtly different between 
groups at 19 months of age, suggesting that major dysfunction in the ovary is unlikely. Finally, 
at 19 months of age, follicles achieve ovulation, obviously an important hurdle to overcome to 
achieve fertility. At laparoscopy and/or ultrasound scanning, no gross differences were 
observed in the appearance of corpora lutea.  Thus, while all the evidence would suggest that 
the observed differences in indicators of fertility are likely to extend into differences in fertility, 
this is a projection based on the available data. As already discussed in Section 2.4, to measure 
fertility requires adult animals to be mated with intact rams and the number of offspring from 
that mating recorded. In the current study, insufficient animals were available to undertake this 
experiment. 
The measurement of AMH in plasma was an important component of this study. Plasma 
concentrations of AMH have been used as an indicator of AFC, ovarian reserve and fertility 
(236). Measurement of AMH in plasma samples at the time of ultrasound scanning would have 
added considerably to the current study. The continued development of an AMH assay suitable 
for use in sheep is an ongoing project.  While in some studies FSH has been used as an indicator 
of AFC the correlation between FSH and AFC is highly variable (133). A recent patent proposes 
a combination of FSH, inhibin, and AMH as a reliable indicator of AFC and fertility (378), 
while this seems a useful tool, without a suitable AMH assay it remains impracticable for sheep 
work at this stage. Concentrations of inhibin may also have provided some insights, particularly 
with regards to the lower FSH levels present in adults from restricted dams early in the oestrous 
cycle.  
The differences in the pattern of gene expression are an important finding. However, a 
limitation of all gene expression studies is that expression differences may not necessarily be 
reflected in protein levels. Additionally, the role of citrulline (a product of the reaction 
controlled by both NOS1 and PADI6) in post-translational protein modification has also been 
raised. Thus, within the fetal ovary, both the amount and structure of the key proteins identified 
as being important in this study, need further investigation. 
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7.5 Future directions 
Given the unexpected findings from the current study, the need to replicate these results is 
important. Additionally, from an agricultural industry viewpoint, can these results be achieved 
under a restricted pasture grazing environment? In the current study, indoor feeding was 
selected to allow the greatest control over dietary intake for each maternal ewe. Replicating this 
experiment on outdoor pasture would require intensive monitoring of both pasture availability 
and animal condition, and would inevitably introduce some variation between animals. The 
weight profiles generated from the maternal animals in this study will provide a useful 
benchmark for monitoring animals in future studies. Additionally, the differences observed in 
maternal plasma progesterone concentrations will also provide another indicator of the 
effectiveness of any restricted pasture grazing regimes. 
The timing of restricted nutrition is another issue worthy of attention. Can these effects be 
generated using a shorter restriction period? If so, is the important period immediately prior to 
day 55 of gestation or immediately after mating? Further, how much variation in the timing of 
dietary change (from restricted to ad libitum) is possible? In the current study, animals were 
synchronised and nutrition restriction ended on day 55. From a practical application standpoint, 
synchronisation and daily monitoring for mating marks is not feasible. Discovery of a window 
(ideally a 17-day window corresponding to a complete oestrous cycle) where nutrition 
restriction can end yet still produce the effects observed in this study, is worthy of investigation. 
Extending the period of both restricted and maintenance nutrition from day 55 to day 75 (or day 
90), would offer insights into both the importance of the diet change at day 55 in the current 
study, and the negative effects on post-natal fertility observed in other studies. The hypothesis 
being that genes associated with nitric oxide production will remain differentially regulated 
during extended restricted nutrition, but those associated with Vitamin C (or antioxidants) will 
not. This would potentially result in negative effects on germ cell development/numbers. The 
ideal time to measure these effects would be day 90 following the wave of germ cell atresia 
when 80% of germ cells die (38). Even under the current nutrition regime, examination of day 
90 ovaries would be beneficial as it is unclear whether the differences in germ cell numbers 





If one accepts the hypothesis that it is the change in diet from restricted to ad libitum which is 
important in establishing the observed effects, then some interesting possibilities arise. Can this 
effect be induced, not by nutrition restriction, but by administration of a dietary supplement at 
the appropriate age? The current study does give some insights into potential components of 
such a supplement. 
The gene expression data highlights differences in the arginine, citrulline, and nitric oxide 
pathways in response to nutrition restriction. From this, one could speculate that arginine 
supplementation around day 55 of gestation may be a useful strategy.  While rapid degradation 
of arginine in the rumen is an issue, rumen protected forms of arginine are available (379). 
Vitamin C may also be worth considering as a supplement component. IPA identified three 
pathways related to vitamin C metabolism as being affected by the restricted nutrition regime 
at day 75. One of the properties of vitamin C is potentiation of the arginine to citrulline and 
nitric oxide reaction. Vitamin C is also a recognised antioxidant, providing protection against 
ROS (380). ROS, in combination with nitric oxide, produce N2O3 or ONOO-, both of which are 
known to damage DNA (373). Thus, if the goal of a supplement was to increase nitric oxide 
(by arginine supplementation), addition of vitamin C may help to limit the negative effects of 
nitric oxide while retaining the positive effects. Ruminant animals produce their own vitamin 
C as, like arginine, it is rapidly degraded in the rumen. However, rumen protected forms of 
vitamin C are available which could be used in an oral supplement (381). 
In Section 7.3 it was highlighted that extrapolating the data from this study to explain the 
relationship between restricted gestational nutrition and reduced fertility (as observed in most 
published studies) could not be done with any degree of confidence. The limiting factors aside, 
it is worth considering the following. Gestational under-nutrition appears to up-regulate the 
production of nitric oxide, either in, or adjacent to, the developing germ cells. Only following 
the change of diet, are pathways associated with vitamin C affected. If nutrition restriction were 
to continue for an extended period, would continued effects on the nitric oxide pathways (in the 
absence of effects on vitamin C pathways) result in increased germ cell DNA damage leading 
to reduced fertility? If this were indeed the case, would a vitamin C supplement around the time 
of germ cell meiosis afford some protection from negative effects of nitric oxide and help to 
maintain normal fertility in the offspring.  
The discussion of possible mechanisms underlying the increase in indicators of fertility in 
female offspring highlights some potential avenues for future research. For example, the effects 
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of nitric oxide on germ cells requires further work. While many studies examining the effects 
of nitric oxide on cell function and health use exogenous nitric oxide, the approach adopted by 
Phoa and Epe(355), using fibroblast cells transfected with macrophage iNOS, would more 
closely replicate the increased concentrations hypothesized to occur in the fetal ovaries from 
this study. In principle, fetal germ cells could be co-cultured with iNOS transfected cells (either 
fetal ovarian cells or a mixture of fibroblasts and ovarian cells). The effects of nitric oxide on 
germ cells (oxidative DNA modifications) could be monitored by the alkaline elution assay 
described by Phoa and Epe. Establishment of a system based on that described by Phoa and Epe 
for use with fetal ovary cells may help to determine if there are positive effects on germ cells 
following exposure to a moderate increase in levels of nitric oxide. Such a system could also 
be used to determine whether antioxidants (e.g. vitamin C) can mitigate any detrimental effects 
on germ cells. 
In reviewing the literature relating to the protease inhibitor genes which were identified as 
differentially expressed in the current study, the opportunity for further work in this area 
becomes apparent. Firstly, the cell specific expression of these genes (using in situ 
hybridisation), or protein localisation (using IHC) in the fetal ovary needs to be established. 
The expression of genes or localisation of proteins may give a better indication of their role in 
the development of the ovary, and from that, a more informed assessment of their potential 
contribution to the effects observed in this study.  For assessment of the effects of these protease 
inhibitors on fetal ovary development, cell culture would seem the most viable option. This 
could involve culture of whole fetal ovaries (33) or pieces of ovaries (270). However,  given 
that at day 55 and 75 fetal sheep ovaries are relatively large and a representation of all cell types 
would be required, then a disaggregation-re-aggregation technique as described by Dolci (382) 
may be best suited for this application. 
7.6 Concluding remarks 
The results from this study suggest that changes to gestational nutrition can alter developmental 
programming, leading to enhanced function of the reproductive system. Van de Pavert and 
colleagues (383) demonstrated in mice that maternal vitamin A levels regulate the development 
of the immune system (383). Mice whose mothers where fed a high vitamin A diet during 
gestation showed improved development of their immune system, and an enhanced ability to 
fight infection.  Thus, while most studies focus on the negative implications of altered 
gestational nutrition, there is perhaps, potential to investigate the induction of positive effects 
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Appendix A. Assay protocols 
 
A. Procedure for the iodination of ovine Follicle Stimulating Hormone or ovine 
Luteinizing Hormone 
B. Procedure for the ovine FSH Competition RIA 
C. Procedure for the ovine Luteinizing Hormone Displacement RIA 
 
Reagents for iodination, RIA standard curve and RIA primary antibody are available from 
http://www.humc.edu/ National Hormone and Peptide program (NHPP).  
 
1 x ovine FSH kit contains antigen, antisera and a reference hormone:  
Antigen for iodination, NIDDK-oFSH-19-SIAFP (AFP4117A)  
Reference hormone for the standard curve, NIDDK-oFSH-RP-2 (AFP4117A) 
Antisera for the primary antibody, NIDDK-anti-oFSH-1 (AFP-C5288113) 
 
1 x ovine LH kit contains antigen and antisera : 
Antigen for iodination, NIDDK-oLH-I-4 (AFP8614B) 
Antisera for the primary antibody, NIDDK Rabbit anti oLH-1 (AFP192279) 









A. Procedure for the iodination of ovine Follicle Stimulating Hormone or ovine 
Luteinizing Hormone 




• Both the ovine FSH and LH for iodination are supplied at 30 – 40 µg. This is dissolved 
in 0.05 M PBS (FSH pH7.2, LH pH 7.4) to a concentration of 2.5 µg/20 µL.   This 
solution is then dispensed in 20 µL aliquots into eppendorf tubes and stored at -70°C. 
• Iodine -125 radionuclide, 5mCi (185MBq) (Scimed #BD-NEZ033A005MC)  
• Bovine Serum Albumin 
• Chloramine T, Laboratory reagent 
• Sodium metabisulphite, Laboratory reagent  
• Tris (hydroxymethyl) methylamine, AnalaR  
• Potassium chloride, AnalaR grade  
• Hydrochloric Acid sp.gr. 1.18, AnalaR grade  





• 0.05 M Phosphate Buffer (FSH pH 7.2, LH pH 7.4) 
• 20 mM Tris (FSH pH 8.6, LH pH 9.0) contains Tris 0.242 g/100 mL  
• 400 mM KCI in 20 mM Tris (FSH pH 8.6, LH pH 9.0) contains Tris 0.242 g/100 mL, 
KCI 2.982 g/100 mL. Dissolve salt in deionised distilled water and adjust pH (FSH pH 
8.6, LH pH 9.0) 
• 10% BSA in 20 mM Tris (FSH pH 8.6, LH pH 9.0) 
• 1.6 mg/mL chloramine T in 0.05 M PBS (FSH pH 7.2, LH pH 7.4) 
• 4 mg/mL sodium metabisulphite in 0.05 M PBS (FSH pH 7.2, LH pH 7.4) 
 
Ion exchange column: 
1. Swell 0.5 g QAE Sephadex A25 in 10 mL MilliQ for at least one hour.  
2. Allow swollen gel to equilibrate to room temperature. 
3. Add Sephadex to Poly-Prep column to give a bed volume of 1 mL. Equilibrate the 
column with at least 10 mL of 20 mM Tris (FSH pH 8.6, LH pH 9.0). 
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4. Stopper column until ready for use in the Iodination Laboratory. 
5. Make up the following elution solutions as set out in the table below. 
• Buffer A = 20 mM Tris (FSH pH 8.6, LH pH 9.0) 
• Buffer B = 400 mM KCI in 20 mM Tris (FSH pH 8.6, LH pH 9.0) 
 








20 mM Tris pH 8.6 
(mL) 
Buffer A 
KCL 400 mM in Tris pH 
8.6 (mL) 
Buffer B 
1 0.00 3.00 0.00 
2 0.10 2.25 0.75 
3 0.12 2.10 0.90 
4 0.14 1.95 1.05 
5 0.16 1.80 1.20 
6 0.18 1.65 1.35 
7 0.20 1.50 1.50 
8 0.22 1.35 1.65 
9 0.26 1.05 1.95 
 








20 mM Tris pH 9.0 
(mL) 
Buffer A 
KCL 400 mM in Tris pH 
9.0 (mL) 
Buffer B 
1 0.00 3.00 0.00 
2 0.02 2.85 0.15 
3 0.04 2.70 0.30 
4 0.06 2.55 0.45 
5 0.08 2.40 0.60 
6 0.12 2.10 0.90 
7 0.16 1.80 1.20 
8 0.24 1.20 1.80 
 
     
Chloramine T iodination and purification: 
1. Thaw a 2.5 µg aliquot of oFSH or LH iodination standard. Add 0.5mCi (5 µL) of 125I-
Na radionuclide. 
2. Add 10 µL of 1.6 mg/mL chloramine T in 0.05 M Phosphate buffer (FSH pH 7.2, LH 
pH 7.4). 
3. Mix and allow the mixture to react for 30 seconds. 
4. Add 10 µL of 4 mg/mL sodium metabisulphite in 0.05 M Phosphate buffer, (FSH pH 
7.2, LH pH 7.4) to stop the reaction.  
5.  Add 200 µL of 20 mM Tris (FSH pH 8.6, LH pH 9.0). 
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6. Transfer the mixture onto the equilibrated ion exchange column. 
7. Add 2 mL of each elution buffer in order of increasing KCI concentration to the column 
and collect each fraction into a 12 x 75mm polystyrene tube containing 100 µL of 10% 
BSA in 20 mM Tris (FSH pH 8.6, LH pH 9.0). 
 
Elution profile: 
1. Transfer 5 µL of each fraction into 12 x 75 mm polystyrene tubes. Count the 5 µL 
fractions for 1 minute in the gamma counter. 
2. Plot the counts per minute (cpm) against the concentration of KCI and keep as a record 
of the elution profile of the iodination. It should be consistent with previous iodinations. 
3. The elution profile should have two peaks of activity. Pool the two or three fractions 
with highest cpm from the first peak. 










• Upon receipt, store at 1:80 dilution in assay buffer 
• Before use, dilute 300 times to an initial tube dilution of 1:24,000 
Tracer: 
Dilute iodinated Iodine in assay buffer to give 15000 cpm/100 µL. 
 
Second antibody pre-precipitated:  
(Prepare day 1 and leave at 4°C overnight) 
• Sheep anti-rabbit (in house)  use at 1:35 
• Normal rabbit serum (in house) use at 1:350 
• Prepare 5% PEG 8000 in 0.01M PBS  
 
Standards for FSH Competition Assay:  
• Use NIDDK ovine FSH-19-SIAFP-RP-2 supplied with the FSH kit 
• Supplied aliquot contains 10 µg lyophilized FSH which should be reconstituted with 1 
mL distilled water 
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• This gives a solution containing 10,000 ng/mL = solution (A) 
• Add 10.0 mL of 0.01M PBS + 0.1% BSA to solution (A) = 1000 ng/mL = solution (B) 
• Distribute solution (B) into 2.0 mL aliquots and freeze = solution (C).  Keep 1 aliquot for 
immediate dilution 
• Dilute solution (C) to 20 mL and then make doubling dilutions to give 25, 12.5, 6.25, 3.12, 
1.56, 0.8 and 0.39 ng/mL 
• Distribute in 750 µL aliquots to give 13 standard curves. Freeze at -20°C until required 
 
Assay Buffer: 








• 100 µL sample /standard/control in duplicate 
• 100 µL assay buffer to all tubes except total and NSB which get 300 µL (see table below) 
• 100 µL tracer to all tubes 
• 100 µL primary antibody to all tubes except NSB and Total 




• Add 100 µL second antibody to all tubes except Total. Mix the antibody thoroughly before 
using 
• Vortex and incubate on the bench for 1 hour 
• Add 1.0 mL 5% W/V PEG to all tubes (except Total) and centrifuge at 3200 rpm for 35 
minutes at 4°C 















100 µL 100 µL 100 µL 100 µL 100 µL 1000 µL 
Std 
tube 
100 µL 100 µL 100 µL 100 µL 100 µL 1000 µL 
NSB 
tube 
none 300 µL 100 µL none 100 µL 1000 µL 
Total 
tube 




C. Procedure for the ovine Luteinizing Hormone Displacement RIA 
 
1. Stock Phosphate 0.5 M pH 7.4. 
• 15.6 g NaH2PO42H2O in 200 mL MilliQ (A) 
• 71.02 g NaH2PO4 anhydrous in 1000 mL MilliQ (B) 
• Add 164 mL A to B, adjust pH to 7.4 
• Store at -20°C in 40 mL aliquots 
 
2. LH Assay Buffer. 
• 40 mL PO4 stock 
• 37.22 g EDTA 
• 18 g NaCl 
• 2 g  NaN3 
• 2 g  BSA (add last) 
• Adjust to pH 7.0 and make up to 2 litres 
 
3. Normal Rabbit Serum (NRS). 
• Dilute 1:500 in assay buffer 
• Add to NSB 100 µL/tube 
 
4. LH Wash buffer. 
• 40 mL PO4 stock 
• 18 g NaCl 
• 2 g  NaN3 
• 4 mL NRS 
• Adjust to pH 7.0 and make up to 2 litres  
 
5. Primary Antibody NIDDK Rabbit  anti oLH-1. 
• Stored at 1:100 
• Dilute 1:600 in NRS/Assay Buffer (working dilution 1:60 000) 
 
6. Tracer oLH I125.  
- Count 5 µL  
- Add tracer to assay buffer in dilution of 30000 cpm/100 µL (calculated as for FSH 
assay) 
 
7. Second Antibody generated in house. 
- Dilute sheep anti-rabbit 1:40 (SAR) in assay buffer 
 
8. Standard for ovine LH Assay.  
• Use CY1085 aliquots of 10 µg. Make dilutions of 20, 10, 5, 2.5, 1.25, 0.625 and 0.3125 
ng/mL in assay buffer 





 TC NSB Std Sample Time 
Assay Buffer --- 200 µL 100 µL 200 µL Day 1 
Filler (OVX serum) --- 100 µL 100 µL --- Day 1 
Sample/Std --- --- 100 µL 100 µL Day 1 
1°Ab (#2) --- --- 100 µL 100 µL Day 1 
NRS/Buffer --- 100 µL --- --- Day 1 
Tracer 100 µL 100 µL 100 µL 100 µL Day 2 
2°Ab (SAR10) --- 100 µL 100 µL 100 µL Day 3 
 
- Day 1, after adding buffer, sample, filler, NRS and antiserum (#2), vortex (lid on) 
and incubate overnight at 4°C 
- Day 2, add the tracer, vortex and incubate overnight at 4°C 
- Day 3, add second antibody, vortex and incubate overnight at 4°C 
- Day 4, add 1 mL of wash buffer to all tubes except TC  
- Centrifuge at 3200rpm at 4°C 35 minutes (not TC) 




IBL Progesterone Coat-a-Count Kit Protocol 
 
• Standard concentrations may vary between batches, but are in the order of 0, 0.12, 
0.90, 3.00, 7.90, 15.00, 36.00 ng/mL 
• Label tubes. Tubes 1-4 should be regular laboratory uncoated tubes for total counts (1 
& 2) and NSB (3&4) 
• Vortex all samples, calibrators and controls, use while still cold 
• Each assay should have high, med and low internal controls 
• Set up a 100 tube assay as per table, 20 tubes at a time 
 
Tubes  Sample Standard Tracer 
1-2 Total counts   500 µL 
3-4 NSB  0 std, 50 µL 500 µL 
5-18 Standards  50 µL 500 µL 
19-24 QC samples 50 µL  500 µL 
25-194 Experimental samples 50 µL  500 µL 
195-200 QC samples 50 µL  500 µL 
 
• Gently shake tube to liberate air bubbles 
• Wrap in foil and incubate overnight at 4°C 
• Dilute wash solution 1:70 with distilled water and mix thoroughly 
• Except total counts, tip off liquid and blot dry 
• Except total counts, wash tubes with 3 mL of wash solution 
• Let stand for 2 minutes 






Millipore Multi species Leptin RIA 
• Set up assay as per the table 
• Supplied standards are at 0, 0.78, 1.56, 3.13, 6.25, 12.5, 25 ng/mL 
 
Tube Sample µL sample µL buffer µL antisera Tracer µL 2°Ab 
1-2 TC    50 500 
3-4 NSB 50 100 0 50 500 
5-18 Standards 50 50 50 50 500 
19-20 Kit QC sample 50 50 50 50 500 
21-28 qc samples 100 0 50 50 500 
28-xx Experimental 
samples 
100 0 50 50 500 
Xx- end qc samples 100 0 50 50 500 
 
Day 1. Add sample, standard, buffer and antisera. 
Mix, cover, incubate 20-24 hours at 4°C. 
Day 2. Add tracer. 
Mix, cover, incubate 20-24 hours at 4°C. 
Day 3.  Add 2°Ab (precipitation reagent). 
Mix, incubate 20 minutes at 4°C. 
Centrifuge at 2500 g for 20 minutes at 4°C. 





Appendix B. Fixation and histology processing protocols 
Solutions 
Solution A. 8% Paraformaldehyde: 
Add 16 g paraformaldehyde to approximately 180 mL water. 
Heat to 60 °C while stirring.  
While at 60 °C add 5 M NaOH drop wise until solution clears. Make up to 200 mL with water. 
Solution B. Double Strength Phosphate Buffered Saline (0.2 M): 





On the day of use mix solutions A and B, 1:1 and pH to 7.4. 
Fix overnight at 4°C. 
 
Histology processing schedule 
 
80% Alcohol 1.50 hours 
95% Alcohol 1 hour 
95% Alcohol 1 hour 
Absolute Alcohol 1.50 hours 
Absolute Alcohol 1.15 hours 
Absolute Alcohol   1.15 hours 
Abs Alcohol/Xylene 1.50 hours 
Xylene 1 hour 
Xylene 1 hour 
Wax 1.50 hours 








Appendix C. H&E staining protocol 
Haematoxylin and Eosin 
(For 5µm Paraffin Sections) 
 
Procedure 
1. Deparaffinise and hydrate sections to running tap water. Stain Nuclei in Gill’s 
Haematoxylin.  4 minutes 
2. Wash well in running tap water. 
3. Blue in Scott’s tap water.  1 minute  
4. Wash in running tap water.  5 minutes 
5. Counter stain in Alcoholic Eosin.  3 minutes 
6. Wash well in running tap water. 
7. Dehydrate, briskly in two changes of 95% Alcohol  
then two changes of 100% Alcohol, leaving in last 100%  
Alcohol.   2 minutes 
8. Clear in three changes of Xylene.  
9. Leave in last Xylene.   5 minutes 
10.  Mount in DPX. 
 
Results  
               Nuclei                      Blue 
              Other elements         Varying shades of pink 
 
Solutions 
Gill’s Haematoxylin No. 3 
Haematoxylin      6 g 
Distilled Water     690 mL 
Ethylene Glycol     250 mL 
Sodium Iodate     0.6 g  
Aluminium Sulphate        52.8 g 




Add acid after all solids have dissolved. Mix in order given. Can be used at once. Requires no 
differentiation. Maintain acid content by adding 1 drop of acetic acid per 100 mL of stain, do 
this weekly. Change solution monthly. 
 
Alcoholic Eosin  
1% aqueous Eosin (C. I. 45380) 100 mL 
1% aqueous Phloxine 10 mL 
95% ETOH  880 mL 
Acetic acid  5 mL    
     
Scotts Tap Water 
Sodium Bicarbonate  7 g 
Magnesium Sulphate    40 g 






Appendix D. IHC protocols 
 
Standard deparaffinisation, hydration, rehydration and clearing procedure 
 
Solution Time 
Xylene 10 min 
Xylene 10 min 
Abs EtOH 10 secs agitating 
Abs EtOH 5 min 
Abs EtOH 5 min 
70% EtOH 5 min 
70% EtOH 5 min 
TBS 5 min 
TBS 5 min 
IHC protocol starts here 
Deionised water 2 min 
2% Methyl Green  
TBS 5 min 
TBS 5 min 
TBS 5 min 
70% EtOH 5 min 
70% EtOH 5 min 
95% EtOH 5 min 
95% EtOH 5 min 
Abs EtOH 5 min 
Abs EtOH 5 min 
Xylene 10 secs agitating 
Xylene 10 min 



















IHC procedure for Ki-67 and MAPLC3 using Dako envision system 
 
 MAPLC3 Ki-67 
 Reagents 
1°Ab Santa Cruz 271625 1:100 dilution 
Dako M7240 
1:50 dilution 
Antibody diluent Dako S3022 Dako S3022 
-ve control reagent Dako X0944 Dako X0931 
Antigen retrieval solution 10 mM citrate buffer pH 6.0 
10 mM EDTA, 5% Tween20 
pH 8.0 
 Procedure 
Reagent Time/temp Time/temp 
Antigen retrieval 2x 5 min  at 95°C 2x 10 min at 95°C 
Cool  20 min 20 min 
Peroxidase block 5 min 5 min 
TBS 2 x 5 min 2 x 5 min 
1°Ab (or –ve control reagent) 30 min 30 min 
TBS 2 x 5 min 2 x 5 min 
Peroxidase labelled polymer 30 min 30 min 
TBS 2 x 5 min 2 x 5 min 
DAB/Substrrate/Chromogen 10 min 7 min 
TBS 5 min 5 min 
TBS 5 min 5 min 
 
Protocol for TUNEL 
 
Reagent Time/Temp (RT unless specified) 
Proteinase K (1:50) 15 min @ 37°C 
Deionised water 2 x 2 min 
3% H2O2 5 min 
PBS 1 min 
TdT labelling buffer 5 min 
Labelling reaction 60 min @ 37°C 
TdT stop buffer 5 min 
Deionised water 2 x 5min 
Strep-HRP 10 min @ 37°C 
PBS 2 x 2min 
DAB 3.5 min 









Appendix E. PCR protocol for sex determination 




• Platinum Hot Start PCR 2X Master Mix (Invitrogen Cat  13000-013, Thermo Fisher 
Scientific, Auckland, NZ) 
• Primers were sourced from Intergrated DNA Technologies via Thermo Fisher Scientific 
 
• SRY specific primers (sheep)  
Use primers at a final concentration of 10 pmol/µL 
 
SRYfor (5’ to 3’) TGA AAG ACG ATG TTT ACA GTC CAG C 
SRYrev (5’ to 3’) AAT CAC GGA CTG GGA GCG GCT TAA T 
Product size 527 bp 
 
• β-actin primers 
β-actin forward   (5’ to 3’) ATG AAG ATC CTC ACG GAA CG 
β-actin reverse (5’ to 3’) GAA GGT GGT CTC GTG AAT GC 
Product size 420 bp 
 
• TAE Electrophoresis Buffer 50x TAE Stock  
242 g    Tris 
57.1 mL  Glacial Acetic Acid 
37.2 g    EDTA 
Milli-Q to 1L 
Dilute stock in Milli-Q to 1x  
 
 
• DNA Loading Dye 
Glycerol    500 µL 
0.5M EDTA    100 µL   
Bromophenol Blue 1%    125 µL  
MilliQ Water    275 µL  
 
• DNA gels 
2% Agarose containing 10 µL of 10 mg/mL ethidium bromide /100 mL of agarose 
 
 




2X Master Mix 12.5 
Forward primer 1 
Reverse primer 1 




PCR Programs (Eppendorf Master Cycler) 
 
1  95 °C   10 mins 1 cycle 
   
 
2     95 °C    20 secs 
  60 °C    20 secs        35 cycles 
  72 °C     40secs 
 
3   72 °C   5 mins  1 cycle 
 




Run electrophoresis gels at 67v for 45 minutes 
Wells contain either: 
5 µL sample, 3 µL loading buffer, or 
3 µL marker  





























Appendix F. ERCC control mixes, concentrations and expected fold 
changes 
 
ERCC ID subgroup concentration in Mix 1 (attomoles/µL) 
concentration in 





(Mix 1/Mix 2) 
ERCC-00002 D 15000 30000 0.5 -1 
ERCC-00003 D 937.5 1875 0.5 -1 
ERCC-00004 A 7500 1875 4 2 
ERCC-00009 B 937.5 937.5 1 0 
ERCC-00012 C 0.11444092 0.17166138 0.67 -0.58 
ERCC-00013 D 0.91552734 1.83105469 0.5 -1 
ERCC-00014 D 3.66210938 7.32421875 0.5 -1 
ERCC-00016 C 0.22888184 0.34332275 0.67 -0.58 
ERCC-00017 A 0.11444092 0.02861023 4 2 
ERCC-00019 A 29.296875 7.32421875 4 2 
ERCC-00022 D 234.375 468.75 0.5 -1 
ERCC-00024 C 0.22888184 0.34332275 0.67 -0.58 
ERCC-00025 B 58.59375 58.59375 1 0 
ERCC-00028 A 3.66210938 0.91552734 4 2 
ERCC-00031 B 1.83105469 1.83105469 1 0 
ERCC-00033 A 1.83105469 0.45776367 4 2 
ERCC-00034 B 7.32421875 7.32421875 1 0 
ERCC-00035 B 117.1875 117.1875 1 0 
ERCC-00039 C 3.66210938 5.49316406 0.67 -0.58 
ERCC-00040 C 0.91552734 1.37329102 0.67 -0.58 
ERCC-00041 D 0.22888184 0.45776367 0.5 -1 
ERCC-00042 B 468.75 468.75 1 0 
ERCC-00043 D 468.75 937.5 0.5 -1 
ERCC-00044 C 117.1875 175.78125 0.67 -0.58 
ERCC-00046 D 3750 7500 0.5 -1 
ERCC-00048 D 0.01430512 0.02861023 0.5 -1 
ERCC-00051 B 58.59375 58.59375 1 0 
ERCC-00053 B 29.296875 29.296875 1 0 
ERCC-00054 C 14.6484375 21.9726563 0.67 -0.58 
ERCC-00057 C 0.01430512 0.02145767 0.67 -0.58 
ERCC-00058 C 1.83105469 2.74658203 0.67 -0.58 
ERCC-00059 D 14.6484375 29.296875 0.5 -1 
ERCC-00060 B 234.375 234.375 1 0 
ERCC-00061 D 0.05722046 0.11444092 0.5 -1 
ERCC-00062 A 58.59375 14.6484375 4 2 
ERCC-00067 B 3.66210938 3.66210938 1 0 
ERCC-00069 D 1.83105469 3.66210938 0.5 -1 
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ERCC ID subgroup concentration in Mix 1 (attomoles/µL) 
concentration in 





(Mix 1/Mix 2) 
ERCC-00071 C 58.59375 87.890625 0.67 -0.58 
ERCC-00073 B 0.91552734 0.91552734 1 0 
ERCC-00074 C 15000 22500 0.67 -0.58 
ERCC-00075 B 0.01430512 0.01430512 1 0 
ERCC-00076 C 234.375 351.5625 0.67 -0.58 
ERCC-00077 D 3.66210938 7.32421875 0.5 -1 
ERCC-00078 D 29.296875 58.59375 0.5 -1 
ERCC-00079 D 58.59375 117.1875 0.5 -1 
ERCC-00081 D 0.22888184 0.45776367 0.5 -1 
ERCC-00083 A 0.02861023 0.00715256 4 2 
ERCC-00084 C 29.296875 43.9453125 0.67 -0.58 
ERCC-00085 A 7.32421875 1.83105469 4 2 
ERCC-00086 D 0.11444092 0.22888184 0.5 -1 
ERCC-00092 A 234.375 58.59375 4 2 
ERCC-00095 A 117.1875 29.296875 4 2 
ERCC-00096 B 15000 15000 1 0 
ERCC-00097 A 0.45776367 0.11444092 4 2 
ERCC-00098 C 0.05722046 0.08583069 0.67 -0.58 
ERCC-00099 C 14.6484375 21.9726563 0.67 -0.58 
ERCC-00104 B 0.22888184 0.22888184 1 0 
ERCC-00108 A 937.5 234.375 4 2 
ERCC-00109 B 0.91552734 0.91552734 1 0 
ERCC-00111 C 468.75 703.125 0.67 -0.58 
ERCC-00112 D 117.1875 234.375 0.5 -1 
ERCC-00113 C 3750 5625 0.67 -0.58 
ERCC-00116 A 468.75 117.1875 4 2 
ERCC-00117 B 0.05722046 0.05722046 1 0 
ERCC-00120 C 0.91552734 1.37329102 0.67 -0.58 
ERCC-00123 A 0.22888184 0.05722046 4 2 
ERCC-00126 B 14.6484375 14.6484375 1 0 
ERCC-00130 A 30000 7500 4 2 
ERCC-00131 A 117.1875 29.296875 4 2 
ERCC-00134 A 1.83105469 0.45776367 4 2 
ERCC-00136 A 1875 468.75 4 2 
ERCC-00137 D 0.91552734 1.83105469 0.5 -1 
ERCC-00138 B 0.11444092 0.11444092 1 0 
ERCC-00142 B 0.22888184 0.22888184 1 0 
ERCC-00143 C 3.66210938 5.49316406 0.67 -0.58 
ERCC-00144 A 29.296875 7.32421875 4 2 
ERCC-00145 C 937.5 1406.25 0.67 -0.58 
ERCC-00147 A 0.91552734 0.22888184 4 2 
ERCC-00148 B 14.6484375 14.6484375 1 0 
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ERCC ID subgroup concentration in Mix 1 (attomoles/µL) 
concentration in 





(Mix 1/Mix 2) 
ERCC-00150 B 3.66210938 3.66210938 1 0 
ERCC-00154 A 7.32421875 1.83105469 4 2 
ERCC-00156 A 0.45776367 0.11444092 4 2 
ERCC-00157 C 7.32421875 10.9863281 0.67 -0.58 
ERCC-00158 B 0.45776367 0.45776367 1 0 
ERCC-00160 D 7.32421875 14.6484375 0.5 -1 
ERCC-00162 C 58.59375 87.890625 0.67 -0.58 
ERCC-00163 D 14.6484375 29.296875 0.5 -1 
ERCC-00164 C 0.45776367 0.68664551 0.67 -0.58 
ERCC-00165 D 58.59375 117.1875 0.5 -1 
ERCC-00168 D 0.45776367 0.91552734 0.5 -1 
ERCC-00170 A 14.6484375 3.66210938 4 2 




Appendix G. Nanostring primers 
 
































































































































































Appendix H. Day 55 differentially expressed genes 
 




log2(fold change) Test stat p value q value 
ENSOARG00000009954 - 2.35431 0.301884 -2.96324 -3.62567 5.00E-05 0.013907 
ENSOARG00000010604 - 0 2.03906 inf  5.00E-05 0.013907 
ENSOARG00000017575 - 1.49058 5.46257 1.8737 3.68223 5.00E-05 0.013907 
ENSOARG00000019994 - 21.6299 6.12529 -1.82017 -4.45544 5.00E-05 0.013907 
ENSOARG00000008517 - 6.13368 12.8323 1.06496 1.93129 5.00E-05 0.013907 
ENSOARG00000008061 - 33.7653 19.7285 -0.77526 -1.61402 5.00E-05 0.013907 
ENSOARG00000017859 - 42.6436 25.1198 -0.76351 -3.83172 5.00E-05 0.013907 
ENSOARG00000000617 - 11.458 28.9567 1.33754 1.99478 5.00E-05 0.013907 
ENSOARG00000004939 - 94.9776 54.9841 -0.78857 -2.44909 0.0001 0.025456 
ENSOARG00000020259 - 187.425 86.2568 -1.1196 -1.95851 5.00E-05 0.013907 
ENSOARG00000011986 - 164.821 98.0049 -0.74997 -1.72592 0.00015 0.034134 
ENSOARG00000009299 - 372.221 713.806 0.939375 2.10516 5.00E-05 0.013907 
ENSOARG00000007855 - 2432.45 1279.02 -0.92737 -2.19929 5.00E-05 0.013907 
ENSOARG00000012079 - 1193.4 1909.5 0.678119 1.66424 0.00015 0.034134 
ENSOARG00000016430 ACACB 5.08823 2.67092 -0.92983 -1.71305 5.00E-05 0.013907 
ENSOARG00000001408 ACVR2B 3.52827 6.83484 0.953948 2.58695 5.00E-05 0.013907 
ENSOARG00000013966 AFP 0.622928 30.0446 5.5919 7.64149 5.00E-05 0.013907 
ENSOARG00000003055 AGT 0.691858 3.91933 2.50206 2.13353 0.0002 0.043533 
ENSOARG00000020528 AHSG 10.4652 184.878 4.14291 5.44999 5.00E-05 0.013907 
ENSOARG00000013782 ALB 1.34437 16.148 3.58635 8.72235 5.00E-05 0.013907 
ENSOARG00000006134 AMBP 0.286185 7.20928 4.65483 2.59983 5.00E-05 0.013907 
ENSOARG00000015661 APOH 1.54216 10.401 2.75371 2.51958 5.00E-05 0.013907 
ENSOARG00000010703 ATP2C2 8.96587 17.6561 0.977653 1.99168 5.00E-05 0.013907 
ENSOARG00000000788 BAIAP2L1 33.9505 16.1308 -1.07361 -2.7145 5.00E-05 0.013907 
ENSOARG00000011174 C1orf112 18.1453 29.9208 0.721555 2.13097 5.00E-05 0.013907 
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log2(fold change) Test stat p value q value 
ENSOARG00000012206 CA5A 0.587683 5.69766 3.27726 2.47812 5.00E-05 0.013907 
ENSOARG00000000817 CALY 7.8467 18.0158 1.19911 2.34406 5.00E-05 0.013907 
ENSOARG00000004318 CDC2 4.61195 7.756 0.749936 3.06653 5.00E-05 0.013907 
ENSOARG00000009067 CHL1 3.3508 1.45061 -1.20785 -2.37123 5.00E-05 0.013907 
ENSOARG00000011479 CRTAC1 19.6994 7.24429 -1.44323 -2.21369 5.00E-05 0.013907 
ENSOARG00000012632 DHX40 47.7179 72.9756 0.612882 1.94524 5.00E-05 0.013907 
ENSOARG00000005161 DNAH1 1.85491 0.960314 -0.94977 -1.53714 5.00E-05 0.013907 
ENSOARG00000015028 DNAH9 0.987453 1.93032 0.967053 1.82872 5.00E-05 0.013907 
ENSOARG00000015375 ERC2 3.0182 1.2941 -1.22174 -2.17977 0.0002 0.043533 
ENSOARG00000018378 FAM3C 55.7943 33.7199 -0.72652 -3.03996 0.0001 0.025456 
ENSOARG00000020526 FETUB 0.245131 10.6503 5.44119 3.60959 5.00E-05 0.013907 
ENSOARG00000000291 FGB 1.1661 3.0032 1.36482 4.78969 5.00E-05 0.013907 
ENSOARG00000011205 FIGLA 8.19908 0.835125 -3.2954 -2.74694 5.00E-05 0.013907 
ENSOARG00000011919 FOXR1 5.50283 0.301097 -4.19187 -3.24832 5.00E-05 0.013907 
ENSOARG00000002203 FUS 79.9934 51.279 -0.64151 -1.80146 0.0001 0.025456 
ENSOARG00000012835 GC 0.220897 5.29353 4.58278 2.65218 5.00E-05 0.013907 
ENSOARG00000013229 GDF9 9.44508 2.57939 -1.87254 -2.85607 5.00E-05 0.013907 
ENSOARG00000020669 HIST2H2BF 29.8712 5.30623 -2.49299 -2.1468 5.00E-05 0.013907 
ENSOARG00000018312 HPX 2.08873 6.19099 1.56754 1.89409 0.00015 0.034134 
ENSOARG00000008800 HSP70 30.2673 10.7441 -1.49421 -2.53271 5.00E-05 0.013907 
ENSOARG00000008817 HSP70 6.85096 30.1346 2.13704 3.19285 5.00E-05 0.013907 
ENSOARG00000013662 ITIH2 0.210432 2.15385 3.35549 2.84795 5.00E-05 0.013907 
ENSOARG00000014780 KIAA1324L 2.75739 0.462474 -2.57586 -3.20494 5.00E-05 0.013907 
ENSOARG00000004281 NEFH 16.8981 8.95828 -0.91556 -1.84514 5.00E-05 0.013907 
ENSOARG00000004210 NOS1 1.67547 0.499325 -1.74651 -1.7184 0.00015 0.034134 
ENSOARG00000010997 PADI6 15.91 2.48478 -2.67875 -3.14989 5.00E-05 0.013907 
ENSOARG00000004585 PNLDC1 7.81273 2.53961 -1.62122 -2.54699 5.00E-05 0.013907 
ENSOARG00000008453 RIBC1 13.3927 5.82082 -1.20215 -1.76308 5.00E-05 0.013907 
ENSOARG00000020791 RPS27L 247.854 114.927 -1.10878 -2.19818 5.00E-05 0.013907 
ENSOARG00000002474 SAMD15 6.91406 2.41784 -1.51581 -3.76059 5.00E-05 0.013907 
ENSOARG00000014882 SERPINA1 3.32337 84.8135 4.67358 5.08455 5.00E-05 0.013907 
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log2(fold change) Test stat p value q value 
ENSOARG00000015144 SERPINA5 15.2224 25.1028 0.721659 1.55178 0.0002 0.043533 
ENSOARG00000003976 SH2D4A 2.51641 6.62471 1.39649 2.08323 0.00015 0.034134 
ENSOARG00000006804 SPCS3 119.602 250.43 1.06616 2.56796 5.00E-05 0.013907 
ENSOARG00000018567 SPESP1 5.2307 1.98085 -1.40089 -3.4209 0.0001 0.025456 
ENSOARG00000019162 SPP2 0.619347 6.43414 3.37693 2.42679 5.00E-05 0.013907 
ENSOARG00000001996 TADA2A 125.163 198.291 0.663805 1.81793 0.00015 0.034134 
ENSOARG00000019474 TDRD15 7.16202 3.26655 -1.1326 -4.32998 5.00E-05 0.013907 
ENSOARG00000016633 TMED2 152.878 417.808 1.45046 4.0733 5.00E-05 0.013907 
ENSOARG00000001811 TNNI3 25.6115 12.0031 -1.09338 -1.53237 0.00015 0.034134 
ENSOARG00000018004 VTN 0.481068 5.5989 3.54083 2.5518 5.00E-05 0.013907 
ENSOARG00000005507 WDR87 5.40362 2.34813 -1.20241 -2.85052 5.00E-05 0.013907 
ENSOARG00000003901 ZNF19 3.30003 1.83378 -0.84766 -1.96789 0.0001 0.025456 





















Appendix I. Day 75 differentially expressed genes 
 




log2(fold change) Test stat p value q value 
ENSOARG00000001279 - 9.44453 27.0592 1.51857 1.84808 0.0001 0.016123 
ENSOARG00000002402 - 8.83006 5.04559 -0.8074 -2.29628 0.0003 0.034708 
ENSOARG00000004556 - 781.176 1169.4 0.582046 1.73145 5.00E-05 0.00913 
ENSOARG00000005542 - 378.406 582.199 0.621577 1.80296 5.00E-05 0.00913 
ENSOARG00000005549 - 563.981 838.408 0.572006 1.96443 0.0002 0.027064 
ENSOARG00000006661 - 11.178 6.50995 -0.77995 -2.15932 5.00E-05 0.00913 
ENSOARG00000008061 - 26.6971 41.2605 0.628077 1.56828 0.00035 0.039587 
ENSOARG00000009868 - 14.6866 6.09321 -1.26922 -1.79615 0.00035 0.039587 
ENSOARG00000009954 - 17.4997 7.92298 -1.14322 -3.29522 5.00E-05 0.00913 
ENSOARG00000010944 - 639.952 994.647 0.636222 1.75352 5.00E-05 0.00913 
ENSOARG00000011629 - 1.76303 10.1326 2.52287 1.8382 0.0002 0.027064 
ENSOARG00000011986 - 161.868 266.109 0.717201 1.96258 5.00E-05 0.00913 
ENSOARG00000012947 - 90.1067 43.8499 -1.03906 -1.96213 5.00E-05 0.00913 
ENSOARG00000013149 - 81.2957 143.602 0.820825 1.56286 0.0002 0.027064 
ENSOARG00000016402 - 78.3751 118.919 0.601513 1.78981 0.0001 0.016123 
ENSOARG00000017111 - 517.912 908.721 0.811131 1.75298 5.00E-05 0.00913 
ENSOARG00000017575 - 2.12044 4.23029 0.996392 1.9807 5.00E-05 0.00913 
ENSOARG00000017944 - 34.455 51.5948 0.582512 2.23261 0.0002 0.027064 
ENSOARG00000018884 - 95.389 144.912 0.603279 1.73382 5.00E-05 0.00913 
ENSOARG00000019174 - 325.645 501.883 0.624048 1.58656 0.00025 0.031314 
ENSOARG00000019479 - 25.4592 5.54325 -2.19939 -2.56134 5.00E-05 0.00913 
ENSOARG00000019994 - 28.7556 11.7446 -1.29185 -3.28852 5.00E-05 0.00913 
ENSOARG00000020231 - 52.7698 161.393 1.61279 4.86633 5.00E-05 0.00913 
ENSOARG00000016430 ACACB 15.5031 10.2957 -0.59051 -1.72352 0.0002 0.027064 
ENSOARG00000006156 ADAMTS14 13.3968 5.31634 -1.33338 -2.87617 5.00E-05 0.00913 
ENSOARG00000013966 AFP 2.93872 12.4881 2.0873 5.94092 5.00E-05 0.00913 
ENSOARG00000020528 AHSG 18.3058 108.964 2.57348 3.86726 5.00E-05 0.00913 
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log2(fold change) Test stat p value q value 
ENSOARG00000013782 ALB 4.07948 16.3494 2.00278 5.84517 5.00E-05 0.00913 
ENSOARG00000012705 ALDH1A1 9.92088 18.1286 0.869725 2.20799 5.00E-05 0.00913 
ENSOARG00000006134 AMBP 1.39912 9.03182 2.6905 2.50429 5.00E-05 0.00913 
ENSOARG00000013137 APAF-1 24.0295 15.5152 -0.63112 -2.02888 5.00E-05 0.00913 
ENSOARG00000017104 APCDD1L 7.03592 21.2088 1.59185 2.64517 5.00E-05 0.00913 
ENSOARG00000010709 ARMC2 13.1026 6.92312 -0.92035 -2.17126 5.00E-05 0.00913 
ENSOARG00000011996 ASB11 15.9816 8.18096 -0.96607 -2.45282 0.0001 0.016123 
ENSOARG00000000788 BAIAP2L1 96.641 61.9162 -0.64232 -1.98854 5.00E-05 0.00913 
ENSOARG00000014065 C11orf16 26.8497 16.6668 -0.68794 -1.60554 0.00045 0.047036 
ENSOARG00000001641 C20orf27 64.5303 99.0619 0.618354 1.641 0.00035 0.039587 
ENSOARG00000008549 C7orf25 39.6799 26.044 -0.60746 -1.69577 0.00025 0.031314 
ENSOARG00000000193 CADPS2 23.4923 15.5127 -0.59874 -1.78384 0.00015 0.02186 
ENSOARG00000003936 CALB2 8.99995 18.3736 1.02964 1.64976 0.0001 0.016123 
ENSOARG00000010904 CCDC64 64.6144 43.8887 -0.55801 -1.60712 0.0003 0.034708 
ENSOARG00000011731 CCDC88C 13.9998 9.04836 -0.62968 -1.77025 0.00015 0.02186 
ENSOARG00000004893 CCL16 0 2.30365 inf #NAME? 0.0001 0.016123 
ENSOARG00000005718 CEP164 17.074 11.5727 -0.56107 -1.66459 0.0001 0.016123 
ENSOARG00000009067 CHL1 21.8493 9.72801 -1.16737 -3.36599 5.00E-05 0.00913 
ENSOARG00000017833 CHRDL1 17.7895 29.899 0.749068 1.67308 0.00025 0.031314 
ENSOARG00000019611 CLIP4 13.7178 8.33321 -0.71911 -1.66939 0.00025 0.031314 
ENSOARG00000019995 CNR1 7.97799 15.4845 0.956728 1.90415 0.0003 0.034708 
ENSOARG00000007080 CNTNAP4 7.79422 13.7689 0.820936 2.06854 5.00E-05 0.00913 
ENSOARG00000005504 COCH 36.8878 22.9595 -0.68405 -1.88365 0.00025 0.031314 
ENSOARG00000002812 COX5A 472.734 301.379 -0.64945 -1.70878 0.0001 0.016123 
ENSOARG00000015209 DACH1 31.4012 46.7392 0.573814 1.61597 0.00025 0.031314 
ENSOARG00000018383 DHX58 18.7391 11.7385 -0.6748 -1.82158 5.00E-05 0.00913 
ENSOARG00000000853 DLEC1 7.91677 4.43796 -0.83501 -1.96488 5.00E-05 0.00913 
ENSOARG00000005161 DNAH1 5.54745 3.1531 -0.81505 -2.1632 5.00E-05 0.00913 
ENSOARG00000009918 DOCK5 15.2172 8.13754 -0.90304 -2.59871 5.00E-05 0.00913 
ENSOARG00000010103 ENTPD4 29.1735 18.6488 -0.64558 -2.27722 5.00E-05 0.00913 
ENSOARG00000007009 EPB41L4B 37.6249 24.1522 -0.63954 -1.62713 0.00045 0.047036 
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log2(fold change) Test stat p value q value 
ENSOARG00000000113 FAM204A 41.5036 24.5765 -0.75596 -2.36766 5.00E-05 0.00913 
ENSOARG00000006246 FAP 10.6741 18.3454 0.781301 2.28731 5.00E-05 0.00913 
ENSOARG00000011205 FIGLA 45.0748 22.9697 -0.97259 -2.15599 0.0001 0.016123 
ENSOARG00000011919 FOXR1 32.0543 15.3523 -1.06206 -2.24573 5.00E-05 0.00913 
ENSOARG00000013615 FSTL4 12.4105 6.66113 -0.89772 -1.86402 5.00E-05 0.00913 
ENSOARG00000009427 GLRX 263.993 132.171 -0.99809 -2.01433 5.00E-05 0.00913 
ENSOARG00000006913 GPANK1 143.943 90.0858 -0.67612 -2.05449 5.00E-05 0.00913 
ENSOARG00000012389 GPRC5B 46.8659 70.8761 0.596762 1.68601 0.00015 0.02186 
ENSOARG00000016103 GREB1 28.3305 42.105 0.571634 1.75102 5.00E-05 0.00913 
ENSOARG00000008232 GUCY1A3 16.0194 10.2048 -0.65058 -1.58042 0.0003 0.034708 
ENSOARG00000002271 HAX1 150.078 104.337 -0.52447 -1.52832 0.0004 0.04393 
ENSOARG00000007725 HIP1R 107.056 52.6993 -1.02251 -3.28444 5.00E-05 0.00913 
ENSOARG00000015415 HPCAL1 111.438 168.195 0.593897 1.60274 0.0003 0.034708 
ENSOARG00000007452 HSPA6 18.3515 32.9817 0.845767 1.97669 5.00E-05 0.00913 
ENSOARG00000008248 HSPG2 36.8144 59.5639 0.694168 2.07812 5.00E-05 0.00913 
ENSOARG00000011513 IRF8 50.8752 28.7638 -0.82271 -2.01341 5.00E-05 0.00913 
ENSOARG00000007233 ISG17 89.5322 45.5016 -0.97649 -1.86511 0.0001 0.016123 
ENSOARG00000008230 ITM2B 299.92 427.073 0.509907 1.70218 0.00045 0.047036 
ENSOARG00000010523 JAG1 88.3776 52.5666 -0.74953 -2.19709 5.00E-05 0.00913 
ENSOARG00000014631 JAK3 33.9899 49.2082 0.533795 1.59374 0.0002 0.027064 
ENSOARG00000009874 KCTD9 37.4257 22.9342 -0.70653 -1.78394 5.00E-05 0.00913 
ENSOARG00000013162 LGMN 169.799 257.295 0.599597 1.71884 0.00015 0.02186 
ENSOARG00000012587 LHX8 17.1096 8.96052 -0.93315 -3.56015 5.00E-05 0.00913 
ENSOARG00000011565 LIG1 99.4201 69.2417 -0.5219 -1.6401 0.0002 0.027064 
ENSOARG00000011888 MAEL 38.188 24.9926 -0.61162 -2.32919 5.00E-05 0.00913 
ENSOARG00000014746 MAP3K15 14.0655 9.27188 -0.60123 -1.54024 0.0003 0.034708 
ENSOARG00000000249 MAP7 31.9318 21.3404 -0.58141 -1.63208 0.0003 0.034708 
ENSOARG00000003214 MATER 7.05085 3.08533 -1.19237 -2.04573 0.00015 0.02186 
ENSOARG00000014271 MOXD1 6.74105 15.7278 1.22227 2.90159 5.00E-05 0.00913 
ENSOARG00000005356 MVP 134.713 92.1745 -0.54745 -1.64435 0.00015 0.02186 
ENSOARG00000010283 MX1 59.0945 37.5668 -0.65357 -1.97096 5.00E-05 0.00913 
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ENSOARG00000006257 MYBPC3 30.4213 20.9249 -0.53986 -1.57483 0.0004 0.04393 
ENSOARG00000018916 MYH15 6.86614 3.7088 -0.88855 -2.0572 5.00E-05 0.00913 
ENSOARG00000016029 NETO2 40.491 25.4291 -0.67112 -2.17581 5.00E-05 0.00913 
ENSOARG00000018834 NLRC5 4.70296 2.17149 -1.11489 -2.0951 5.00E-05 0.00913 
ENSOARG00000018472 NOBOX 21.7722 10.3635 -1.07098 -3.50804 5.00E-05 0.00913 
ENSOARG00000004210 NOS1 9.64095 4.72687 -1.02829 -2.15454 5.00E-05 0.00913 
ENSOARG00000010990 OOEP 17.7975 11.4802 -0.63254 -2.27774 0.0001 0.016123 
ENSOARG00000010997 PADI6 96.6276 45.7188 -1.07965 -2.99871 5.00E-05 0.00913 
ENSOARG00000019777 PARP2 20.5256 14.1422 -0.53742 -2.13645 0.0003 0.034708 
ENSOARG00000006333 PCBD1 227.6 143.79 -0.66254 -1.70811 0.0001 0.016123 
ENSOARG00000005330 PGS1 91.7791 62.5533 -0.55308 -1.60916 0.0003 0.034708 
ENSOARG00000019841 PHTF1 16.4991 9.52387 -0.79276 -2.9265 5.00E-05 0.00913 
ENSOARG00000004726 PLG 0.387388 1.81374 2.22712 1.76747 0.00015 0.02186 
ENSOARG00000015895 PLXNC1 9.13778 5.68209 -0.68542 -1.65533 0.00045 0.047036 
ENSOARG00000004585 PNLDC1 42.3089 21.5407 -0.9739 -2.59118 5.00E-05 0.00913 
ENSOARG00000017730 POLDIP2 285.529 198.278 -0.52611 -1.59421 0.00015 0.02186 
ENSOARG00000001660 PRELP 106.415 155.312 0.545462 1.66136 0.00025 0.031314 
ENSOARG00000009728 PTN 2467.97 1536.09 -0.68406 -1.8156 5.00E-05 0.00913 
ENSOARG00000012973 RALB 125.609 79.5862 -0.65835 -1.81456 5.00E-05 0.00913 
ENSOARG00000010208 RBM20 3.80177 1.67841 -1.17958 -1.76804 5.00E-05 0.00913 
ENSOARG00000008453 RIBC1 40.8603 23.0327 -0.82701 -1.89797 5.00E-05 0.00913 
ENSOARG00000007850 ROR2 18.9176 29.7259 0.651989 1.78168 5.00E-05 0.00913 
ENSOARG00000006329 RP9 40.733 64.3408 0.659536 1.83441 5.00E-05 0.00913 
ENSOARG00000011291 RPL13 165.65 312.035 0.913569 2.52034 5.00E-05 0.00913 
ENSOARG00000013272 RPL31 3521.58 5316.72 0.594315 1.54689 0.00025 0.031314 
ENSOARG00000019941 RYR3 1.96152 0.907717 -1.11166 -2.28551 5.00E-05 0.00913 
ENSOARG00000001249 SCD5 55.6473 106.013 0.92986 2.45427 5.00E-05 0.00913 
ENSOARG00000004852 SCN1A 4.84708 2.73424 -0.82597 -1.96005 5.00E-05 0.00913 
ENSOARG00000004415 SEMA3G 17.4536 8.78345 -0.99067 -2.07313 5.00E-05 0.00913 
ENSOARG00000014882 SERPINA1 13.4193 57.4378 2.09769 4.07701 5.00E-05 0.00913 
ENSOARG00000021024 SLC12A1 7.11233 3.43632 -1.04946 -2.20238 5.00E-05 0.00913 
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log2(fold change) Test stat p value q value 
ENSOARG00000018749 SLC12A3 3.41004 1.16085 -1.55461 -1.66723 0.00045 0.047036 
ENSOARG00000009523 SLC25A15 37.0628 22.5169 -0.71896 -2.57932 5.00E-05 0.00913 
ENSOARG00000020471 SLC2A1 25.2854 39.6862 0.65033 1.78035 0.0004 0.04393 
ENSOARG00000019186 SLC5A6 30.1794 17.8977 -0.75379 -2.0361 5.00E-05 0.00913 
ENSOARG00000003389 SLC7A6 49.9783 34.0024 -0.55567 -1.54455 0.00045 0.047036 
ENSOARG00000008875 SLC8B1 28.3019 15.0924 -0.90708 -2.13119 5.00E-05 0.00913 
ENSOARG00000007202 SPON1 113.046 184.991 0.710539 2.00034 5.00E-05 0.00913 
ENSOARG00000020448 SPTBN5 2.35738 1.07548 -1.1322 -2.04303 5.00E-05 0.00913 
ENSOARG00000002772 TDRD10 49.8906 21.8189 -1.19319 -2.71706 5.00E-05 0.00913 
ENSOARG00000019474 TDRD15 18.1475 9.69982 -0.90374 -3.345 5.00E-05 0.00913 
ENSOARG00000021052 TDRKH 47.1024 29.3589 -0.68201 -2.70108 5.00E-05 0.00913 
ENSOARG00000004216 TFB1M 52.1608 32.9568 -0.66239 -1.61389 0.00025 0.031314 
ENSOARG00000016713 TKT 97.4171 141.647 0.540053 1.7033 0.0002 0.027064 
ENSOARG00000002868 TMC4 23.2602 13.8031 -0.75288 -1.84753 5.00E-05 0.00913 
ENSOARG00000016633 TMED2 268.158 135.889 -0.98065 -2.77942 5.00E-05 0.00913 
ENSOARG00000013455 TSKS 9.38945 4.32438 -1.11855 -1.66341 0.00045 0.047036 
ENSOARG00000017195 TTN 2.48797 1.62481 -0.6147 -1.88397 5.00E-05 0.00913 
ENSOARG00000002800 UBE2Q1 307.867 214.703 -0.51997 -1.59699 0.0003 0.034708 
ENSOARG00000020918 UNC13C 1.61475 0.813592 -0.98893 -1.98386 0.0004 0.04393 
ENSOARG00000009004 UPF3A 33.0526 20.5359 -0.68661 -1.71926 0.00015 0.02186 
ENSOARG00000005507 WDR87 22.0535 13.3182 -0.72761 -2.36442 5.00E-05 0.00913 
ENSOARG00000003121 WIF1 58.8667 37.1015 -0.66597 -1.77155 5.00E-05 0.00913 
ENSOARG00000011562 YBX2 65.566 37.3915 -0.81024 -1.81632 5.00E-05 0.00913 
ENSOARG00000011296 ZNF541 27.5026 18.3756 -0.58178 -1.66929 0.00015 0.02186 
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Application of Next Generation Sequencing in Determining Trans- generational Effects of 
Gestational Under-nutrition 
Peter Smith1,2, Jennifer Juengel1, Christy Rand2 and Jo Ann Stanton2 
1. AgResearch Invermay, Mosgiel 
2. Department of Anatomy, University of Otago, Dunedin 
Developmental origins of health is of increasing interest. Negative effects of gestational under-
nutrition on reproductive performance within the ensuing generation has been studied in a 
number of species. In this study sheep were fed either a maintenance diet or a diet 0.6 of 
maintenance for the first 55 days of gestation. Female fetuses were collected at gestational days 
55 and 75. Remaining animals progressed to lambing and the reproductive performance of the 
offspring monitored through their first two breeding seasons to assess the impacts of maternal 
gestational under-nutrition. A transcriptome analysis using the Ion Proton is being undertaken 




Society for the Study of Reproduction 2015. San Juan, Puerto Rico. 
 
Effects of Early Gestational Undernutrition on Lamb Performance and Post Natal Fertility in 
Sheep 
 
Peter Smith1,2, Jo-Ann Stanton2  and Jennifer L Juengel1. 1. AgResearch Invermay, Mosgiel, 
New Zealand: 2.Department of Anatomy, University of Otago, Dunedin, New Zealand 
 
The impact of nutritional restriction during gestation on the fetus varies depending on the 
species, timing, severity and type of the restriction. In this study, sheep were placed on a 
maintenance diet, based on the metabolisable energy intake, or a diet equivalent to 60 % of 
maintenance for the first 55 days of gestation. Maternal blood samples were collected at 
gestational days 55 (n=36) and 75 (n=15). These samples were assayed for leptin and 
progesterone. Fetuses from these animals were also collected at gestational days 55 (n=34) and 
75 (n=25). Birth weight and weaning weight of male and female lambs were recorded (n=65) 
from animals brought to term within each diet group. Age at puberty was determined through 
weekly monitoring of marking by a harnessed vasectomized ram. The ovaries of female 
offspring (n=30) were assessed at 6-7 months of age by laparoscopy and transrectal ultrasound 
scanning to determine ovulation rates and antral follicle counts; two indicators of fertility. 
During the first 55 days of gestation, maintenance ewes increased body weight by 4.2 % while 
body weight decreased 6.4 % in those on the restricted diet. Differences in body weights were 
maintained between the groups until at least day 90 of gestation. At both days 55 and 75 of 
gestation, no nutrition induced differences in fetal weight or fetal gonad weight were observed 
in either male or female fetuses. At cessation of nutrition restriction (day 55), maternal plasma 
leptin levels were significantly lower in those animals exposed to reduced nutrition 
(maintenance 2.9 ng/ml vs restricted 2.2 ng/ml, P=0.048). By gestational day 75 maternal leptin 
levels in restricted animals had returned to levels comparable to those found in maintenance 
animals (maintenance 3.4 ng/ml vs restricted 2.9 ng/ml). Progesterone concentrations were 
increased in restricted animals at gestational day 55 (maintenance 6.68 ng/ml vs restricted 7.78 
ng/ml, P=0.021) while levels at day 75 were similar (maintenance 9.51 ng/ml vs restricted 9.03 
ng/ml). At birth, there were no differences between the groups in the number of lambs born per 
ewe (maintenance = 1.77, restricted =1.73) or in the weights of those lambs born (maintenance 
= 5.4 kg vs restricted =5.7 kg). Growth of the lambs to weaning was also unaffected. Weights 
of female lambs remained similar between the groups until at least 7 months of age. The 
gestational nutrition restriction did not affect the onset of puberty in female offspring with the 
average time taken to attain puberty being 225 days for maintenance animals vs 226 days for 
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those from the restricted group. At 6-7 months of age, no significant differences were noted 
between the groups in either ovulation rate (maintenance 1.40 vs restricted 1.48) or antral 
follicle counts (maintenance 14.3 vs restricted 15.5). While further studies are ongoing with 
this cohort of sheep, the nutritional regime used here, 60 % of maintenance for the first 55 days 
of gestation, did not appear to affect birth rates, size or growth of offspring or peripubertal 





Society for the Study of Reproduction. San Diego, USA 2016. 
 
Changes in Gestational Nutrition can Positively Affect Post Natal Indicators of Fertility. 
 
Peter Smith1,2, Christy Rand2, Laurel Quirke1, Jennifer Juengel1,  and Jo-Ann Stanton2 
1. AgResearch Invermay, Mosgiel New Zealand; 2. Dept of Anatomy, University of Otago, 
Dunedin, New Zealand 
 
While many studies report negative impacts on fertility following gestational under nutrition, 
we describe positive effects on indicators of female fertility in offspring following nutritional 
restriction of the dam during early pregnancy. Ewes (n=79) were housed indoors and fed either 
a maintenance diet (n=39) or a diet equivalent to 0.6 of maintenance (n=40) for the first 55 days 
of gestation. At day 55 animals were returned to pasture provided ad-lib. Female fetuses were 
recovered at day 55 (6 per group), and day 75 of gestation (6 per group) with one ovary 
processed for histology and one used for RNAseq analysis. Remaining animals (37) progressed 
to lambing, and female offspring (17 maintenance, 13 restricted) were monitored through to 
their second breeding season (approximately 2.5 years of age). Progesterone, FSH and LH 
concentrations were measured by radioimmunoassay.  Statistical procedures were applied using 
the Genstat software package. Over the 55 days of gestation, restricted animals lost 5kg of body 
weight while maintenance animals gained 2kg (p<0.01). From 55-75 days, restricted animals 
gained 6.5kg and maintenance animals gained 2.8kg (p<0.01). At two years of age 
ultrasonography showed ewes from restricted dams had increased antral follicle counts (9.6 vs 
6.8, p<0.05) and increased ovulation rates (2.0 vs 1.6, p<0.05). Further, these animals also 
showed increased concentrations of progesterone during the luteal phase (p<0.05). While no 
overall effect of group was observed on FSH concentrations, a significant group x day of cycle 
interaction was noted (p<0.05). Nutritional group did not affect LH pulse characteristics. 
Stereological analysis of fetal ovaries did not detect differences in germ cell numbers at day 55 
of gestation. However, at day 75, fetuses from restricted dams had significantly more germ cells 
compared to controls (1,122,285 vs 766,344, p<0.05). RNAseq analysis of fetal ovaries 
collected on day 55 of gestation showed 100 differentially expressed (q<0.05) genes, of which 
33 were down regulated and 67 were up regulated. At day 75, 145 genes were differentially 
expressed (q<0.05) of which 50 were down regulated and 95 were up regulated. At day 55 
Ingenuity Pathway Analysis (IPA, Qiagen) identified the top functions affected as being lipid 
release, gonadogenesis and cell generation. At day 75, IPA identified the top functions affected 
as being quantity of oocytes, gonadogenesis and cell death. At both day 55 and 75 of gestation 
differentially expressed genes of particular interest included the germ cell specific genes 
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MATER, NOBOX, PADI6, and ZP3.  Additionally at day 75 FIGLA and MAEL were also 
differentially expressed. These data indicate that manipulating gestational nutrition has the 
potential to increase fertility in female offspring. Additionally, the data is consistent with the 
hypothesis that the underlying mechanisms responsible for the effects of gestational nutrition 
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The relationship between maternal under-nutrition and reduced post-natal fertility in female 
offspring has been the subject of numerous studies and reviews. Results vary markedly between 
studies, dependent on timing and severity of nutrition restriction, and the species studied. It is 
clear however, given the right conditions, that maternal under-nutrition can negatively impact 
the fertility of female offspring. In this study female sheep (n=40) were housed indoors and fed 
a diet equivalent to 0.6 of maintenance for 55 days from the day of mating. Under the same 
conditions control animals were fed a maintenance diet. At day 55 of gestation all animals were 
moved to pasture and fed ad-lib. Fetal ovaries were recovered at day 55 and 75 of gestation. 
Stereology was used to quantify germ cells in these ovaries and IHC used to determines germ 
cell proliferation, apoptosis and autophagy. Offspring (13 restricted and 17 maintenance 
animals) were monitored until 19 months of age. Hormone and metabolic profiles were 
generated for maternal ewes and fetuses at day 75 of gestation. Antral follicle counts (AFC) 
and ovulation rates (OR) were recorded in the peri-pubertal period (8 months of age), and in 
mature ewes (19 months of age) where hormone profiles were also generated. Hormone and 
metabolic profiles were generated for maternal ewes and day 75 fetuses. 
 Maternal ewes exposed showed elevated progesterone levels throughout the restricted period. 
No differences were observed in maternal leptin or steroid concentrations. At day 55 of 
gestation restricted maternal ewes showed elevated levels of albumin and Ca2+, but lower 
creatinine levels at both days 55 and 75.No differences were observed in the metabolic factors 
measured in fetal plasma at day 75. Other than maternal progesterone concentrations there were 
no differences in either maternal or day 75 fetal plasma levels of steroids determined using 
LCMS. Day 75 fetal ovaries exposed to restricted nutrition contained more germ cells than 
control ovaries, but a lower proliferation rate (IHC using Ki-67) was observed. There were no 
differences observed in the levels of germ cell apoptosis (determined by TUNEL staining) or 
autophagy (IHC using MAPLC3) at either day 55 or day 75. Surprisingly, female offspring at 
19 months of age, but not 8 months of age, showed increases in key indicators of fertility: 
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ovulation rate (p < 0.05) and antral follicle count (AFC, p < 0.01). Additionally, these animals 
showed an increase in plasma progesterone concentration (p < 0.05) and changes to the pattern 
of FSH secretion (p < 0.05).  We propose that changes to  gestational nutrition can increase 
indicators of fertility in female offspring and that this  may be the result of  the change from 





Manuscript 2. Submit to BMC Genomics 
Gene expression in sheep fetal ovaries exposed to changes in gestational nutrition 
Abstract 
Background: Numerous studies have shown the given the right conditions gestational under-
nutrition can have negative impacts on the fertility of the female offspring. The cohort of 
animals used in the current study produced female offspring with higher indicators of fertility 
and morphological changes to fetal ovarian development at day 75 of gestation. While fetal 
germ cell development have been implicated as a process likely to be involved in the gestational 
nutrition post-natal fertility relationship, the mechanism(s) underlying this relationship have yet 
to be clearly established. 
Results: Female sheep (n=40) were housed indoors and fed a diet equivalent to 0.6 of 
maintenance for 55 days from the day of mating (control animals were fed a maintenance diet). 
We used RNAseq and CuffDiff to differential gene expression in fetal ovaries recovered at day 
55 and 75 of gestation. Of 15,600+ sequences RNAseq reported at day 55, 69 were differentially 
expressed in fetal ovaries at day 55, and 145 sequences at day 75. Fold changes observed at day 
75 were less than those observed at day 55. Amongst differentially expressed genes, germ cell 
specific genes were prominent at both ages. Prominent Gene Ontology categories at both ages 
were ion transport and protease inhibitors. Pathways identified as affected using IPA analysis 
included some related to the arginine to nitric oxide and citrulline reaction, LXR/RXR and 
FXR/RXR activation, quantity of germ cells, GADD45 signalling, and acute phase response 
signalling. 
Conclusion: The data shows that alterations to gestational nutrition alters the transcriptome of 
the fetal ovary. Further, differential expression of germ cell specific genes reinforce the concept 
that germ cell development is a major contributor to the gestational nutrition post-natal fertility 
relationship. Finally while the precise mechanism remains unresolved the data implicates both 
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